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ABSTRACT 
 
Hybrid Polyethylene Glycol Hydrogels for Tissue Engineering  
Applications. (May 2011) 
Dany Jair Munoz Pinto, B.S, Universidad Industrial de Santander 
Chair of Advisory Committee: Dr. Mariah Hahn 
 
Currently, organ transplant procedures are insufficient to address the needs of the 
number of patients that suffer of organ failure related disease. In the United States alone, 
only around 19% of the patients are able to get an organ transplant surgery and 25% die 
while waiting for a suitable donor. Tissue engineering (TE) has emerged as an 
alternative to organ transplant; thus, the aim of the present study was to validate a 
poly(ethylene glycol) diacrylate (PEG-DA) hydrogel system as a model for material 
scaffolding in TE applications. 
This work explores the influence of scaffold material properties on cell behavior. 
Specifically, scaffold modulus, mesh size, and biochemical stimuli were characterized 
and their influence on cell response was analyzed at the biochemical, histological and 
microenvironmental levels. Three different TE targets were evaluated: vocal fold 
restoration, vascular grafts and osteochondral applications. 
Vocal fold fibroblast (VFF) phenotype and extracellular matrix (ECM) 
production were impacted by initial scaffold mesh size and modulus. The results showed 
increasing levels of SM-α-actin and collagen production with decreasing initial mesh 
size/increasing initial modulus, which indicated that VFFs were induced to take an 
undesirable myofibroblast-like phenotype. In addition, it was possible to preserve VFF 
phenotype in long-term cultured hydrogels containing high molecular weight hyaluronan 
(HAHMW). On the other hand, regarding vascular graft applications, smooth muscle cell 
(SMC) phenotype was enhanced by increasing scaffold mesh size and modulus. Finally, 
the effect of scaffold inorganic content (siloxane) on rat osteoblasts and mouse 
mesenchymal stem cells was evaluated. Interestingly, the impact of inorganic content on 
 iv 
cell differentiation seemed to be highly dependent on the initial cell state. Specifically, 
mature osteoblasts underwent transdifferentiation into chondrocyte-like cells with 
increasing inorganic content. However, Mesenchymal stem cells appeared to be 
preferentially driven toward osteoblast-like cells with an associated increase in 
osteocalcin and collagen type I production. 
The use of PEG-DA based hydrogels as scaffold model showed the relative 
effect of scaffold material properties on cell behavior. Therefore, desired cell phenotype 
as well as specific profile of ECM production could be potentially modulated with the 
appropriate tuning of material properties.  
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CHAPTER I 
INTRODUCTION  
 
1.1 Problem statement 
Each year millions of people around the world die of organ failure related 
diseases such as stroke, arteriosclerosis, kidney and liver failure. In the United States 
alone, around 100,000 people are enrolled in the organ transplant waiting list from which 
approximately a quarter of the patients die while waiting for a suitable donor, and only 
around 19,000 patients are able to get an organ transplant surgery [1]. Given the needs 
for organ replacement, the study of alternative treatments to organ donation constitutes a 
major challenge.  A possible alternative is tissue engineering (TE), which combines 
synthetic, natural or hybrid scaffolds with or without the incorporation of patients own 
living cells. However, the success of these engineered tissues depends on the appropriate 
design of the scaffolds properties and their interaction with living cells. 
This work focuses on the understanding of cell material interactions with the 
systematic and controlled design of material properties and their isolated effect on cell 
response for 3D tissue engineering applications: vocal fold restoration, small diameter 
vascular graft, and bone regeneration.      
Cell responses were analyzed at the biochemical, histological and microstructural 
levels. The specific aims for this work were: 
     
 Quantitatively characterize cell density, collagen type I and III in the human 
midmembranous vocal fold lamina propria. 
 Investigate the effects of the initial scaffold elastic modulus and mesh size on 
encapsulated vocal fold fibroblast and smooth muscle cells responses. 
 Validate a 3D model system for probing the effects of hyaluronan molecular 
weight on vocal fold fibroblast behavior. 
 
____________ 
This dissertation follows the style of Tissue Engineering: Part A. 
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 Analyze the effect of scaffold inorganic content on mesenchymal cell fate and 
differentiation. 
 
The achievement of these goals attempts to highlight the relevance of scaffold 
properties on cell behavior and tissue regeneration. This work represents a novel strategy 
for the tuning and optimization of scaffold properties for tissue engineering applications 
in a 3D context, which was accomplished by the use of polyethylene glycol hybrid 
hydrogels as a material platform.  The implementation of this innovative approach can 
bring to light the relative influence of different material properties on cell response, 
which in turn allows for the analysis of the individual impact of each property in order to 
reduce the number of variables and range of stimuli applied. This understanding will 
contribute to the creation of more efficient scaffolds capable of sustaining cell function 
based on a desired application.   
 
1.2 Background  
Tissue regeneration is a natural process that involves a very complex collection 
of interactions between cells, soluble factors and the micro-environment surrounding the 
cells. These surrounding materials are known as extracellular matrix (ECM), which is 
mostly composed of proteins and polysaccharides such as collagens, hyaluronic acid, 
and glycosaminoglycans that reside outside the cells (Figure 1.1). From a structural 
standpoint, ECM is not randomly arranged; instead, it is highly organized at the nano 
and microstructural levels, being such spatial orientation distinct from tissue to tissue. 
Initially, it was believed that ECM played a passive role, which was limited to serving as 
a structural support for tissues. However, early studies performed by Hauschka, 
Konigsberg and Hay [2] showed that ECM components were actively involved in 
differentiation, morphogenesis and cell function. The ECM started to be seen as a 
dynamic structure not only responsible for offering mechanical support to the cell, but 
also able to regulate water content, select and retain different growth factors as well as 
interact with the cells through cell receptors. 
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Figure 1.1 Model of extracellular matrix (ECM) and cell-ECM interactions* [3]. 
 
Tissue engineering applications require the adequate selection and design of 
materials that closely mimic the natural cell environment provided in vivo by the ECM. 
The active role of materials in tissue regeneration motivates the need for a better 
understanding of the relative influence of material properties on cell response. This has 
become an area of increasing interest, which is reflected on the multiple contributions 
from scientists worldwide: for instance, Benoit et al. [4] demonstrated that human 
mesenchymal stem cell (hMSC) differentiation was guided towards multiple lineages by 
small synthetic functional groups that were covalently tethered to the scaffold. On the 
other hand, Engler et al [5]. showed the relevance of matrix stiffness on cell 
differentiation in 2D systems. However, these results cannot be directly extrapolated to 
3D contexts due to the increased complexity associated with the interplay between 
variables such as mesh structure, modulus, and bioactivity.   
 
 
 
 
____________ 
*Adapted with permission from ―Bioactive modification of poly(ethylene glycol) hydrogels for tissue 
engineering‖ by Junmin Zhu, 2010, Biomaterials 31(17):4639-4656, Copyright 2010, Elsevier Limited. 
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Poly (ethylene glycol) (PEG) hydrogels can be used as a platform in 3D 
environments in order to study the isolated influence of material properties on cell 
behavior in a systematic manner. Poly(ethylene glycol) is an aliphatic polyether [6] that 
can be chemically modified by the addition of terminal vinyl groups so as to create a 
three-dimensional cross-linked hydrophilic polymer network (Figure1.2).  
 
 
Figure 1.2 Schematic representation of PEG-DA synthesis. 
 
PEG-DA in aqueous solutions can be rapidly photopolymerized in direct contact 
with cells and tissues without deleterious effects in the presence of the adequate photo-
initiator [7]. The physical properties of PEG-DA hydrogels are highly versatile and they 
vary depending on the concentration, molecular chain length, and crosslinking density 
[8]. PEG-DA is hydrophilic, biocompatible and intrinsically resistant to protein 
adsorption and cell adhesion [7]. Thus, PEG-DA hydrogels provide a ―blank slate‖ 
devoid of biological interactions. Figure 1.3 shows the ideal representation of a PEG-DA 
crosslinked network. 
 
Polyethylene glycol diacrylate (PEG-DA) 
O
CH2
O
O
O
CH2
n
+ 
O
Cl
CH2
Acryloyl choride 
HO
HO
n
PEG 
TEA, DCM 
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Figure 1.3 Idealized network for crosslinked PEG-DA** [9]. 
 
The ―blank slate‖ condition of PEG-DA can be modified by the addition of 
biomolecules (amino acid, peptides, proteins, glycosaminoglycans GAGs) that are 
covalently bound to PEG-DA chains either directly [10] or by the use of acryloyl-PEG-N 
hydroxysuccinimide [11, 12]. This exceptional ability of PEG-DA hydrogels makes 
them desirable materials for further studying the function of biomolecules and their role 
in cell behavior. 
Figures 1.4 and 1.5 present examples in which biomolecules can be chemically 
modified in order to be covalently linked onto the PEG-DA hydrogel network. Heparin, 
a highly sulfated glycosaminoglycan is conjugated with methacrylic anhydride, and 
Arginine-Glycine-Aspartic Acid-Serine, an adhesion peptide, is conjugated to acryloyl-
PEG-N hydroxysuccinimide. 
 
 
____________ 
**Reprinted with permission from ―Molecular relaxation in cross-linked poly(ethylene glycol) and 
poly(propylene glycol) diacrylate networks by dielectric spectroscopy‖ by Sumod Kalakkunnath; 
Douglass S. Kalika; Haiqing Lin; Roy D. Raharjo; Benny D. Freeman―, 2006, Polymer 48(2):579-589, 
Copyright 2006, Elsevier Limited. 
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Figure 1.4 Chemical Structure of (A) heparin and (B) methacrylated heparin*** [13]. 
 
Figure 1.5 Peptide conjugation with ACRL- PEG-NHS. 
 
Although PEG is considered a non degradable polymer, its degradation can be 
systematically tailored. Pure PEG-DA hydrogels degrade by hydrolytic cleavage of the 
ester bonds between the aliphatic PEG polymer backbone and the crosslinking units [14, 
15]. Variations in this degradation rate can be achieved by conjugating α-hydroxy acids 
or enzymatically cleavable peptides to the PEG macromer backbone [14, 16]. 
 
____________ 
***Adapted with permission from ―Heparin functionalized PEG gels that modulate protein adsorption for 
hMSC adhesion and differentiation‖ by Danielle S.W. Benoid; Kristi S. Anseth, 2005, Acta Biomaterialia 
1(4): 461-470, Copyright 2005, Elsevier Limited. 
 
+  RGDS 
PEPTIDE 
pH 8.5 
ACRL-PEG-RGDS 
A 
B 
 7 
CHAPTER II 
LAMINA PROPRIA CELLULARITY AND COLLAGEN COMPOSITION: AN 
INTEGRATED ASSESSMENT OF STRUCTURE IN HUMANS
* 
 
 
2.1 Overview 
 Objectives: In this study, we quantitatively examined cell density, collagen types 
I and III, in the human midmembranous vocal fold lamina propria (LP).  
Methods: Lamina propria samples were solubilized with proteinase K or with 
cyanogen bromide. Cell density was assessed in proteinase K digests by measuring DNA 
and normalizing it to tissue total protein. Collagen types I and III were quantified by 
enzyme-linked immunosorbent assaySbased detection of collagen typeSspecific peptides 
generated by cyanogen bromide digestion. In addition, LP total collagen was determined 
by measuring sample hydroxyproline levels.  
Results: The mean (±SEM) cell density in the LP and associated epithelium was 
approximately 0.57 ± 0.09 million cells per milligram of tissue total protein. Collagen 
type III composed an average of 34% to 40% of LP total collagen. 
Conclusions: The total cell density of the LP and associated epithelium was 
intermediate between that of hyaline cartilage and dermis. The ratio of collagen type III 
to total collagen in the LP was similar to that of highly elastic lung parenchyma and 
roughly twice that of the comparatively less-elastic dermis.  
 
 
 
 
 
____________ 
*Reprinted with permission from ―Lamina propria cellularity and collagen composition: an integrated 
assessment of structure in humans‖ by Dany Muñoz-Pinto; Peter Whittaker, PhD; Mariah S. Hahn, PhD, 
2009, Annals of Ototogy. Rhinology & Laryngology 118(4):299-306, Copyright 2009, Annals Publishing 
Company. 
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2.2 Introduction  
Characterizing the cellularity and collagen composition of the normal vocal fold 
lamina propria (LP) is important for understanding LP disease processes and for 
designing LP repair strategies. For instance, the cellular composition and density within 
tissues are frequently altered in growth, aging, disease, and repair [17]. Several studies 
have histologically evaluated the relative abundance of the various cell types 
(fibroblasts, myofibroblasts, macrophages) composing the midmembranous LP [18]. 
Although these studies indicate that fibroblasts constitute approximately 80% of the cells 
within the normal adult human LP, the cell density (cells by tissue weight or volume) 
characteristic of normal LP has not yet been quantified. A primary aim of the present 
study was therefore to measure the total cell density in the human LP and associated 
epithelium.  
As with cell density, the relative abundance of the various collagen types is 
altered in a number of physiological and pathological processes [19]. These changes in 
collagen type composition can have a profound impact on tissue mechanical properties 
[20]. Although at least 27 different collagen types have been identified, [20] the fibrillar 
collagen types I, II, and III constitute 80% to 90% of total collagen in most tissues [21]. 
A number of studies have investigated collagen types in the LP. These qualitative 
histology studies indicate that collagen types I and III are the dominant collagens in the 
midmembranous LP, [22-25] collagen types IV and V also present in localized regions 
[23-25]. However, the relative levels of these collagen types have not yet been 
quantitatively evaluated. An additional aim of the current work was therefore to quantify 
the collagen composition of the vocal fold LP, with a focus on collagen types I and III. 
 
2.3 Material and methods 
2.3.1 Tissue procurement and preparation  
 Fifteen human larynges were obtained from Massachusetts General Hospital 
(MGH; Boston, Massachusetts), Clinomics Biosciences (Pittsfield, Massachusetts), and 
the National Disease Research Interchange (Philadelphia, Pennsylvania). The human 
 9 
donors had no known medical history of vocal fold surgery or chronic voice disorders. 
All larynges were placed in neutral buffered formalin within 24 hours of death and 
remained in formalin for 1 day to 6 months, depending on the source of the specimen. 
One specimen of human lung parenchyma (MGH) and 3 specimens of porcine hyaline 
cartilage (Research 87, Inc, Cambridge, Massachusetts) were processed as controls for 
the collagen type and cellularity assays, respectively. All tissues were procured with the 
approval of and in accordance with institution committees on human and animal 
experimentation, respectively. For the specimens reserved for the cellularity or collagen 
type assays, the midmembranous vocal folds were retrieved and transferred to 70% 
ethanol. The underlying muscle and glandular tissues that border the LP ventricular and 
subglottic regions were then removed with the aid of a dissecting microscope. The 
remaining LP was lyophilized and stored at -80°C until the time of analysis. Further 
information on each specimen is provided in the Table 2.1.  
 
Table 2.1 Vocal fold specimen information. 
 SPECIMEN INFORMATION 
  Assay 
Age (y) Sex Cellularity Collagen Typing 
16 F  + 
40 F +  
40 F  + 
47 F + + 
57 F +  
81 F  + 
82 F  + 
94 F  + 
48 M +  
49 M + + 
61 M  + 
61 M +  
79 M  + 
Child* Unknown  + 
Child* Unknown  + 
*Define age unknown.  Estimated ages based on laryngeal size are 
approximately 2 years and 6 to 10 years. 
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2.3.2 Sample preparation and DNA and total protein quantitation  
 Tissue DNA content is a standard indirect measure of tissue cellularity, since 
normal diploid cells from a given species each contain characteristic levels of DNA [17]. 
Therefore, tissue DNA assessments can be translated to cell numbers by dividing by the 
DNA levels characteristic of a diploid cell. To release DNA from the 6 selected vocal 
fold samples and the hyaline cartilage controls, we added approximately 200 µL of a 
solution containing 50 µg/mL DNase-free proteinase K (Worthington Biochemical, 
Lakewood, New Jersey) in 100 mmol/L sodium acetate buffer, pH 7.0, per 1 mg of 
tissue dry weight. Digestion proceeded for 24 hours at approximately 58 °C. The DNA 
content of each digest was measured in triplicate with the PicoGreen DNA assay kit 
(Invitrogen, Carlsbad, California) according to the manufacturer instructions [17]. The 
human LP and porcine cartilage DNA levels were converted to cell numbers by dividing 
by 6.9 pg DNA per cell or by 6.6 pg DNA per cell, respectively [26]. As a normalization 
measure for the DNA assessments, sample total protein was quantitated in triplicate by 
AAA Service Laboratory, Inc (Boring, Oregon). 
 
2.3.3 Collagen type assessments   
As collagen becomes increasingly cross-linked, it becomes more difficult to fully 
extract from tissue while simultaneously preserving information required distinguishing 
individual collagen types [27, 28]. One approach that enables this type of extraction is 
cyanogen bromide (CNBr)-based digestion [27, 29]. In the presence of 70% formic acid, 
CNBr cleaves collagen molecules at methionine residues, yielding peptide fragments 
that are characteristic of each collagen type [27, 29]. In addition, CNBr digestion can 
solubilize approximately 90% of total collagen from highly cross-linked tissues. We 
therefore used CNBr-based digestion in the present study, and resultant collagen type I 
and type III peptides were quantified by enzyme-linked immunoabsorbent assay 
(ELISA). 
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 Sample digestion. We conducted CNBr digestion according to a modification of 
the method of Light [27].  In brief, 11 LP samples (9 from adults and 2 from children) 
were transferred to 2-mL screw-cap tubes containing 1 mL of stainless steel beads (3.2-
mm diameter, Biospec Products, Inc, Bartlesville, Oklahoma) and 1 mL of 70% formic 
acid. The tubes were then inserted into a Bead-beater homogenizer (Biospec Products, 
Inc) and were shaken at the highest speed setting in two 10-second bursts with an 
intervening 1-minute period on ice. A 100-mg/mL stock solution of CNBr (MP 
Biomédicals, Solon, Ohio) in 70% formic acid was prepared, and argon was bubbled 
into the solution for 1 minute. One hundred microliters of this solution was added to 
each sample tube. Digestion was allowed to proceed at room temperature for 24 hours, 
after which samples were dried (and formic acid and CNBr evaporated) in a Centrivap 
(Labconco, Kansas City, Missouri). Fresh 70% formic acid and CNBr were added to the 
dried samples, and a second 24-hour digestion cycle was conducted. The samples were 
then dried as described above. To remove residual formic acid and CNBr, we 
resuspended the dried samples in 1 mL deionized water and dried them again. This cycle 
of rehydration and drying was repeated twice, after which 600 µL of deionized water 
was added to each dried sample. The samples were then vortexed and centrifuged at 
8,000g for 10 minutes. Aliquots of the supernatant were used in collagen type I and III 
immunoassays and for total collagen quantification. Collagen Type I and III 
Immunoassays. Aliquots of CNBr-solubilized samples were diluted in phosphate- 
buffered saline solution (PBS) and passed through a charcoal-packed centrifugal 
microcolumn (Nunc, Rochester, New York). One hundred microliters of each filtered 
sample was applied to a high-binding 96-well enzyme immunoassay plate (Corning, 
Lowell, Massachusetts) for 3 hours at room temperature. Each well was then blocked for 
3 hours with 300 µL of a 3 weight percent (wt%) solution of bovine serum albumin 
(BSA) in PBS (3 wt% BSA). For detection of collagen type III, an antibody specific for 
a collagen type III peptide released by CNBr digestion (Calbiochem, San Diego, 
California) was diluted 1:100 in 3 wt% BSA, and 100 µL of the resultant solution was 
applied to each sample well for 1 hour at room temperature. After application of donkey 
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anti-rabbit horseradish peroxidase (HRP) secondary antibody (1:1,000 in 3 wt% BSA, 
Jackson ImmunoResearch, West Grove, Pennsylvania), 100 µL of 2,2'-azino-bis(3-
ethylbenzotbiazoline-6-sulfonic acid) (Sigma-Aldrich, St Louis, Missouri) was added to 
each well. After 20 minutes of incubation, color development was quenched with an 
equal volume of a 1% sodium dodecyl sulfate solution and well absorbance was read at 
410 nm. To quantify collagen type I, we repeated the above procedure, except that we 
applied an antibody specific for a collagen type I peptide preserved in CNBr digestion 
(Clone H-197, Santa Cruz Biotechnology, Santa Cruz, California), followed by a bovine 
antigoat HRP secondary antibody (Jackson ImmunoResearch). Purified human collagen 
type I and collagen type III (Rockland Immunochemicals, Gilbertsville, Pennsylvania) 
that had been subjected to the same CNBr digestion conditions as the samples served as 
standards and as negative controls (for the antibody of the opposite collagen type). Each 
sample was measured in duplicate for collagen type I and in triplicate for collagen type 
III. 
Hydroxyproline analyses. The total collagen levels in all CNBr-solubilized 
samples were assessed in duplicate by a standard colorimetric assay for hydroxyproline 
(OHPr), an amino acid found almostexclusively in collagen [30]. Aliquots of the CNBr 
solubilized fraction of each specimen were digested with 6 mol/L hydrochloric acid for 
24 hours at 100°C to convert proteins into free amino acids. Each sample was then dried 
on a Labconco Centrivap to remove hydrochloric acid, resuspended in deionized water, 
and passed through a charcoalpacked centrifugal microcolumn (Nunc). The resultant 
samples were reacted with chloramine T and p-dimethylbenzaldehyde reagents, and 
sample color development was read at 550 nm [31]. L-4-OHPr (Sigma-Aldrich) was 
used as a standard. The conversion factors for relating measured grams of OHPr to 
grams of collagen type I or collagen type III are 0.125 and 0.15, respectively [30]. 
Similarly, the corresponding conversion factor for collagen type IV is 0.135. Therefore, 
the appropriate conversion factor relating OHPr to total collagen depends on the 
collagen type composition of the tissue.  
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Calculation of fraction of collagen type III. For each adult human LP sample, the 
ratio of collagen type III to total collagen was calculated according to two methods, each 
involving a different set of assumptions: Fraction 1 = [mg type IIIELISA]/[(mgtotal 
OHPr)/0.135], and Fraction 2 = [mg type IIIELISA]/[mg type IELISA + mg type 
IIIELISA]. Fraction 1 assumes, via use of an OHPr conversion factor of 0.135, that 
collagen types I and III are present in roughly equal proportion. However, this 
conversion factor also leaves room for other collagen types (ie, the 0.135 conversion 
factor holds for a tissue containing 50% collagen type I, 33% collagen type III, and 17% 
collagen type IV, as well as for a tissue containing 40% collagen type I, 27% collagen 
type III, and 33% collagen type IV). In contrast, fraction 2 assumes collagen types aside 
from I and III to be negligible contributors to LP total collagen. The degree of agreement 
between these two fractions gives insight into the dominance of collagen types I and III 
in the LP. For the lung parenchymal controls, an OHPr conversion factor of 0.130 [29] 
was used in calculating fraction 1. 
 
2.4 Results 
Based on DNA assessments, the LP and associated epithelium contained 
approximately 0.57 ± 0.09 million cells per milligram of tissue total protein (Figure 
2.1A). This translates to approximately 57 ± 9 million cells per gram of tissue wet 
weight (per g ww), assuming the LP contains similar protein levels by wet weight 
(approximately 10%) as other loose connective tissues. By the same assumption, hyaline 
cartilage contains approximately 17 million cells per g ww (Figure 2.1A), in line with 
previous literature [17]. Approximately 33.6% ± 6.5% of total collagen in the adult LP 
specimens was collagen type III, according to the combined OHPr and collagen type III 
ELISA results (fraction 1; Figure2.1B). In contrast, the combined collagen type I and 
collagen type III ELISA results indicated that collagen type III constituted 
approximately 40.4% ± 2.7% of adult LP total collagen (fraction 2; Figure 2.1B). The 
collagen in the child LP samples contained 5.5% ± 2.8% to 8.4% ± 1.5% collagen type 
III (fraction 1 and fraction 2, respectively). For the human lung parehchyma control, 
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fraction 1 was determined to be 0.170 and fraction 2 to be 0.320, in agreement with the 
most recent literature values for these quantities of approximately 0.22 ± 0.08 and 
approximately 0.24 ± 0.08, respectively [29]. 
 
 
Figure 2.1. Cellularity and collagen type. (A) Total cells per mg tissue total protein in human LP and in 
hyaline cartilage. * indicates significant difference, p < 0.05. (B) The average fraction LP total collagen 
comprised by collagen type III as calculated by two separate methods. 
 
 
2.5 Discussion 
This study quantitatively examined cell density, collagen types I and III, in the 
humanmidmembranous vocal fold LP. Based on DNA assessments, the total cell density 
in the human LP and associated epithelium was ~57 ± 9 million cells per g ww, ~3.3 
times greater than that of the hyaline cartilage control. This value should be regarded as 
an upper bound on LP fibroblast density, since vocal fold epithelial cells contributed to 
themeasured cell density in addition to LP fibroblasts, myofibroblasts and macrophages. 
We can estimate LP fibroblast density from the measured total cell density using 
information regarding average vocal fold epithelial thickness and LP geometry provided 
in literature. Assuming the vocal fold epithelium consists of a 4 layer thick sheet [32] of 
continuous ~10 μm x 10 μm squamous cells and that the underlying LP is ~1.1 mm 
thick, [33] epithelial cells comprise ~60% of the measured total cell number. According 
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to the results of Catten et al., [34] ~80% of the remaining ~23 million cells per g ww are 
fibroblasts. Thus, the human LP can be estimated to contain ~18 million fibroblasts per g 
ww. This fibroblast cell density is similar cell density of hyaline cartilage, a relatively 
low cell density connective tissue. As an additional comparison, human papillary dermis 
contains ~100x106 fibroblasts per g ww [35]. Thus, the present results support the view 
of the vocal fold LP as a relatively low cell density connective tissue. Furthermore, the 
above estimate of LP fibroblast cell density is in good agreement with that predicted by 
the results of Catten et al. [34]. Although the latter reported cell count data relative to 
―imaged field‖ (IF) rather than relative to tissue wet weight, we can use incidental 
information included in the manuscript to approximate cells per g ww from measured 
cells per IF. These calculations indicate average LP fibroblast cell density to be ~21 ± 4 
million cells per g ww [34]. 
 Based on combined OHPr and collagen type III ELISA assessments, collagen 
type III constitutes ~34% of total adult LP collagen (fraction 1). These results are further 
underscored by the combined collagen type I and collagen type III ELISA measures, 
which indicate that collagen type III composes ~40% of total adult LP collagen (fraction 
2). The degree of agreement between these two calculations for the fractional presence 
of collagen type III suggests that collagen types I and III are the dominant collagen types 
within the adult LP. Interestingly, the child LP appears to have significantly lower 
collagen type III content than the adult LP, with child LP collagen containing less than 
10% collagen type III. To place these results in context, the percent that collagen type III 
comprises of total collagen types I and III is ~15% in the dermis [36] but is 24-33% in 
the relatively more elastic lung parenchyma [28, 29]. Since collagen type III tends to be 
more highly concentrated in dynamic/elastic tissues, [19] alterations in collagen type III 
presence in disease, repair, or aging [19, 27] may impair the elasticity critical to normal 
LP function. 
Due to limited sample number (n = 9 adult LP samples, n = 2 child LP samples), 
care should be taken in making generalizations based on the present collagen type data. 
In addition, the average donor age of the adult tissues used for collagen typing was 61 
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years, and thus the degree to which the present results are representative of normal 
healthy adult LP awaits confirmation. The same caveats regarding limited sample size 
and age apply to the cellularity (n = 6).  
In summary, our study provides the first quantitative measures of cell density and 
collagen type in human midmembranous LP.  
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CHAPTER III 
INFLUENCE OF HYDROGEL MECHANICAL PROPERTIES AND MESH SIZE 
ON VOCAL FOLD FIBROBLAST EXTRACELLULAR MATRIX 
PRODUCTION AND PHENOTYPE
*
 
 
 
3.1 Overview 
Current clinical management of vocal fold (VF) scarring produces inconsistent 
and often suboptimal results. Researchers are investigating a number of alternative 
treatments for VF lamina propria (LP) scarring, including designer implant materials for 
functional LP regeneration. In the present study, we investigate the effects of the initial 
scaffold elastic modulus and mesh size on encapsulated VF fibroblast (VFF) 
extracellular matrix (ECM) production toward rational scaffold design. Poly(ethylene 
glycol) diacrylate (PEG-DA) hydrogels were selected for this study since their material 
properties, including mechanical properties, mesh size, degradation rate and bioactivity, 
can be tightly controlled and systematically modified. Porcine VFF were encapsulated in 
four PEG-DA hydrogels with degradation half lives of ~25 days, but with initial elastic 
compressive moduli and mesh sizes ranging from ~30 to 100 kPa and from ~9 to 27 nm, 
respectively. After 30 days of static culture, VFF ECM production and phenotype in 
each formulation was assessed biochemically and histologically. Sulfated 
glycosaminoglycan synthesis increased in similar degree with both increasing initial 
modulus and decreasing initial mesh size. 
 
 
 
 
____________ 
*Reprinted with permission from ―Influence of hydrogel mechanical properties and mesh size on vocal 
fold fibroblast extracellular matrix production and phenotype‖ by Huimin Liao a, Dany Munoz-Pinto, Xin 
Qu, Yaping Hou , Melissa A. Grunlan, Mariah S. Hahn, 2008, Acta Biomaterialia 4 (2008) 1161–1171, 
Copyright 2008, Acta Materialia Inc. Published by Elsevier Ltd. 
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In contrast, elastin production decreased with increasing initial modulus but increased 
with decreasing initial mesh size. Both collagen deposition and the induction of a 
myofibroblastic phenotype depended strongly on initial mesh size but appeared largely 
unaffected by variations in initial modulus. The present results indicate that scaffold 
mesh size warrants further investigation as a critical regulator of VFF ECM synthesis. 
Furthermore, this study validates a systematic and controlled approach for analyzing 
VFF response to scaffold properties, which should aid in rational scaffold 
selection/design. 
 
3.2 Introduction  
Although no firm statistics exist, voice disorders, including scarring of the vocal 
fold (VF) lamina propria (LP), are estimated to affect 3-9% of the population to various 
degrees [37]. The VFs are paired, multi-layered structures (Figure 3.1), each consisting 
of underlying muscle, followed by the LP and overlying epithelium [38]. When the VFs 
are brought together by the intrinsic laryngeal muscles, they can be set into vibratory 
motion by airflow from the lungs. Ordered oscillation yields efficient cycle-to-cycle 
closure of the VFs and high quality voice [39]. The human LP is generally subdivided 
into superficial (SLP), intermediate (ILP), and deep (DLP) layers (Figure 3.1) [40, 41]. 
At normal pitch and loudness, the SLP is believed to ―slide‖ over the ILP, undergoing 
the high frequency and strain excursions required for cyclic VF closure [40, 41]. When 
the pliability and physical volume of the VF SLP are reduced by scarring, voice changes 
ranging from hoarseness to complete voice loss result, depending on the severity of scar 
[39, 42-44].  
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Figure 3.1. Schematic of a coronal section through the human vocal folds.  
 
VF scar has proven difficult to treat with current surgical techniques and standard 
augmentation substances (e.g., collagen and fat) [39, 42, 45]. As such, researchers are 
actively exploring alternative treatment routes, including the development of designer 
implants for functional LP regeneration [46-51]. Although it is understood that scaffold 
properties, such as bioactivity, [52] mesh size, [53] mechanical properties, [54-56] and 
degradation rate [57] critically impact cell behavior, it has proven difficult to directly 
attribute alterations in VF fibroblast (VFF) response to specific changes in scaffold 
parameters. This situation has hampered rational selection/design of implant materials 
for LP regeneration. The aim of the present study is validate an approach for the 
systematic and quantitative assessment of the influence of scaffold properties on VFF 
behavior. Specifically, the current work focuses on the impact of initial scaffold mesh 
size and mechanical properties on VFF extracellular (ECM) production and phenotype. 
Ultimately, these data will be applied toward the rational design of LP regeneration 
matrices.  
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Central to these studies is the selected scaffold material: poly(ethylene glycol) 
diacrylate (PEG-DA). PEG-DA hydrogels have several properties which make them 
appropriate for systematic exploration of cell response to specific alterations in scaffold 
material properties. Pure PEG-DA hydrogels function as biological ―blank slates,‖ 
meaning that they do not significantly adsorb bioactive plasma proteins. Thus, these 
hydrogels do not promote cell interaction without the specific conjugation of 
biochemical stimuli to the scaffold [58]. This is significant since most synthetic and 
natural scaffolds adsorb a range of bioactive proteins from serum (in the in vitro setting) 
or from plasma (in the in vivo setting). These adsorbed proteins are often major 
determinants of cell behavior, in addition to any bioactive moiety deliberately 
conjugated or adsorbed to the scaffold [59, 60]. In contrast, the biological ―blank slate‖ 
nature of PEG-DA hydrogels permits the controlled and defined investigation of 
bioactivity on cell behavior. In the present study, we explored the effects of initial PEG-
DA scaffold modulus and mesh size in the presence of constant initial levels of cell 
adhesion peptide, RGDS, thus removing initial scaffold bioactivity as a design variable 
[61]. 
An additional benefit of PEG-DA hydrogels is the ability to tune their initial 
mesh size and mechanical properties over a broad range simply by varying the molecular 
weight (MW) and/or concentration of PEG-DA [62]. Moreover, the degradation rate of 
PEG-based hydrogels can be systematically tailored. Pure PEG-DA hydrogels degrade 
by hydrolytic cleavage of the ester bonds between the aliphatic PEG polymer backbone 
and the crosslinking units [14, 15]. Variations in this degradation rate can be achieved by 
conjugating α-hydroxy acids or enzymatically cleavable peptides to the PEG macromer 
backbone [14, 16]. Thus, PEG-based hydrogels have the property that their bioactivity, 
mesh size, modulus, and degradation rate can each be systematically tuned, [53, 57, 62] 
a critical property for the proposed studies. 
In the present work, porcine VFF were encapsulated in four PEG-DA hydrogel 
formulations with initial elastic compressive moduli ranging from ~30 to 100 kPa and 
with initial mesh sizes ranging from ~9-27 nm. To simplify the investigation of the 
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dependence of VFF ECM synthesis and phenotype on scaffold properties, PEG-DA 
hydrogel formulations with similar degradation rates were selected [15]. After 30 days of 
static culture, VFF collagen, elastin, and sulfated glycosaminoglycan (sGAG) production 
as well as VFF phenotype in each hydrogel formulation were analyzed using 
biochemical and histological techniques. 
 
3.3 Materials and methods 
3.3.1 Polymer synthesis 
PEG-DA was prepared as previously described [63] by combining 0.1 mmol/ml 
dry PEG (8 kDa or 10 kDa, Fluka), 0.4 mmol/ml acryloyl chloride, and 0.2 mmol/ml 
triethylamine in anhydrous dichloromethane (DCM) and stirring under argon overnight. 
The resulting solution was washed with 2 M K2CO3 and separated into aqueous and 
DCM phases to remove HCl. The DCM phase was subsequently dried with anhydrous 
MgSO4, and PEG-DA was precipitated in diethyl ether, filtered, and dried under 
vacuum. 
 
3.3.2 Synthesis of acrylate-derivatized peptides 
Cell adhesion peptide RGDS (American Peptide) was conjugated to an acrylated 
PEG derivative (3.4 kDa) by reaction with acryloyl-PEG-Nhydroxysuccinimide (ACRL-
PEG-NHS, Nektar) at a 1:1 molar ratio for 2 h in 50 mM sodium bicarbonate buffer, pH 
8.5 [63]. The product (ACRL-PEG-RGDS) was purified by dialysis, lyophilized, and 
stored at -20 ºC until use. 
 
3.3.3Hydrogel characterization 
Hydrogel preparation. The following four hydrogel formulations were examined: 
(1) 10wt % of 10 kDa PEG-DA (10% 10 kDa), (2) 10 wt % of 8 kDa PEG-DA (10% 8 
kDa), (3)20 wt % of 10 kDa PEG-DA (20% 10 kDa), and (4) 30 wt % of 10 kDa PEG-
DA (30% 10 kDa). Precursor solutions were prepared by dissolving PEG-DA 
macromers and ACRLPEG-RGDS in HEPES buffered saline (HBS; 10 mM HEPES, 
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150 mM NaCl, pH 7.4). The solutions were then sterilized using 0.22 μm PVDF filters, 
and 10 μl of a 300 mg/ml solution of 2,2-dimethoxy-2-phenyl-acetophenone dissolved in 
N vinylpyrrolidone was added per ml precursor solution. Each solution was poured into 
molds composed of two glass plates separated by 1.1 mm polycarbonate spacers and 
then polymerized by 2 min exposure to longwave UV light (Spectroline, ~ 6 mW/cm2, 
365 nm) [64, 65]. 
 
Hydrogel swelling. To isolate the effects of scaffold modulus and mesh size on 
VFF ECM production and phenotype, it was important that the cell density and 
bioactivity presented to the cells remain constant among formulations. Since PEG-DA 
hydrogels swell significantly post-polymerization, the amount of ACRL-PEG-RGDS 
and cellsadded to each hydrogel precursor solution had to account for the change in 
hydrogel volume with swelling. To characterize the equilibrium swelling of each 
hydrogel, PEG-DA hydrogels were prepared as described above. One cm diameter 
samples were cored from each PEG-DA hydrogel immediately following polymerization 
and weighed. The samples were then transferred to HBS supplemented with 0.05 wt % 
sodium azide (HBS-azide) and incubated at 37 ºC. After 24 h, samples were blotted and 
weighed. Since swollen PEG-DA hydrogels are primarily water, the increase in weight 
with swelling can be directly related to the increase in gel volume (V) with swelling, 
i.e., 
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Hydrogel mesh size. PEG-DA hydrogel mesh size cannot be visualized using 
standard techniques such as scanning electron microscopy (SEM) [67]. Thus, a variety 
of methods to estimate PEG-DA hydrogel mesh size have been developed, including 
correlations linking measurable quantities, such as equilibrium hydrogel swelling, to 
mesh size [66, 68]. Although these correlations appear to yield reasonable mesh size 
estimates for relatively high weight percent PEG-DA hydrogels, [66, 68] the predictions 
for lower weight percent hydrogels have been called into question. Thus, in this study, 
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hydrogel mesh size was characterized via a series of dextran diffusion experiments based 
on an adaptation of the methodology of Watkins et al. [69]. 
 In brief, PEG-DA hydrogels containing 2 µmol/mL ACRL-PEG-RGDS 
postswelling were prepared and allowed to swell overnight at 37 ºC in HBS-azide. One 
cm diameter discs were cored from each hydrogel formulation. Fluorescently-labeled 
dextrans (10 kDa, 20 kDa, 40 kDa, 70 kDa, or 150 kDa, Sigma) were dissolved at 0.01 
mg/mL in HBS-azide and added at 1 mL per hydrogel disc (3 discs per dextran MW). 
Dextran solutions were allowed to diffuse into the hydrogels for 24 h at 37 ºC. Each gel 
disc was gently blotted and transferred to 1 mL fresh HBS-azide. Dextran that had 
penetrated into the hydrogels was then permitted to diffuse out into the surrounding 
solution at 37 ºC. After 24 h, the fluorescence of the HBS-azide solution surrounding 
each disc was measured at ex/em 488/532. Dextran standard curves were used to convert 
each fluorescence signal to a concentration.  
For the 30% 10 kDa hydrogel formulation, the dextran readings fell to 
background levels for dextran Mws exceeding 20 kDa (data not shown). The 20 kDa 
dextran had a mean hydrodynamic radius of ~3.2 nm, whereas the next largest dextran 
investigated (40 kDa) had a mean hydrodynamic radius of ~4.5 nm. Thus, the mesh size 
of the 30% 10 kDa hydrogel was taken to be ~(2 x 4.5) = 9 nm. The mesh sizes of the 
remaining formulations were calculated relative to that of the 30% 10 kDa hydrogel as 
follows. For each hydrogel formulation, the measured concentration readings for each 
dextran Mw were divided by gel thickness and then plotted versus dextran hydrodynamic 
radius [70]. The area (A) under the resulting curve served a quantitative indicator of 
hydrogel permissivity over the hydrodynamic radii range assayed. For a given hydrogel 
(x), the mesh size (ξ) could then be calculated according to the following 
equation:  nm
A
A
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x
x 9
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 Hydrogel mechanical properties. To assess the mechanical properties of the 
selected PEG-DA formulations, hydrogels containing 2 µmol/mL ACRL-PEG-RGDS 
postswelling were prepared and allowed to swell at 37 ºC. After 48 h swelling, three 
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samples, each 1.25 cm in diameter, were cored from each hydrogel and mechanically 
tested under unconstrained compression at room temperature using a DMA 800 (TA 
Instruments). During mechanical testing, samples were immersed in silicone oil to 
prevent hydrogel dehydration. Following application of a 0.01 N preload, each hydrogel 
was subjected to 10 μm cyclic compression (~1% cyclic strain) at frequencies of 0.01-
100 Hz (100 Hz being the system maximum) The higher frequency testing conditions 
were selected to approach the frequencies of cyclic LP loading experienced during 
phonation [71]. The elastic and viscous compressive moduli of each hydrogel 
formulation were extracted from the resulting stress-strain data. In assessing the impact 
of initial scaffold properties on VFF ECM production and phenotype, the elastic 
compressive modulus of each hydrogel formulation at 0.01 Hz (approximately static 
conditions) was utilized since static culture conditions were employed. In evaluating the 
initial mechanical properties of each PEG-DA hydrogel relative to those of the VF LP, 
hydrogel elastic compressive moduli data at 40 Hz (mechanical measures above 40 Hz 
being neglected due to data quality limitations) were compared to literature values of LP 
elastic shear moduli at similar frequencies [71]. The fact that PEG-DA hydrogels can be 
considered homogenous and isotropic was used in these comparisons [15, 72]. For 
homogenous, isotropic materials, the elastic compressive modulus (E) is related to the 
elastic shear modulus (G) by the following relationship: G = E/(2+2υ), where υ is the 
hydrogel Poisson ratio. For polymeric hydrogels, υ ~ 0.5, and thus, G = E/3 [15]. 
 
Hydrogel degradation rate. A PEG-DA hydrogel is a 3D network of inter-
crosslinked PEG-DA macromers. The modulus and mesh size of this hydrogel is 
intimately related to the organization and density of these crosslinks. As PEG-DA 
hydrogels degrade hydrolytically, the crosslinks among PEG-DA chains are broken, 
resulting in a decrease in hydrogel modulus and a corresponding increase in hydrogel 
mesh size [73]. At the low cell densities used in the present study (~0.5x106 cells/mL), 
change in hydrogel modulus with time can be assumed to be dominated by the 
hydrolytic degradation of the hydrogel network rather than by ECM deposited by 
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encapsulated cells. Thus, by monitoring the change in construct mechanical properties 
with time, the degradation rate of each hydrogel network can be assessed. 
To confirm that our initial assumption that selected hydrogels had similar 
degradation rates, the compressive elastic modulus of each hydrogel formulation at day 
30 was assessed according to the methodology described above. The resulting modulus 
data were compared to the corresponding measures at day 0 to determine a degradation 
half-life for each hydrogel formulation assuming first-order degradation kinetics [73]. 
 
3.3.4 Cell culture 
Frozen VFF at passage 3 (provided by Robert Langer, ScD)[31] were thawed and 
cultured at 37 ºC/5% CO2 in DMEM supplemented with 10% FBS, 1 mg/L bFGF, 100 
U/mL penicillin, and 100 mg/L streptomycin (Hyclone). These VFF were isolated via 
primary explantation from the mid-membranous LP of 6-12 month old pigs, a common 
animal model for the human VF LP [74]. The discarded animal tissue was obtained via 
the MIT Division of Comparative Medicine with the approval and according to the 
guidelines of the MIT animal care committee. 
 
3.3.5 Cell encapsulation and hydrogel maintenance 
VFF at passage 8-9 were harvested and resuspended in each precursor solution 
such that the post-swelling cell density would be ~0.5x106 cells/mL. A low cell density 
was selected so that the evolution in each hydrogel modulus with time could be 
attributed primarily to scaffold degradation. ACRL-PEG-RGDS was added to each 
precursor solution so that the concentration of RGDS in the swollen hydrogel would be 2 
μmol/mL. The cell-precursor solution mixtures were photopolymerized into hydrogels as 
described above. The hydrogel slabs were transferred to Omnitrays (Nunc) fitted with 4 
sterile polycarbonate bars to simultaneously prevent gel flotation and prevent gel contact 
with the tray bottom. Gels were immersed in DMEM supplemented with 10% FBS, 100 
U/mL penicillin, and 100 mg/L streptomycin and maintained at 37 ºC/5% CO2. Media 
was changed every two days. At day 30 of culture, a series of 1.25 cm diameter samples 
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were collected from each hydrogel formulation for biochemical, histological and 
mechanical analyses. Mechanical analyses were conducted as described above. 
 
3.3.6 Biochemical analyses 
Samples harvested for biochemical analyses were transferred to screw-cap vials, 
weighed, flash-frozen in liquid nitrogen, and stored at -80 ºC. At time of analysis, 
hydrogel samples were digested for 24 h at 37 ºC in 1 ml of 0.1 M NaOH per 0.2 g 
hydrogel wet weight [75]. The samples were then centrifuged (10,000xg for 10 min), 
and aliquots were taken for DNA and sGAG quantification. Any material pelleted during 
centrifugation was resuspended by vortexing, and additional hydrolysis was carried out 
by transferring the samples to a 100 ºC oven for 90 min to solubilize collagen but not 
elastin [75]. These samples were then centrifuged (10,000xg for 10 min), and the 
supernatant was retrieved for collagen quantification. The pellets (containing elastin) 
were washed with dIH2O at least four times and stored at -80 ˚C until use. 
 
DNA analysis. Aliquots of the hydrolyzed samples (n = 6 per formulation) were 
neutralized and their DNA content determined using the PicoGreen assay (Invitrogen) 
[75]. DNA measures were translated to cell number using a conversion factor of 6.6 pg 
DNA per cell [76]. Calf thymus DNA (Sigma) served as a standard. 
 
Sulfated GAG analysis. sGAG production was measured using a modification of 
the Blyscan assay (Biocolor). In brief, 80 μL of each sample digest (n = 4 per 
formulation) was neutralized, mixed with 120 μL Blyscan dye reagent, and the 
absorbance at 525 nm immediately measured relative to chondroitin sulfate B (Sigma). 
 
Collagen analysis. Levels of hydroxyproline were quantified as an indirect 
measure of total collagen. In brief, supernatants (n = 3-4 per formulation) collected for 
collagen quantitation were hydrolyzed for 18 h at 110 ºC in 6 M HCl. Hydrolyzed 
samples were then dried (Centrivap, Labconco) followed by resuspension in dIH2O and 
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reaction with chloramine T and p-dimethylbenzaldehyde reagents [31]. Sample 
absorbance was read at 550 nm relative to that of L-4-hydroxyproline (Sigma) [31]. 
Total collagen content was estimated from measured grams of hydroxyproline by 
dividing by 0.13 [77]. 
 
Elastin analysis. Elastin levels were determined according to the procedure 
detailed in Long et al.48 Briefly, material pelleted following 100 °C NaOH exposure 
was further digested in 6 M HCl at 110 ºC for 18 h. Samples (n = 3 per formulation) 
were then dried (Centrivap, Labconco), and the resulting free amino acids were 
dissolved in 100 μl of 0.1M sodium citrate buffer (pH 5.0). Following addition of an 
equal volume of ninhydrin reagent (Sigma), samples were boiled for 15 min, cooled, and 
their absorbance read at 570 nm. Hydrolyzed α-elastin (MP Biochemicals) was used as 
the standard. 
The ninhydrin-based elastin readings were verified for a subset of samples (n = 2 
per formulation) using direct ELISA [78] according to the following protocol. 
Undigested samples were hydrolyzed with 0.1 M NaOH for 24 h at 37 ºC, neutralized, 
and further digested with 0.25 M oxalic acid at 100 ºC overnight. Oxalic acid was then 
removed and exchanged for PBS using Microcon YM-3 centrifugal filters (Millipore). 
100 μL of the resulting samples were applied to a high binding EIA 96 well plate (Nunc) 
for 3 h at room temperature. After blocking the plate with bovine serum albumin, 
adsorbed elastin fragments were detected by applying elastin antibody (clone B4, Santa 
Cruz Biotechnology, SCBT) followed by donkey anti-mouse HRP secondary antibody 
(SCBT) and 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid). Absorbance was 
read at 410 nm, with bovine aortic elastin (Sigma) serving as a standard. 
For the DNA, sGAG, hydroxyproline and direct ELISA assays, the standards 
used were subjected to the same association with PEG-DA, hydrolysis, and processing 
conditions as the samples. Resulting collagen, elastin, and sGAG levels were normalized 
to cell number. 
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3.3.7 Histological analysis 
Samples collected for histological analyses were fixed with 10% formalin for 30 
min, embedded in Tissue-Tek media, and cut into 35 μm sections. ECM deposition was 
analyzed in duplicate sections for each formulation using standard immunohistochemical 
technique. In brief, sections were exposed to Terminator (Biocare Medical) for 30 min 
followed by 1 h exposure to primary antibody for elastin (B4, Sigma), fibrillin-1 (12A.5, 
LabVision), or collagen type I (Rockland) diluted in HBS. After 30 min treatment with 
Peroxidase (Biocare Medical), bound primary antibody was detected using the AEC 
Histostain-SP kit (Invitrogen). To detect GAG, sections were stained with toluidine blue 
solution (0.0714% toluidine blue, 0.0714% pyronin Y, and 0.143% borax) for 6 min and 
rinsed with distilled water [31]. Stained sections were imaged using an Axiovert A200 
microscope (Zeiss). 
To identify VFF displaying a myofibroblast-like phenotype and cells undergoing 
proliferation, immunohistochemical staining for SM-α-actin (1A4, LabVision) was 
conducted as described above. For each stained section, the number of cells which 
stained positively for SM-α-actin was counted by two separate observers relative to total 
cells in each section. To assess cell proliferation, immunostaining for PCNA (Zymed) 
was carried out. 
 
3.3.8 Statistical analyses 
All data is reported as mean ± standard deviation. Comparison of sample means 
was performed using ANOVA and Tukey`s post-hoc test (SPSS software), p < 0.05. 
 
3.4 Results 
The aim of the present study was to analyze the effects of initial scaffold mesh 
size and elastic modulus on VFF ECM production and phenotype. To isolate these 
scaffold parameters, 4 PEG-DA hydrogel formulations with similar degradation rates but 
differing moduli and mesh sizes were examined: (1) 10% 10 kDa, (2) 10% 8 kDa, (3) 
20% 10 kDa, and (4) 30% 10 kDa. Furthermore, cell adhesion peptide RGDS was 
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conjugated into each hydrogel so that scaffold bioactivity could be considered a design 
constant. 
 
3.4.1 Hydrogel mesh size, mechanical properties, and degradation rate 
To evaluate initial scaffold material properties, average mesh size was evaluated 
for each hydrogel formulation at day 0. As previously mentioned, the mesh size of PEG-
DA hydrogels cannot be visualized using conventional SEM. Thus, hydrogel resistance 
to the diffusion of dextrans of various Mws was used as a quantitative indicator of 
scaffold mesh size. The resulting mesh sizes are displayed in Figure 3.2A. As expected, 
initial mesh size increased as the weight percent of PEG-DA decreased [66, 68].  
 
 
 
Figure 3.2 Scaffold material properties. (A) Hydrogel mesh size at day 0, (B) elastic compressive modulus 
at approximately static (0.01 Hz) conditions at days 0 and 30, and (C) time-zero mesh size-elastic modulus 
sample-space. Gray dots correspond to initial mesh size-modulus combinations explored. Dashed lines are 
intended to highlight alterations in initial mesh size and modulus among the formulations. (D) Hydrogel 
elastic compressive modulus at 40 Hz at day 0. 
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To assess the initial mechanical environment experienced by encapsulated VFF 
and to confirm that the degradation rate of each hydrogel formulation was similar, the 
elastic compressive modulus of each hydrogel at ~1% cyclic strain was measured over a 
range of frequencies at day 0 and day 30. To represent the scaffold stiffness experienced 
by cells under the selected culture conditions, static (0.01 Hz) mechanical property data 
are presented in Figure 3.2B. Concordant with existing literature, hydrogel elastic 
compressive modulus at a given time-point increased significantly as PEG-DA Mw 
decreased and/or concentration increased (Figure 3.2B) [75]. Furthermore, the elastic 
moduli of all hydrogel formulations decreased significantly from day 0 to day 30 (Figure 
3.2B).  
Since the cell density in each hydrogel was low, the evolution in the elastic 
modulus of each hydrogel could be assumed to be dominated by the material degradation 
kinetics rather than by cell ECM deposition. Based on the modulus data at day 0 versus 
day 30, the mean degradation half-life of all hydrogel formulations was determined to be 
25.4 ± 3.3 days, assuming first order degradation kinetics [73]. Thus, since each 
hydrogel formulation displayed a similar degradation rate, the rate of change in hydrogel 
elastic modulus (and, hence, hydrogel mesh size) [73] could be treated as a design 
―constant‖. This allowed variations in VFF ECM deposition and phenotype with scaffold 
formulation to be evaluated relative to initial scaffold material properties without loss of 
information. VFF ECM production and phenotype will therefore be discussed 
referencing time-zero hydrogel mesh size and elastic modulus. To aid in this discussion, 
Figure 3.2C shows a map of the time-zero mesh size - modulus sample space probed in 
the present study. 
Note that the maximum initial mesh size explored was ~3 times that of the 
minimum and that the maximum initial elastic modulus was ~3.4 times the minimum. 
Thus, similar ranges of initial mesh size and of initial elastic modulus were explored in 
the present study, enhancing our ability to compare the relative impact of these two 
scaffold variables on VFF behavior. As demonstrated in Figures 3.2A, B, the initial 
mesh size and elastic modulus of hydrogels formed from PEG-DA macromers of a 
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single Mw cannot be independently modified (i.e., as the concentration of PEG-DA is 
increased from 10% to 30% for the 10 kDa PEG-DA hydrogels, the mesh size decreases 
and modulus increases). However, we can explore the effects of mesh size and elastic 
modulus in an uncoupled manner by appropriately varying both PEG-DA concentration 
and Mw. For instance, the 10% 10 kDa and the 10% 8 kDa hydrogels have similar initial 
mesh sizes but significantly different initial elastic moduli. Similarly, the 10% 8 kDa 
hydrogel and the 20% 10 kDa hydrogels have mesh sizes that differ by ~55% but elastic 
moduli which differ by only ~19%. To demonstrate that the initial mechanical properties 
of the selected hydrogels are within a stiffness range appropriate for VF LP tissue 
engineering, 40 the time-zero elastic compressive modulus of each hydrogel at 40 Hz 
(nearer adult phonatory threshold) is presented in Figure 3.2D. 
 
3.4.2 Biochemical and histological analyses 
PEG-DA constructs were harvested at day 30 for biochemical and histological 
analyses. Cell density in each formulation at day 30 was > 60% of the initial seeding 
density based upon DNA assessments, consistent with results from previous PEG-DA 
tissue engineering studies [55]. Measured collagen, elastin, and sGAG levels for each 
hydrogel formulation are given on a per cell basis in Figure 3.3 sGAG production 
increased smoothly and ~16 fold from the 10% 10 kDa to the 30% 10 kDa hydrogels (p 
< 0.032). A significant increase in collagen (p < 0.001) was observed at the transition 
between 10% 8 kDa and 20% 10 kDa hydrogels, although no further significant change 
was observed progressing from the 20% 10 kDa to the 30% 10 kDa hydrogels. Elastin 
levels increased between the 10% 8 kDa and 20% 10 kDa hydrogels (p < 0.001) but then 
decreased proceeding to the 30% 10 kDa formulation (p = 0.003). A significant increase 
in the fraction of cells expressing SM-α-actin (p = 0.019) was observed from the 10% 8 
kDa to the 20% 10 kDa hydrogels, although no further change was observed between the 
20% 10 kDa and 30% 10 kDa hydrogels (Figure 3.3). 
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Figure 3.3 Vocal fold fibroblast ECM deposition and phenotype. (A) collagen, (B) elastin, (C) sulfated 
glycosaminoglycan (sGAG), and (D) relative SM-α-actin expression at day 30 in each hydrogel 
formulation. *indicates a significant difference with the 10% 10 kDa formulation. ξ indicates a significant 
difference with the 20% 10 kDa formulation. 
 
Histological analyses of collagen, elastin, and GAG supported the biochemical 
results (Figure 3.4). To gain insight into the quality of elastic fiber formation, staining 
was also conducted for the elastin organizing microfibril, fibrillin-1. The relative 
intensity of fibrillin-1 staining among formulations corresponded closely with that of 
elastin staining, suggesting that the deposited elastin may be organizing into functional 
fibers, in contrast to elastin deposition in many tissue engineered situations [79]. 
Immunostaining for PCNA indicated heightened rates of VFF proliferation with 
increasing scaffold mesh size and/ordecreasing modulus (data not shown). 
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Figure 3.4 Representative images of staining for collagen type I, elastin, fibrillin-1, and GAG. GAG 
images are shown in grayscale to enhance contrast. Scale bars = 50μm. 
 
3.5 Discussion 
A range of scaffold properties are known to influence cell behavior, including 
bioactivity, mesh size, mechanical properties, and degradation rate [30, 53-57]. For 
controlled examination of the effects of various scaffold properties on cell behavior, we 
selected the scaffold material PEG-DA. Like many scaffolds formed from synthetic 
materials, the mechanical properties, mesh size, and degradation rate of PEG-DA 
hydrogels can be tuned over a relatively broad range [62, 80]. However, unlike most 
synthetic material scaffolds, PEG-DA hydrogels do not significantly adsorb bioactive 
plasma proteins [58]. Thus, scaffold presentation of bioactive stimuli can be tightly 
controlled in addition to mesh size, modulus, and degradation rate. For the PEG-DA 
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hydrogels investigated (with degradation half lives of ~25 days), both VFF ECM 
deposition and phenotype demonstrated a strong dependence on initial hydrogel mesh 
size and elastic modulus. sGAG synthesis increased both with increasing initial elastic 
modulus (e.g., 10% 10 kDa vs 10% 8 kDa) and with decreasing initial mesh size (e.g.,, 
10% 8 kDa vs 20% 10 kDa). 
The relative expression of SM-α-actin, a marker indicative of fibroblast 
differentiation into a myofibroblast phenotype, demonstrated a similar trend as collagen 
(Figure 3.3D). VFF are believed to transform into myofibroblasts in response to LP 
injury, and higher myofibroblast levels have been linked with increased collagen 
deposition [18]. Studies of lung and arterial tissue indicate that cell elastin [81] and GAG 
secretion [82] are also elevated with increasing myofibroblast phenotype. Furthermore, 
elevated VFF proliferation rates (fraction of cells expressing PCNA) were observed with 
increasing mesh size and decreasing modulus. Increased cell proliferation has frequently 
been correlated with decreased matrix synthesis. Thus, the increased induction of a 
myofibroblast-like phenotype and decreased proliferation rates observed with decreasing 
initial mesh size may contribute to the observed dependence of collagen, elastin, and 
GAG levels on initial scaffold mesh size. Given the mesh sizes of the selected hydrogel 
formulations relative to the diameters of collagen (~4-25 nm), elastin (~2-10 nm), and 
moderately sized proteoglycans (~9 nm), the heightened potential of these molecules to 
diffuse out of the hydrogel network as mesh size increased may also contribute to the 
observed dependence of ECM deposition on mesh size.  
A limitation of the present study is the range of mesh-size and mechanical 
properties probed. Future experiments will explore a broader range of initial moduli and 
mesh sizes as well as investigate the impact of degradation rate. A drawback of the 
current approach can be seen in examining Figure 3.4. Despite the presence of adhesion 
peptide RGDS, encapsulated VFF took on rounded or stellate morphologies within the 
PEG-DA hydrogels, in agreement with previous 3D PEG-DA studies. These 
morphologies are non-native for VFF in the midmembranous VF LP, in which 
fibroblasts generally take on spindle-shaped morphologies. The cell morphologies and 
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pericellular localization of deposited ECM localization observed herein arise from the 
basic character of PEG-DA hydrogels that have not been modified with additional 
hydrolytically or enzymatically degradable segments [55, 57, 58, 75, 83]. This particular 
characteristic of the selected PEG-DA formulations is not optimal for fibroblasts. 
However, as indicated in the Introduction, PEG-DA hydrogels were selected for the 
present study not because they are necessarily the optimal materials for vocal fold 
restoration, but for our ability to systematically tune their material properties. This 
characteristic of PEG-DA hydrogels permits more controlled examination of the 
dependence of cell ECM production and phenotype on specific scaffold material 
properties, enhancing our ability to rationally design scaffolds to achieve desired cell 
responses. 
Interestingly, the trends in collagen and elastin production with respect to 
alterations in initial scaffold modulus/mesh size appear to mimic those observed in 
native LP [25, 31, 84]. Specifically, the SLP is a relatively loose, low modulus, 
connective tissue, containing low levels of collagen and elastin relative to deeper regions 
of the LP [31, 84]. The ILP and DLP are traditionally demarcated from the SLP by a 
marked increase in tissue density, stiffness, and elastin and collagen levels [25, 31, 84]. 
Thus, the initial 10% 10 kDa hydrogel material properties and stimulated ECM 
production correspond to those of the SLP, whereas the initial 20% 10 kDa and 30% 10 
kDa hydrogel material properties and resultant ECM synthesis are more similar to those 
of the ILP and DLP. The correspondence between the dependence of ECM deposition 
with varying scaffold mesh size/modulus observed in the current work and the 
dependence of ECM composition with regional LP mesh size/modulus lends further 
strength to the present data. While it is perhaps natural that many LP bioimplant studies 
have focused on implant modulus rather than on microstructure [46-51] due to the LP‘s 
key biomechanical function, the present results suggest that implant mesh size may be as 
critical as its mechanical properties in modulating observed ECM levels. 
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CHAPTER IV 
PROBING VOCAL FOLD FIBROBLAST RESPONSE TO HYALURONAN 
USING PEG-BASED HYDROGELS
*
 
 
 
4.1 Overview 
A number of treatments are being investigated for vocal fold (VF) scar, including 
designer implants. The aim of the present study was to validate a 3D model system for 
probing the effects of various bioactive moieties on VF fibroblast (VFF) responses 
toward rational implant design. We selected poly(ethylene glycol) diacrylate (PEG-DA) 
hydrogels as our base-scaffold due to their broadly tunable material properties. However, 
since cells encapsulated in PEG-DA hydrogels are forced to take on rounded/stellate 
morphologies, validation of PEG-DA gels as a 3D VFF model system required that the 
present work directly parallel previous studies involving more permissive scaffolds. We 
therefore chose to focus on hyaluronan (HA), a polysaccharide that has been a particular 
focus of the vocal fold community. 
Toward this end, porcine VFFs were encapsulated in PEG-DA hydrogels 
containing consistent levels of high Mw HA (HAHMW), intermediate Mw HA (HAIMW), or 
the control polysaccharide, alginate, and cultured for 7 and 21 days. HAHMW promoted 
sustained increases in active ERK1/2 and collagen type III relative to HAIMW and 
alginate. In contrast, VFFs in HAIMW gels displayed a more myofibroblast-like 
phenotype, higher elastin production, and greater protein kinase C (PkC) levels at day 21 
than VFFs in HAHMW gels. 
 
 
____________ 
*Reprinted with permission from ―Probing vocal fold fibroblast response to hyaluronan in  3D contexts‖ 
by Dany J. Munoz-Pinto, Andrea Carolina Jimenez-Vergara, L. Marcela Gelves, Rebecca E. McMahon,1 
Viviana Guiza-Arguello,1 Mariah S. Hahn, 2008, Biotechnology and bioengineering (2009) 821-31, 
Copyright 2009, Wiley Periodicals, Inc. 
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The present results are in agreement with a previous 3D study of VFF responses 
to HAIMW relative to alginate in collagen-based scaffolds permissive of cell elongation, 
indicating that PEG-DA hydrogels may serve as an effective 3D model system for 
probing at least certain aspects of VFF behavior.       
 
4.2 Introduction          
Voice disorders resulting from scarring of the vocal fold (VF) lamina propria 
(LP) affect millions in the US alone and can significantly impact quality of life [37]. VF 
scar has proven difficult to treat with current surgical techniques and standard 
augmentation substances, such as collagen and fat [39, 42, 45]. Researchers are actively 
exploring alternative treatment routes, including the development of designer implants 
for functional LP regeneration [46-51].  
Hyaluronan (HA) has been a particular focus as a component of these designer 
implants due to its role in wound healing and in VF mechanical properties[46-48, 50, 
51]. Although several in vivo studies suggest HA to be a promising material for VF 
regeneration, [50, 85, 86] to rationally improve the design and formulation of these HA-
based implants requires a deeper understanding of the impact of HA on VFF 
extracellular matrix (ECM) production and phenotype.  
A number of tissue engineering studies have examined cellular response to HA in 
2D scenarios [87-90]. However, evaluating the specific influence of HA in more 
physiologically-relevant 3D contexts has proven challenging due to the additional, often 
interdependent, matrix variables introduced in 3D. To understand this, examine a recent 
study in which mesenchymal stem cells encapsulated within collagen  beads displayed 
an increased tendency to differentiate into chondrocytes as collagen density increased 
[91]. Whether this increased chondrocytic potential was due primarily to the increased 
spatial density of bioactivity (collagen) or to the increased matrix stiffness associated 
with heightened collagen concentration is unclear. Being able to make such distinctions 
is particularly important since both scaffold modulus [92] and bioactivity [93] have been 
shown to exert profound effects on cell behavior in 2D. 
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To begin to uncouple the effects of various stimuli on VFF behavior in 3D 
requires a scaffold whose material properties can be more tightly controlled. Hydrogels 
prepared from poly(ethylene glycol) diacrylate (PEG-DA) are intrinsically resistant to 
cell attachment and spreading [58]. This biological ―blank slate‖ character of PEG-DA 
hydrogels permits the controlled introduction of desired bioactivity and examination of 
its effects on cell behavior [94]. Furthermore, the initial bulk average mesh size and 
modulus of PEG-DA hydrogels can be tuned in an uncoupled manner by simultaneously 
varying both the molecular weight (Mw) and/or concentration of PEG-DA [95]. PEG-DA 
gels have been widely employed incartilage tissue engineering due to their tailorable 
material properties [52, 62, 96]. However, they are rarely used for encapsulation of 
natively elongated cells, such as fibroblasts, due to the fact that encapsulated cells are 
forced to take on rounded/stellate morphologies. Thus, validation of PEG-DA gels as a 
3D VFF model system requires that the present study be performed so as to permit direct 
comparison with previous studies involving scaffolds permissive of cell elongation. 
We therefore designed the current work to be a direct analog of a previous 3D 
study of the influence of HA on VFF behavior by Hahn et al. [31]. In that work, porcine 
VFF responses to intermediate Mw HA (HAIMW, ~490 kDa) relative to the control 
polysaccharide alginate (~300-350 kDa, 65–75% guluronate) were investigated in 
basehydrogels of collagen type I. In the present work, porcine VFFs from the same 
explant population employed in Hahn et al. [31] were encapsulated in 100 mg/mL (10 
wt%) PEG-DA hydrogels containing 0.5 wt% of high Mw HA (HAHMW, ~1.65x103 kDa), 
HAIMW (~600 kDa), or alginate (~300-350 kDa, 65–75% guluronate). The promiscuous 
integrin adhesion peptide RGDS [97] was used in place of integrin adhesion ligand 
collagen type I. Following 7 and 21 days of culture, VFF ECM production and 
phenotype in each formulation was assessed biochemically and histologically. 
Furthermore, the modulation of two primary signaling pathways (protein kinase C (PkC) 
and ERK) triggered by HA interactions with cell receptors, RHAMM (receptor for 
hyaluronan-mediated motility) and CD44, [98-100] were semi-quantitatively evaluated. 
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4.3 Materials and methods 
4.3.1 Polymer synthesis and characterization 
PEG-diacrylate synthesis .PEG-DA was prepared as previously described by 
Hahn et al. [94] by combining 0.1mmol/mL dry PEG (10 kDa, Sigma, St. Louis, MO), 
0.4 mmol/mL acryloyl chloride, and 0.2 mmol/mL triethylamine in anhydrous 
dichloromethane (DCM) and stirring under argon overnight. The resulting solution was 
washed with 2M K2CO3 and separated into aqueous and DCM phases to remove HCl. 
The DCM phase was subsequently dried with anhydrous MgSO4, and PEG-DA was 
precipitated in diethyl ether, filtered, and dried under vacuum. The degree of acrylate 
functionalization was determined by 1H-NMR to be ~70%. 
 
Synthesis of acrylate-derivatized. Cell Adhesion Peptide Cell adhesion peptide 
RGDS (American Peptide, Sunnyvale, CA) was reacted with acryloyl-PEG-N 
hydroxysuccinimide (ACRL-PEG-NHS, 3.4 kDa, Nektar, San Carlos, CA) at a 1:1 
molar ratio for 2 h in 50mM sodium bicarbonate buffer, pH 8.5 [94]. The product 
(ACRLPEG- RGDS) was purified by dialysis, lyophilized, and stored at -20 ºC until use. 
 
Synthesis of methacrylate-derivatized high molecular weight HA and alginate. 
Methacrylate-derivatized high Mw HA (HAHMW-MA) and methacrylate-derivatized 
alginate (alginate-MA) were prepared according to standard methodologies (Masters et 
al., 2005). HA (Streptococcus equi, Mw ~1.65x103 kDa, Fluka) or alginate (Laminaria 
hyperborea, 300–350 kDa, 65–75% guluronate, FMC BioPolymer Philadelphia, PA) was 
dissolved at 1-wt% in dIH2O and the pH of the resulting solution was adjusted to 8.0 
using NaOH. A 10-fold molar excess of methacrylic anhydride (Polysciences, 
Warrington, PA) was added per disaccharide unit. Each reaction was allowed to proceed 
under constant stirring at 4 ºC, with the solution pH being maintained at ~8.0 by periodic 
addition of 5M NaOH. The product of each reaction was precipitated twice into chilled 
ethanol 95%, dialyzed against dIH2O for 48 h, and lyophilized. The extent of 
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methacrylatederivatization of both HA and alginate was characterized by 1H-NMR to be 
~3.2%. 
  
Synthesis of methacrylate-derivatized Intermediate molecular weight HA. 
HAHMW-MA was dissolved at 1 mg/mL in PBS containing 0.05% sodium azide and 5 
U/mL hyaluronidase IV-S (H3884, Sigma). Following incubation at 37 ºC for 12 h, the 
enzyme was heat-inactivated. The digestion time and conditions were selected to yield a 
mean HA product size consistent with the HA Mw used in Hahn et al. [31] The resulting 
digestion product (HAIMW-MA) was dialyzed against dIH2O for 48 h and lyophilized. 
The Mw of the isolated HAIMW-MA was determined to be ~600 kDa using gel 
permeation chromatography (Viscotek, Houston, TX). 
 
Assessment of alginate as a control and of HA-MA activity The ability of alginate 
and HAHMW-MA to interact with HA link protein (HABP) was evaluated relative to 
HAHMW using an HA competitive ELISA assay (Echelon Biosciences, Salt Lake City, 
UT). 
 
4.3.2 Cell culture 
Cryopreserved porcine VFFs at passage 3 from the same VFF explant culture 
employed in Hahn et al. [31] were obtained from Robert Langer, ScD (Massachusetts 
Institute of Technology (MIT), Cambridge, MA). These cells had been isolated from the 
mid-membranous LP of 6- to 12-month-old pigs, a common animal model for the human 
VF LP [74]. The discarded animal tissue was obtained via the MIT Division of 
Comparative Medicine and with the approval and according to the guidelines of the MIT 
animal care committee. The cryopreserved VFFs were thawed and expanded at 37 
ºC/5% CO2 in Dulbecco‘s Modified Eagle‘s Media (DMEM, Hyclone, Logan, UT) 
supplemented with 10% fetal bovine serum (FBS), 2 ng/mL bFGF, 100 mU/mL 
penicillin, and 100 mg/L streptomycin (Hyclone). 
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4.3.3 Cell encapsulation and hydrogel maintenance 
Hydrogels were fabricated by preparing precursor solutions containing 100 
mg/mL (10 wt%) PEG-DA, 5 mg/mL of methacrylate-derivatized polysaccharide 
(HAHMW-MA, HAIMW-MA, or alginate-MA), and 1 mmol/mL ACRLPEG- RGDS in 
HEPES buffered saline (HBS; 10mM HEPES, 150mM NaCl, pH 7.4). The 
concentrations of HA and alginate were selected to be consistent with Hahn et al. [31]. A 
10-wt% 10 kDa PEG-DA hydrogel was chosen for the base-scaffold due to a previous 
study of VFF responses to PEG-DA gels [101]. In addition, the 100:5 weight ratio of 
PEG-DA to polysaccharide was selected so that the degradation rate, modulus, and 
initial mesh structure of each hydrogel network would be dominated by PEG-DA. 
A 300 mg/mL solution of UV photoinitiator 2,2- dimethoxy-2-phenyl-
acetophenone in N-vinylpyrrolidone was added at 1% (v/v) to each precursor solution. 
VFFs at passages 8–9 were harvested and resuspended in the filtersterilized precursor 
solutions at ~1x106 cells/mL (the seeding density employed in Hahn et al. [31]. The cell 
suspensions were then poured into molds composed of two glass plates separated by 
1.1mm polycarbonate spacers and polymerized by 2 min exposure to longwave UV light 
(Spectroline, Westbury NY, ~6mW/cm2, 365 nm). The hydrogel slabs were transferred 
to Omnitrays (Nunc, Rochester, NY) fitted with four sterile polycarbonate bars to 
simultaneously prevent gel flotation and prevent gel contact with the tray bottom. 
Hydrogels were immersed in DMEM supplemented with 10% FBS, 100 U/mL 
penicillin, and 100 mg/L streptomycin, and maintained at 37 ºC/5% CO2. Media was 
changed every 2 days. 
 
4.3.4 Hydrogel characterization 
Initial water uptake. To compare the extent of initial water uptake by the various 
hydrogel formulations following polymerization, the initial weight (Wi) of each hydrogel 
was determined immediately following polymerization, after which the gelswere 
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submerged in media. Following 3 days of culture, the swollen weight (Ws) of each gel 
was determined. The equilibrium water uptake (S) was calculated as: 
i
s
W
W
S  . 
 
Hydrogel mechanical properties and contraction After 72 h swelling, three 8 mm 
diameter samples were cored from each hydrogel. The thickness of each disc was 
measured using a digital caliper. These thickness measuresserved both as gauge lengths 
for mechanical testing and as indicators of hydrogel degradation and/or VFF-mediated 
gel compaction. Following application of a 0.01N preload, each hydrogel was subjected 
to cyclic unconstrained compression (~1% cyclic strain) at 2.5 Hz using an Instron 3342 
(Instron, Norwood, MA). During mechanical testing, samples were immersed in silicone 
oil to prevent hydrogel dehydration. The dynamic compressive modulus of each 
hydrogel formulation was extracted from the resulting stress–strain data. 
 
4.3.5 Biochemical analyses 
At days 7 and 21 of culture, a series of 8 mm diameter samples were collected 
from each hydrogel formulation for mechanical, biochemical, and histological analyses. 
Mechanical samples were tested as described above. Samples harvested for biochemical 
analyses were transferred to screw-cap vials, weighed, flash-frozen in liquid nitrogen, 
and stored at -80 ºC until time of analysis. The weight of each 8 mm disc was used as a 
second indicator of gel degradation and/or compaction, since associated reductions in gel 
volume would be reflected in a mass loss. Hydrogel samples were digested for 72 h at 37 
ºC in 1 mL of 0.12M NaOH per 0.2 g hydrogel wet weight [75, 102]. Digest aliquots 
were then analyzed for DNA, total collagen, elastin, and sulfated glycosaminoglycan 
(sGAG) content per established protocols. 
DNA analysis. Aliquots of the hydrolyzed samples (n=3–6 per formulation) were 
neutralized and their DNA content determined using the Invitrogen (Carlsbad, CA) 
PicoGreen assay [75]. DNA measures were translated to cell number using a conversion 
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factor of 6.6 pg DNA per cell (Gregory, 2000). Calf thymus DNA (Sigma) served as a 
standard.  
 
Sulfated GAG analysis. sGAG production was measured using a modification of 
the Biocolor Blyscan assay (Accurate Chemical and Scientific Corp., Westbury, NY) 
[95]. In brief, 40 µL of each sample digest (n=3–4 per formulation) was neutralized, 
mixed with 60 µL Blyscan dye reagent, and the absorbance at 525nm immediately 
measured relative to chondroitin sulfate B (Sigma). 
 
Collagen analysis. The amino acid hydroxyproline was quantified as an indirect 
measure of total collagen. In brief, aliquots (n=3–7 per formulation) collected for 
collagen quantitation were hydrolyzed for 18 h at 110 ºC in 6M HCl. Each sample was 
then dried on a Labconco Centrivap to remove HCl, resuspended in deionized water, and 
passed through a charcoal-packed centrifugal microcolumn (Nunc). The resultant 
samples were reacted with chloramine T and p-dimethylbenzaldehyde reagents. [75, 
102]  Sample absorbance was read at 550 nm relative to that of L-4-hydroxyproline 
(Sigma). Total collagen content was estimated from measured grams of 
hydroxyprolineby dividing by 0.13.  
 
Elastin analysis. Elastin production was measured using direct ELISA [78]. 
NaOH digested samples (n=4–11 per formulation) were neutralized and further digested 
with 0.25M oxalic acid at 100 ºC overnight. Oxalic acid was removed from the samples 
and exchanged for PBS using Microcon YM-3 centrifugal filters (Millipore, Billerica, 
MA). One hundred microliters of the resulting samples were applied to a high binding 
multiwell plate for 3 h at room temperature. After blocking the plate with bovine serum 
albumin, adsorbed elastin fragments were detected by applying elastin antibody (BA-4, 
Santa Cruz Biotechnology, [SCBT], Santa Cruz, CA) followed by donkey anti-mouse 
HRP secondary antibody (SCBT) and 2,2‘-azino-bis(3- ethylbenzthiazoline-6-sulphonic 
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acid). Absorbance was read at 410 nm, with bovine aortic elastin (Sigma) serving as a 
standard. 
For each assay, the standards used were subjected to the same association with 
PEG-DA and polysaccharide and to the same digestion conditions as the samples. 
Resulting collagen, elastin, and sGAG levels were normalized to cell number. 
 
4.3.6 Histological analyses 
Days 7 and 21 samples harvested for histological analyses were fixed in 10% 
formalin for 30 min, embedded in Tissue-Tek freezing media, and frozen at -80 ºC. 
Thirty-five micrometer-thick sections were cut using a cryomicrotome. All 
immunostaining steps took place at room temperature unless otherwise noted. 
 
ECM and cell phenotype analyses. ECM deposition was analyzed in duplicate 
sections for each formulation using standard immunohistochemical technique. 
Rehydrated sections were blocked with peroxidase for 10 min followed by 10 min 
exposure to Terminator (Biocare Medical, Concord, CA). Primary antibodies for elastin 
(BA-4, SCBT), collagen type I (Rockland Immunochemicals, Gilbertsville, PA), or 
collagen type III (Rockland Immunochemicals) diluted in HBS were then applied for 1 
h. To identify VFFs displaying a myofibroblast-like phenotype, primary antibody for 
SM-α-actin (1A4, LabVision, Fremont, CA) was applied. HA cell surface receptors were 
also examined using antibodies to RHAMM (H-90, SCBT) and CD44 (F-4 SCBT). 
Bound primary antibody was detected by using AP-conjugated secondary antibody 
followed by application of the chromogen Ferangi Blue (Biocare Medical) or by using 
HRP-conjugated secondary antibody followed by application of the chromogen AEC 
(LabVision). 
 
Cell proliferation and apoptosis and signaling. To identify VFFs undergoing 
proliferation, sections were stained for Proliferating Cell Nuclear Antigen (PCNA; 
PC10, Invitrogen) per the above staining procedure, except that rehydrated sections were 
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permeabilized (10mM HEPES, pH 6.8, 100mM NaCl, 3mM MgCl2, 300mM sucrose, 
0.5% Triton X-100) for 30 min prior to Terminator application. Apoptotic cells were 
identified using a Terminal deoxynucleotidyl transferase dUTP nick end-labeling 
(TUNEL) assay (Roche, Indianapolis, IN) per manufacturer‘s protocol. Cell signaling 
was evaluated by staining permeabilized sections for PkC (C-15, SCBT) and active 
ERK1/2 (pERK1/2(Thr202/Tyr 204), SCBT). 
 
Semi-quantitative assessments. For intracellular markers of cell behavior (SM-α-
actin, pERK1/2, PkC, PCNA, TUNEL), cell counts were carried out to semi-
quantitatively evaluate immunostaining results. These assessments were conducted per 
established protocols [73, 83, 103, 104]. For each cell, i, in a given section, a staining 
intensity, di, was recorded on a scale of 0–3, 0‗‗no staining‘‘ and 3‗‗highest intensity 
among all treatment groups for that antibody.‘‘ The cumulative staining intensity, d, for 
a given antibody in a particular section was calculated using the following equation: 
umberTotalcel
d
d i
ln

 .  
Since deposited ECM remained localized around the parent cells in each 
hydrogel formulation, as is characteristic for PEG-DA gels, [57, 62] the relative levels of 
collagen and elastin among hydrogel formulations were also evaluated by cell counts per 
the above procedure. Each HAHMW and HAIMW cumulative staining intensity assessment 
was normalized to the corresponding intensity assessment for alginate hydrogels. 
 
4.3.7  Statistical analyses 
Data are reported as mean ± standard error of the mean. Comparison of sample 
means was performed by one-way ANOVA and Tukey‘s post hoc test (SPSS software, 
Chicago, IL), P<0.05. 
4.4 Results  
The present study was designed to examine the impact of HAHMW and HAIMW 
relative to alginate on VFF ECM production and phenotype. Following 7 and 21 days of 
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total culture, constructs were harvested and subjected to mechanical, histological, and 
biochemical analyses. 
 
4.4.1 Alginate as a control and HA-MA activity 
We first verified that alginate was an effective control for HA and that HA-MA 
retained similar biological function as pure HA. Alginate was intended to serve as a 
‗‗scrambled‘‘ polysaccharide sequence which would impart similar viscoelasticity to the 
hydrogel network as HA but which would not have the associated cell-interactions. This 
is similar in concept to the use of the ‗‗scrambled‘‘ peptide sequence RGES as a control 
for the cell adhesion peptide RGDS [93]. Competitive ELISA results indicated that 
alginate was unable to effectively interact with HABP (Figure 4.1B), despite the 
physiochemical similarities between alginate and HA (Figure 4.1A). In contrast, HA-
MA appeared to retain a similar level of affinity for HABP as unmodified HA (Figure 
4.1B). This was consistent the work of Masters et al., which demonstrated that HA-MA 
and unmodified HA each resulted in similar valvular interstitial cell (VIC) ECM 
production at the HA methacrylation level used herein. 
 
 
Figure 4.1 A: Structure of hyaluronan (HA) versus alginate disaccharide units. B: Competitive ELISA 
results in which an increased absorbance signal corresponds to a decreased concentration of the test 
molecule and/or lower affinity of the test molecule for HA link protein (HABP). The ELISA results 
demonstrate that alginate does not effectively interact with HABP but that methacrylate-derivatized HA 
(HA-MA) has a similar affinity for HABP as unmodified HA. 
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4.4.2 Hydrogel material properties 
The dense covalent crosslinking and chemical composition of pure PEG-DA 
hydrogels result in gels that are essentially non-degradable and which permit limited 
cell-mediated remodeling [55, 57, 75]. These features, although non-physiological, are 
desirable for studies focused on controlled evaluation of the impact of specific material 
properties (in the present work, bioactivity) on cell responses. To assess the degree to 
which the selected polysaccharide hydrogels retained the character of pure PEG-DA 
hydrogels, the ‗‗bulk‘‘ material properties of each gel formulation were characterized. 
The initial water uptake, S, of each gel following polymerization was similar to 
that of a pure PEG-DA gel (HAHMW: 1.37 ± 0.06, HAIMW: 1.43 ± 0.04, alginate: 1.43 ± 
0.04, pure PEG-DA: 1.40 ± 0.05). Furthermore, the initial (day 3) moduli of the HAHMW, 
HAIMW, and alginate cells were statistically indistinguishable, as were the day 2 moduli 
(Table 4.1). Comparison of the day 7 and day 21 moduli reveals indicated that the 
reduction in modulus for each gel with time in culture was similar to that of pure PEG-
DA hydrogels (also containing encapsulated VFFs). To evaluate the potential 
contribution of gel degradation and VFF-mediated compaction on the observed temporal 
changes in gel modulus, the thickness and mass of harvested gel discs were measured 
with time in culture (Table 4.1). These data correspond to a negligible reduction in gel 
volume with time. Collectively, the bulk modulus, thickness, water uptake, and gel mass 
assessments indicate that the material properties of the polysaccharide-containing gels 
were dominated by the presence of PEG-DA rather than by the associated 
polysaccharides. 
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Table 4.1. Hydrogel modulus, thickness, and mass assessments. 
 Modulus (kPa) Thickness (mm) Mass of 8 mm Discs (mg) 
 Day 3 Day 21 Day 3 Day 21 Day 3 Day 7 Day 21 
HAHWM 58.1 ± 0.9 54.2 ± 6.5 1.12 ± 0.03 1.08 ± 0.03 58.3 ± 1.1 59.9 ± 1.2 57.7 ± 1.1 
HAIMW 55.0 ± 5.3 49.1 ± 2.7 1.12 ± 0.03 1.13 ± 0.03 59.7 ± 1.0 60.6 ± 0.9 59.7 ± 0.9 
Alginate 60.5 ± 7.6 57.0 ± 6.1 1.12 ± 0.02 1.11 ± 0.02 58.1 ± 1.2 59.6 ± 0.8 59.1 ± 0.6 
PEG-DA 51.9 ± 2.6 46.1 ± 3.3 1.12 ± 0.03 1.13 ± 0.02 58.7 ± 1.0 61.6  ±0.5 59.5 ± 0.9 
 
4.4.3 Cell density, proliferation, and apoptosis 
The influence of scaffold composition on VFF proliferation and apoptosis was 
assessed via PCNA and TUNEL-based immunostaining, respectively. At day 7, no 
differences in cell proliferation or apoptosis across hydrogel formulations were noted 
(Figure 4.2. B and C). These day 7 PCNA and TUNEL results are reflected in the day 21 
DNA measures, which indicate that net VFF proliferation and loss was similar across 
hydrogel formulations from day 7 to day 21 (Figure 4.2 A). Similar levels of cell 
apoptosis across hydrogel formulations continued to be observed through day 21 (Figure 
4.2 C). However, PCNA expression was significantly elevated in HAIMW hydrogels 
relative to HAHMW (P=0.013) and alginate gels (P=0.016, Fig. 2B). These day-21 
proliferation and apoptosis results suggest that, if cell densities had continued to be 
monitored past 21 days of culture, differences in cell densities across formulations would 
have begun to be detected. 
 
 
 49 
 
Figure 4.2  Cell density, proliferation, and apoptosis. A: The cell density within each hydrogel at days 7 
and 21. B: Relative levels of proliferation at days 7 and 21 based on PCNA immunostaining. C: Relative 
levels of apoptotic cells at days 7 and 21 based on TUNEL assay results. *Significantly different from 
HAHMW hydrogels, P<0.05. ξSignificantly different from HAIMW hydrogels, P<0.05. 
 
4.4.4 VFF ECM deposition and phenotype 
VFF ECM production showed marked variations with hydrogel bioactivity 
(Figure 4.3). The trends in elastin production at both days 7 and 21 indicated that elastin 
synthesis was greater in HAIMW gels than in HAHMW and alginate gels, with the 
differences at day 21 being statistically significant (HAHMW, P=0.050; alginate, 
P<0.001). Although both days 7 and 21 data suggested an increasing trend for sGAG 
levels in alginate gels relative to both HAIMW and HAHMW hydrogels, these differences 
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fell below statistical significance (Figure 4.3B). Total collagen levels were significantly 
higher at day 7 in HAHMW hydrogels than in HAIMW (P<0.001) and alginate (P=0.03) 
gels. By day 21, this trend had shifted, with collagen levels in the alginate controls 
exceeding those in the HAHMW hydrogels (P=0.025, Figure 4.3C). In contrast, the trend 
of lower total collagen production in HAIMW hydrogels relative to alginate controls was 
stable from day 7 (P=0.015) to day 21.  
 
 
 
Figure 4.3 Evaluation of VFF ECM deposition. A: Elastin, (B) sGAG, and (C) total collagen production 
on a per cell basis at days 7 and 21. *Significantly different from HAHMW hydrogels, P<0.05. ξSignificantly 
different from HAIMW hydrogels, P<0.05. 
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To gain further insight into effects of HAHMW and HAIMW on VFF ECM 
deposition, immunostaining for the two primary VF LP collagen types (collagen types I 
and III) [105] was conducted (Figure 4.4A and B). Expression of both collagen type I 
and collagen type III displayed similar trends with hydrogel formulation at day 7, with 
collagen type I deposition being significantly higher in the HAHMW gel relative to HAIMW 
(P<0.001) and alginate (P=0.001) gels. By day 21, differences in collagen type I 
expression across hydrogels had flattened. However, collagen type III production was 
significantly higher in HAHMW hydrogels relative to alginate controls (P=0.003). As 
expected for PEG-DA gels, [62] staining for collagen types I and III (Figure 4.5) and 
elastin (data not shown) was confined to the immediate pericellular space in each 
formulation. To identify VFFs displaying a myofibroblast-like phenotype, expression of 
SM-α-actin was evaluated. The results for SM-α-actin were analogous to those for 
PCNA in that SM-α-actin levels were statistically indistinguishable across hydrogel 
formulations at day 7 (Figure 4.4C). However, by day 21, VFFs in HAIMW gels 
expressed higher levels of SM-α-actin relative to HAHMW (P=0.004) and alginate 
(P<0.001) gels (Figure 4.4D). 
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Figure 4.4 Assessment of VFF collagen type production, phenotype, and signaling. Relative collagen type 
I and collagen type III expression across hydrogels at (A) day 7 and (B) day 21. Relative expression of 
PkC, pERK1/2, and SM-α-actin at (C) day 7 and (D) day 21. *Significantly different from HAHMW 
hydrogels, P<0.05. ξSignificantly different from HAIMW hydrogels, P<0.05. 
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Figure 4.5 Representative images of day 21 HAHMW, HAIMW, and alginate hydrogel sections 
immunostained for collagen type I, collagen type III, PkC, pERK1/2, or SM-α-actin. The scale bar in the 
upper-left image equals 40 mm and applies to all images. 
 
4.4.5  Cellular signaling 
HA interactions with cell receptors, RHAMM and CD44, [99, 100] trigger two 
primary signaling pathways, PkC and ERK, which then modulate cell gene expression. 
Therefore, the relative levels of RHAMM, CD44, PkC, and active ERK1/2 (pERK1/2) 
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were semi-quantitatively assessed across hydrogel formulations. CD44 staining at both 
day 7 and day 21 was weak (<4 % of cells positively stained despite several antibody 
dilutions being assayed). In contrast, RHAMM staining was prominent at both time 
points and was significantly greater in HAHMW and HAIMW gels than in alginate gels 
(P<0.03). Specifically, VFF expression of RHAMM at day 7 in HAHMW and HAIMW gels 
was 1.94 ± 0.05 and 2.89 ± 0.32 times greater, respectively, than in alginate gels. 
Relative RHAMM levels at day 21 followed a similar trend (data not shown). PkC 
expression was consistently higher in HAHMW than in alginate gels (P<0.006) at both 
days 7 and 21 (Figure 4.4C and D). In addition, day 21 PkC levels were greater in 
HAIMW hydrogels than in HAHMW gels (P=0.038) and alginate gels (P<0.001). Relative 
pERK1/2 levels maintained a similar trend across formulations from day 7 to day 21, 
with day 21 pERK1/2 content being significantly higher in HAHMW hydrogels relative to 
HAIMW (P=0.029) and alginate (P=0.013) gels. 
 
 
4.5 Discussion 
The aim of the present study was to validate PEG-DA hydrogels as a model 
system to probe the effects of various bioactive moieties on VFF responses in 3D toward 
rational VF LP implant design. To accomplish this objective required that the current 
study be conducted so as to permit direct comparison with previous studies involving 
more permissive scaffolds. Therefore, we chose to focus on HA, a polysaccharide that 
has been a particular focus in VF regeneration community. 
In the current work, porcine VFFs were encapsulated in PEG-DA hydrogels 
containing consistent levels of HAHMW (~1.65 x 103 kDa), HAIMW (~600 kDa), or the 
control polysaccharide alginate. Modulus, water uptake, and gel mass assessments 
indicate that the bulk average microstructure, modulus, and degradation rate of the 
polysaccharide- containing gels were dominated by PEG-DA. This enabled focus on the 
identity of the polysaccharide as the main source of variation in net cell responses. 
Although there were certainly local differences in gel properties at the microscale, our 
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ECM and cell phenotypic measures represent averages over the bulk, as do our material 
property measures. Thus, since both the material property and cell response measures 
were made at the same length scales, the data represent an internally consistent set from 
which meaningful deductions can be made.  
Regarding ECM production, VFF elastin deposition demonstrated an increasing 
trend with decreasing HA Mw by day 21 of culture. In comparing these results to 
literature, we are limited by the fact that most HA studies which permit the impact of 
HA Mw to be isolated from other experimental variables have been conducted in 2D with 
soluble, rather than matrix-bound, HA. Thus, the comparisons to follow must be 
interpreted with caution. That being said, the present results are in agreement with a 
recent 2D study of VICs by Masters et al. In that study, elastin synthesis at 20 days of 
culture was significantly higher in VICs exposed to ~400 kDa HA relative to ~800 kDa 
HA. However, a separate 2D study by Joddar and Ramamurthi, [89] showed a decrease 
in vascular smooth muscle cell (SMC) elastin deposition at 21 days of culture with a 
decrease in HA Mw from 2 x 103 kDa to ~200 kDa. Combined, these studies suggest that 
the influence of HA Mw on elastin synthesis may be cell-type dependent. 
Examination of VFF sGAG deposition indicated no significant alteration in 
sGAG synthesis with increasing HA Mw, consistent with the results of Masters et al. 
[106]. Although, VFF total collagen production in HAIMW hydrogels was significantly 
lower than that in HAHMW gels at day 7, their day 21 total collagen content could not be 
statistically distinguished. As with elastin, literature shows conflicting results for the 
dependence of collagen deposition on HA Mw. Masters et al. found no significant 
difference in VIC total collagen production with increasing HA Mw at 20 days of culture. 
Joddar and Ramamurthi, [89] however, observed an increase in vascular SMC collagen 
synthesis with decreasing HA Mw as HA dosages approached those used herein. 
Regarding the synthesis of individual collagen types, VFF collagen type III deposition 
displayed an increasing trend with increasing HA Mw at both days 7 and 21. In contrast, 
although collagen type I expression at day 7 decreased with decreasing HA Mw, day 21 
collagen type I levels did not vary significantly across formulations. This temporal 
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alteration in collagen type I production may be linked to the corresponding shifts in PkC 
signaling with time in culture. The present collagen type III results agree with the effects 
of HA Mw on human dermal fibroblast collagen type III synthesis observed by David-
Raoudi et al. Further comparison of the trends in collagen types I and IIIacross hydrogels 
with that of total collagen suggests that collagen type I was the dominant collagen 
produced by the encapsulated VFFs, in each hydrogel formulation, at least by day 21. 
The ratios of the various collagen types secreted by VFFs are significant because 
collagen type III tends to more abundant in highly elastic tissues, such as the VF LP 
[19]. Furthermore, the ratios of the various collagen types are frequently altered in aging 
and disease [19, 27]. 
Cell phenotype also appeared to be modulated by HA Mw. VFFs in HAIMW 
hydrogels displayed a more proliferative phenotype at day 21 than cells in alginate or 
HAHMW gel, as indicated by PCNA staining. A similar dependence of cell proliferation 
on HA Mw has been previously observed for VICs [106] and for vascular SMCs [89]. In 
addition, VFFs in HAIMW hydrogels demonstrated increased SM-α-actin expression by 
day 21 relative to HAHMW and alginate hydrogels. The increased levels of SM-α-actin 
and PCNA at day 21 in HAIMW gels may be associated with the increased levels of PkC 
in the HAIMW gels relative to alginate gels. Indeed, PkC signaling has previously been 
shown to increase the expression of SM-α-actin in lung fibroblasts [107]. Furthermore, 
the increased myofibroblastic phenotype of cells in the HAIMW hydrogels at day 21 was 
associated with increased elastin deposition, consistent with the literature [81, 108-111]. 
Cumulatively, the present results suggest that HA Mw must be carefully selected 
to achieve desired VFF responses. However, based on the current data, the HAHMW gels 
would be the most appropriate for VF regeneration of the formulations examined. 
Specifically, the HAHMW gel resulted in an elastin and collagen type composition most 
mimetic of normal superficial LP, which contains ~40% collagen type III [105] and a 
relatively low elastin to collagen ratio [31]. Furthermore, the lower induction of a 
myofibroblastic phenotype observed in the HAHMW gels relative to HAIMW gels with 
prolonged culture is desirable for inhibition of LP scar formation [18]. 
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As previously mentioned, the effects of HAIMW on VFF behavior relative to the 
control alginate have been examined in 3D using base-hydrogels of collagen type I [31]. 
However, it is difficult to extend upon that study to probe a broader HA concentration or 
Mw range due the interdependences among collagen gel bioactivity, modulus, and 
microstructure. In addition, collagen gels are prone to fibroblast-mediated contraction, 
making gel material properties difficult to control over time [31]. Although the material 
properties of PEG-DA hydrogels are tunable and more readily controlled, cells 
encapsulated within PEG-DA hydrogels take on rounded/stellate morphologies even in 
the presence of cell adhesion ligands such as RGDS (Fig. 4.4). This particular 
characteristic of PEG-DA hydrogels, which results from their dense crosslinking and 
relatively slow degradation rates, [55, 57, 75] is not optimal for cells such as VFFs, 
which natively take on spindle-shaped morphologies. However, due to several of their 
unique properties, PEG-DA hydrogels have been employed as a model scaffold by 
number of researchers focusing on fibroblast-like cells, in spite of this limitation [75, 
106, 112-114]. To validate PEG-DA hydrogels for the investigation of VFF responses to 
defined bioactivity in 3D, the day 21 setup for the present study was designed to be a 
direct analog of the previous collagen-based 3D study in which encapsulated VFFs were 
able to assume spindle-shaped morphologies [31]. 
Interestingly, each of the aspects of VFF behavior measured for HAIMW-collagen 
relative to alginate-collagen control gels displayed similar trends in the HAIMW-PEG-DA 
gels relative to alginate-PEG-DA gels (Table 4.2). Although elastin deposition was not 
measured in the alginate-collagen and HAIMW-collagen study, the relative trends in day 
21 total collagen synthesis, sGAG production, cell proliferation, and myofibroblastic 
phenotype between hydrogel formulations were maintained across the two studies [31]. 
This similarity in relative VFF response occurred despite the significant difference in 
cell morphologies in the PEG-based gels relative to the collagen gels. The good 
agreement between these two studies indicates that PEG-DA hydrogels can serve as an 
effective model system for probing at least certain aspects of fibroblast-like cell 
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responses to scaffold material properties despite the enforced non-native cell 
morphologies. 
 
Table 4.2. Comparison of HA and alginate impact in PEG-DA-versus collagen-based 
hydrogels. 
, indicates indeterminate,  decrease,  increase, __ not measured. In Hahn et al. [31], the levels of 
proliferative cells were assessed via BrdU incorporation and the levels of myofibroblast-like cells were 
assessed by evaluating the degree of hydrogel compaction with time in culture. Collagen synthesis and 
sGAG production were evaluated histologically by reticular collagen stain and toluidine blue stain, 
respectively. 
* indicates that the result was not statistically significant. 
 
A limitation of the present study is the relatively restricted HA concentration and 
Mw range interrogated. Future experiments will explore a broader range of initial 
concentration and Mw. Furthermore, the present 3D model system can be readily 
extended to examining the influence of other biochemical moieties on VFF cell 
responses. 
 
 
 
 
 
 
 
 
 
PEG-DA hydrogels with RGDS 
functioning as the integrin 
adhesion ligand at day 21 
Collagen hydrogels with collagen 
type I functioning as the integrin 
adhesion ligand [31] 
 
HAHMW relative 
to HAIMW 
HAIMW relative 
to Alginate 
HAHMW relative to 
HAIMW 
HAIMW relative to  
Alginate 
Total collagen   
__ 
 
Collagen type I: type III   
__ __ 
Elastin   
__ __ 
sGAG    * 
__ 
 
Proliferative cells   
__ 
 
Myofibroblast-like cells   
__ 

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CHAPTER V 
UNCOUPLED INVESTIGATION OF SCAFFOLD MODULUS AND MESH SIZE 
ON SMOOTH MUSCLE CELL BEHAVIOR
* 
 
 
5.1 Overview 
Although scaffold material properties are known to critically impact cell 
behavior, it has proven difficult to correlate specific cell responses to isolated scaffold 
parameters, inhibiting rational design of scaffold material properties. The aim of this 
study was to validate a systematic approach for evaluating the influence of initial 
scaffold modulus and mesh size on cell extracellular matrix (ECM) deposition and 
phenotype. Poly(ethylene glycol) diacrylate (PEG-DA) hydrogels were selected for this 
study because of their tunable material properties. Following screening of six distinct 
PEG-DA hydrogels, three formulations were identified which permitted uncoupled 
investigation of scaffold mesh size and modulus within the target incremental modulus 
range of ~100–300 kPa. Smooth muscle cells (SMCs) were encapsulated within these 
three formulations, and cell ECM deposition and phenotype were evaluated following 
days of culture.  
Although elastin content appeared to be correlated with scaffold mesh size and 
modulus to a similar degree, levels of collagen and serum response factor (SRF), a key 
regulator of SMC phenotype, were more strongly correlated with mesh size. To gain 
insight into the cell signaling underlying these observed correlations, variations in cell 
metabolic state and in RhoA signaling were semi-quantitatively evaluated. Both RhoA 
activity, which is largely modulated by scaffold mechanics in 2D, and cell metabolic 
activity were highly correlated with hydrogel mesh size. 
 
____________ 
*Reprinted with permission from ―Uncoupled investigation of scaffold modulus and mesh size on smooth 
muscle cell behavior‖ by Dany J. Munoz-Pinto, Allen Bulick and Mariah S. Hahn, 2009, Journal of 
Biomedical Materials Research: Part A, Copyright 2009, Wiley Periodicals, Inc. 
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These results indicate that the effects of scaffold mechanics on RhoA activity in 
3D may be distinct from those in 2D and underscore the need for uncoupled 
investigation of scaffold parameters on cell behavior. Furthermore, the present data 
suggest that RhoA signaling and cell metabolic regulation may be closely linked.   
 
5.2 Introduction 
The material properties of tissue engineering scaffolds are understood to 
critically influence cell behavior. However, it has proven difficult to attribute alterations 
in cell response to specific changes in scaffold parameters, such as bioactivity, [52] mesh 
size, [53] mechanical properties, [55, 115, 116] and degradation rate [117] due to the 
complexity and/or interdependence of these variables. For instance, an important recent 
study observed that mesenchymal stem cells encapsulated within collagen beads 
displayed an increased tendency to differentiate into chondrocytes as collagen density 
increased [91]. However, whether this alteration in cell behavior resulted primarily from 
the increase in the spatial density of bioactivity (collagen) or from the associated 
increase in bead stiffness (or decrease in gel mesh size) cannot be readily determined 
with this model system. This is because the concentration of collagen cannot be 
uncoupled from changes in modulus and mesh size using standard collagen hydrogel 
formulation strategies. This interdependence of scaffold variables has hampered our 
ability to correlate specific cell responses to isolated scaffold material properties, 
inhibiting the rational selection of scaffold parameters to achieve desired cell behaviors. 
The aim of this study was to validate a systematic approach for evaluating the influence 
of isolated scaffold material properties on cell phenotype and ECM deposition, with a 
focus on initial scaffold modulus and mesh size. Ultimately, these data will be applied 
toward rational scaffold design. 
Central to this work is the selected scaffold material: poly(ethylene glycol) 
diacrylate (PEG-DA). PEG-DA hydrogels have several properties that make them 
appropriate for controlled exploration of cell response to specific alterations in scaffold 
material properties. Specifically, their bioactivity, mesh size, modulus, and degradation 
 61 
rate can be systematically tuned [53, 57, 62, 117]. Regarding bioactivity, pure PEG-DA 
hydrogels function as biological ‗‗blank slates,‘‘ meaning that they do not significantly 
adsorb bioactive plasma proteins. Thus, these hydrogels do not promote cell interaction 
without the specific conjugation of biochemical stimuli to the scaffold [58]. This is 
significant because most synthetic and natural scaffolds adsorb a range of bioactive 
proteins from serum (in the in vitro setting) or from plasma (in the in vivo setting). 
These adsorbed proteins, the levels of which are variable and difficult to quantify, are 
often major determinants of cell behavior, in addition to any bioactive moiety 
deliberately conjugated or adsorbed to the scaffold. This situation complicates the study 
of cell response to defined biochemical stimuli. In contrast, the biological ‗‗blank slate‘‘ 
nature of PEG-DA hydrogels permits the controlled introduction of desired bioactivity 
and examination of its effects on cell behavior [61]. In this study, we explored the 
impact of initial PEG-DA scaffold modulus and mesh size in the presence of constant 
initial levels of cell adhesion peptide, RGDS, thereby removing initial scaffold 
bioactivity as a design variable. 
An additional benefit of PEG-DA hydrogels is the ability to tune their initial 
mesh size and mechanical properties over a broad range simply by varying the molecular 
weight (Mw) and/or concentration of PEG-DA [62]. This particular characteristic of 
PEG-DA hydrogels, although widely recognized, has not been fully exploited in terms of 
analyzing cell responses to specific scaffold properties. This is due, in part, to the 
interdependence of PEG-DA hydrogel modulus and mesh size. Namely, as the 
concentration of PEG-DA of a specific Mw is increased, the mesh size of the resulting 
hydrogel decreases while the modulus increases. Thus, cell responses to hydrogel 
modulus have proven difficult to investigate separated from mesh size. In this study, we 
circumvent this limitation in a unique manner, which permits uncoupled examination of 
the effects of scaffold modulus and mesh size. 
The degradation rate of PEG-DA hydrogels can also be systematically tuned. 
Pure PEG-DA hydrogels degrade by hydrolytic cleavage of the ester bonds between the 
aliphatic polymer backbone and the crosslinking units [60, 73]. Variations in degradation 
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rate can be achieved by conjugating enzymatically-cleavable peptides or a-hydroxy 
acids, such as lactic acid, to the macromer backbone [14, 16]. The PEG-DA formulations 
investigated herein were selected to display similar degradation rates, significantly 
simplifying the systematic interrogation of modulus and mesh size impact on cell 
behavior. In validating this approach, we have employed tissue engineered vascular 
grafts (TEVGs) as a model system. Annually, ~100,000 patients require vascular bypass 
of small-caliber arteries (<6 mm ID) but lack autologous arteries or veins suitable for 
grafting [118]. Tissue engineering represents a potential means to construct vascular 
grafts in situations where autologous tissue is unavailable and current synthetic materials 
fail [119, 120]. Because of its key role in vessel physiology, the smooth muscle cell 
(SMC)-rich medial layer of blood vessels has been a focus of much of TEVG research 
[121, 122]. We therefore concentrated on evaluating the responses of vascular SMC to 
scaffold mesh size and modulus. In assessing SMC response, we examined the 
production of key determinants of mediallayer mechanical properties, including 
collagen, elastin, and sulfated glycosaminoglycans (sGAG). Expression of SMC marker 
calponin h1, as well as two of its regulators, namely, the transcription factors myocardin 
and serum response factor (SRF), [123-125] was employed in evaluating SMC 
phenotype. 
To gain insight into the signaling pathways underlying observed variations in 
SMC ECM production and phenotype with hydrogel mesh size and modulus, alterations 
in RhoA activity and cell metabolic state were semi-quantitatively evaluated. RhoA 
signaling was selected for examination due to its known role in modulating cell response 
to scaffold mechanics in 2D [126, 127]. Cell metabolic state was investigated as gel 
mesh size frequently imposes constraints on nutrient diffusion and gas exchange, both of 
which impact cell metabolism. 
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5.3 Materials and methods 
5.3.1 Polymer synthesis 
PEG-DA was prepared as previously described by combining 0.1 mmol/mL dry 
PEG (10 kDa or 20 kDa, Fluka), 0.4 mmol/mL acryloyl chloride, and 0.2 mmol/mL 
triethylamine in anhydrous dichloromethane (DCM) and stirring under argon overnight. 
The resulting solution was washed with 2M K2CO3 and separated into aqueous and 
DCM phases to remove HCl. The DCM phase was subsequently dried with anhydrous 
MgSO4, and PEG-DA was precipitated in diethyl ether, filtered, and dried under 
vacuum. The extent of acrylation of both products was characterized by 1H NMR to be 
~65%. 
Cell adhesion peptide RGDS (American Peptide) was reacted with acrylate-
derivatized PEG-N-hydroxysuccinimide (ACRL-PEG-NHS, 3.4 kDa, Nektar) at a 1:1 
molar ratio for 2 h in 50 mM sodium bicarbonate buffer, pH 8.5 [128]. The product 
(ACRL-PEG-RGDS) was purified by dialysis, lyophilized, and stored at -20 °C until 
use. 
 
5.3.2 Hydrogel formulation selection 
Human coronary arteries experience mean circumferential stresses of 20–50 kPa 
under normal physiological loading [129]. The slope of the tangent to the stress–strain 
curve at this mean stress point is referred to as the incremental modulus of the vessel 
[129]. The incremental modulus for a normal human coronary artery ranges from ~100–
300 kPa [129]. To identify a set of hydrogels that would permit uncoupled examination 
of scaffold mesh size and mechanical properties within this incremental modulus range, 
the following series of PEG-DA hydrogels were prepared and characterized: (1) 10 wt % 
of 10 kDa PEG-DA (10% 10 kDa), (2) 20 wt % of 10 kDa PEG-DA (20% 10 kDa), (3) 
30 wt % of 10 kDa PEG-DA (30% 10 kDa), (4) 10 wt % of 20 kDa PEG-DA (10% 20 
kDa), (5) 20 wt % of 20 kDa PEG-DA (20% 20 kDa), and (6) 30 wt % of 20 kDa PEG-
DA (30% 20 kDa). 
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Hydrogel preparation. Hydrogel precursor solutions were prepared by dissolving 
PEG-DA macromers in HEPES buffered saline (HBS;10 mM HEPES, 150 mM NaCl, 
pH 7.4). Each precursor solution was sterilized using a 0.22 µm PVDF filter. Ten 
microliters of a 300 mg/mL solution of photoinitiator 2, 2-dimethoxy-2-phenyl-
acetophenone dissolved in N-vinylpyrrolidone was then added per mL precursor 
solution. Each solution was poured into molds composed of two glass plates separated 
by thin polycarbonate spacers and then polymerized by 2 min exposure to longwave UV 
light(Spectroline, ~6 mW/cm2, 365 nm) [62, 65]. 
 
Hydrogel swelling. To isolate the effects of scaffold modulus and mesh size on 
SMC ECM production and phenotype, it was necessary that the initial cell density and 
scaffold bioactivity be consistent across formulations. Because PEG-DA hydrogels swell 
significantly postpolymerization, [130] the amount of ACRL-PEG-RGDS and cells 
added to each hydrogel precursor solution had to account for the change in hydrogel 
volume with swelling. To characterize equilibrium swelling, each PEG-DA gel was 
prepared as described above. Samples of 1 cm diameter were cored from each PEG-DA 
hydrogel immediately following polymerization and weighed. The samples were then 
transferred to HBS supplemented with 0.05 wt % sodium azide (HBS-azide) at 37 °C. 
After 24 h, samples were blotted and weighed. Because PEG-DA hydrogels are 
primarily water, the increase in weight with swelling can be directly related to the 
increase in gel volume (V) with swelling, that is, 





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ratio was used to calculate the amount of cells and ACRL-PEG-RGDS to be added to 
each hydrogel precursor solution so as to ensure the desired cell density and RGDS 
concentration in the swollen hydrogels. 
The desired postswelling RGDS concentration was 2 μmol/g. To confirm that the 
levels of added ACRL-PEGRGDS did not significantly alter the relative swelling ratios 
of the selected PEG-DA formulations, the swelling ratios of RGDS-containing hydrogels 
were characterized, as described above. These swelling ratios were compared with those 
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of the non-RGDS containing gels. No significant differences were found, indicating that 
the incorporated ACRL-PEG-RGDS had minimal impact on the relative hydrogel 
swelling ratios at the selected RGDS concentration (data not shown). 
 
Hydrogel mesh size. PEG-DA hydrogel mesh size cannot be visualized using 
techniques such as conventional scanning electron microscopy (SEM) [131]. Thus, a 
variety of methods to estimate PEG-DA hydrogel mesh size have been developed, 
including correlations linking measurable quantities, such as equilibrium hydrogel 
swelling and PEG-DA Mw, to mesh size [68, 130]. Although these correlations appear to 
yield reasonable mesh size estimates for relatively high-weight percent PEG-DA 
hydrogels [68, 130] the predictions for lower-weight percent hydrogels have been called 
into question. Thus, in this study, hydrogel mesh size was characterized via a series of 
dextran diffusion experiments based on an adaptation of the methodology of Watkins 
and Anseth [69]. 
In brief, PEG-DA hydrogels containing 2 μmol/g ACRLPEG- RGDS 
postswelling were prepared and allowed to swell overnight at 37 °C in HBS-azide. Discs 
of 1 cm diameter were cored from each hydrogel formulation. FITClabeled dextrans (10, 
20, 40, 70, or 150 kDa, Sigma) were dissolved at 0.01 mg/mL in HBS-azide and added 
at 1 mL per hydrogel disc (three discs per dextran Mw). Dextran solutions were allowed 
to diffuse into the hydrogels for 24 h at 37 °C. Each gel disc was then gently blotted and 
transferred to 1 mL fresh HBS-azide. Dextran that had penetrated into the hydrogels was 
permitted to diffuse out into the surrounding solution at 37 °C. After 24 h, the 
fluorescence of the HBS-azide solution surrounding each disc was measured at ex/em 
488/532. Dextran standard curves were used to convert each fluorescence signal to a 
corresponding concentration. 
The mesh size of each gel formulation was calculated relative to that of the 10% 
10 kDa hydrogel as follows. For each hydrogel formulation, the measured concentration 
readings for each dextran Mw were divided by gel thickness and then plotted versus 
dextran hydrodynamic radius. The area (A) under the resulting curve served as a 
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quantitative indicator of hydrogel permissivity over the hydrodynamic radii range 
assayed. The relative mesh size, μ, of hydrogel x, to that of the 10% 10 kDa gels could 
therefore be calculated as the ratio of Ax to A10% 10 kDa. To give insight into the absolute 
mesh sizes represented by these relative mesh size assessments, the 30% 10 kDa 
hydrogel served as a basis. For this gel formulation, the dextran readings fell to 
background levels for dextran Mws exceeding 20 kDa (data not shown). The 20 kDa 
dextran had a mean hydrodynamic radius of ~3.2 nm, whereas the next largest dextran 
investigated (40 kDa) had a mean hydrodynamic radius of ~4.5 nm [132]. Thus, the 
mesh size of the 30% 10 kDa hydrogel was taken to be ~(2 x 4.5) = 9 nm. For a given 
hydrogel (x), the absolute mesh size (n) can be estimated as:  nm
kDa
x
x 9
10%30
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Furthermore, cryoSEM was conducted on the 30% 20 kDa gel formulation. 
Although, as previously noted, conventional SEM does not enable visualization of PEG-
DA hydrogel mesh structure, we reasoned that cryoSEM may prevent the collapse of the 
hydrogel network that appears to accompany conventional and environmental SEM. 
Following high pressure freezing, a 30% 20 kDa sample was split under liquid nitrogen 
using a pre-chilled scapel blade. One sublimation cycle was then conducted in a Balzer 
MED-010 cryo prep vacuum chamber followed by sputter coating with 8–10 nm of 
platinum. The coated sample was then imaged at 5kV and -170 °C. The average mesh 
size observed for the 30% 20 kDa gel using cryoSEM (Figure 5.1) agrees well with ~13 
nm estimated using the above equation. 
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Figure 5.1 Initial (day 3) hydrogel material properties. (A) compressive modulus and (B) relative mesh 
size. *, indicates significant difference, p < 0.05. These dextran diffusion assessments were supplemented 
by cryoSEM imaging of the 30% 20 kDa hydrogel (inset). The mesh structure revealed in this cryoSEM 
image is in good agreement with the absolute mesh size predicted by dextran diffusion for this hydrogel 
formulation (the Table on p.76, footnote a). 
 
Hydrogel mechanical properties. Hydrogels containing 2 μmol/g ACRL-PEG-
RGDS postswelling were prepared and allowed to swell at 37 °C in HBS-azide. To 
compare PEG-DA hydrogel mechanical properties to literature values for the 
incremental tensile modulus of the normal human coronary artery media, hydrogel 
samples were measured under tension after 48 h swelling. Rectangular strips 5 mm in 
width and 2 cm in length were cut from each formulation, mounted onto an Instron 3342 
using rubber-coated grips, and pulled at 6 mm/min until failure. The incremental 
modulus was defined as the slope of the linear region of the stress–strain curve at a 
reference stress of 20 kPa.  
To assess the mechanical properties of the selected PEG-DA formulations as 
experienced by the encapsulated SMC, three additional 1.25 cm discs were cored from 
each hydrogel and mechanically tested under unconstrained compression at room 
temperature using an Instron 3342. Following application of a 0.05N preload, each 
hydrogel was subjected to compression at 1 mm/min up to 10% strain. Hydrogel 
compressive moduli were extracted from the resulting stress–strain data. 
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For both testing methods, samples remained immersed in PBS until immediately 
prior to mechanical testing, and testing was completed for each sample within 60 s. This 
rapid handling avoided sample dehydration during testing. 
 
5.3.3 Cell culture studies 
Based on the mesh size and incremental moduli measured in the above 
characterization studies, the following three hydrogel formulations were selected for 
further examination in cell encapsulation studies: (1) 10% 10 kDa, (2) 30% 20 kDa, and 
(3) 20% 10 kDa. 
 
Cell culture. Cyropreserved aortic SMCs (Cell Applications) isolated from pigs, 
a common animal model for vascular SMC physiology, [133, 134] were thawed and 
expanded in monolayer culture between passages [55, 57, 62, 91, 116, 117]. Prior to 
encapsulation, cells were maintained at 37°C/5% CO2 in Dulbecco‘s Modified Eagles‘ 
Media (DMEM, Hyclone) supplemented with 10% fetal bovine serum (FBS, Hyclone), 1 
mg/L bFGF (BD Biosciences), 100 U/mL penicillin, and 100 mg/L streptomycin 
(Hyclone). 
 
Cell encapsulation and hydrogel maintenance. SMCs at passage [57, 62]  were 
harvested and resuspended in each hydrogel precursor solution such that the 
postswelling cell density would be ~0.5 x 106 cells/mL. ACRL-PEG-RGDS was added 
to each precursor solution so that the concentration of RGDS in the swollen hydrogels 
would be 2 μmol/g. The cell-precursor solution mixtures were photopolymerized into 
hydrogels as described above. The hydrogel slabs were transferred to Omnitrays (Nunc) 
fitted with four sterile polycarbonate bars to simultaneously prevent gel flotation and 
prevent gel contact with  the tray bottom. Gels were immersed in DMEM supplemented 
with 10% FBS, 100 U/mL penicillin, and 100 mg/L streptomycin and maintained at 
37°C/5% CO2. Media was changed every 2 days. After 48 h of culture (day 3), three 
1.25 mm diameter samples were collected from each gel and subjected to the mechanical 
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compression and dextran diffusion studies detailed above. At day 21 of culture, a series 
of 1.25 cm diameter samples were collected from each hydrogel formulation for 
subsequent mechanical, biochemical, and histological analyses. 
 
Hydrogel degradation rate. A PEG-DA hydrogel is a 3D network of inter-
crosslinked PEG-DA macromers. Both the modulus and mesh size of the hydrogel are 
intimately related to the organization and density of these crosslinks. As PEG-DA 
scaffolds degrade by hydrolytic cleavage of the ester bonds between the aliphatic 
polymer backbone and the crosslinking units, [73, 135] the linkages among PEG-DA 
chains are broken. This process results in a decrease in hydrogel modulus and a 
corresponding increase in hydrogel mesh size [73]. At the relatively low cell densities 
employed in this study, changes in hydrogel modulus with time could be assumed to be 
dominated by the hydrolytic degradation of the hydrogel network rather than by ECM 
deposited by encapsulated cells. Hence, by monitoring the change in construct modulus 
with time, the degradation rate of each hydrogel network could be assessed [73]. 
To confirm our initial assumption that the selected hydrogels had similar 
degradation rates, the compressive modulus of each hydrogel formulation at day 21 was 
evaluated according to the methodology described above. The day 21 modulus data were 
compared to the initial (day 3) measures to determine a degradation half-life for each 
hydrogel formulation, assuming pseudo first-order degradation kinetics for the ester 
linkages [73, 135]. 
 
Biochemical analyses. Samples harvested for biochemical analyses were 
transferred to screw-cap vials, weighed, flash-frozen in liquid nitrogen, and stored at -
80°C. At the time of analysis, hydrogel samples were digested for 24 h at 37°C in 1 mL 
of 0.1M NaOH per 0.2 g hydrogel wet weight [75]. The samples were then centrifuged 
(8000g for 10 min), and aliquots were taken for DNA and sGAG quantification. Any 
material pelleted during centrifugation was resuspended by vortexing, and additional 
hydrolysis was carried out by transferring the samples to a 100°C oven for 90 min to 
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solubilize collagen but not elastin [75]. These samples were then centrifuged (8000g for 
10 min), and the supernatants were retrieved for collagen quantification. The pellets 
(containing elastin) were washed with dIH2O at least four times and stored at -80°C until 
use. 
DNA analysis. Aliquots of the hydrolyzed samples (n = 3–6 per formulation) 
were neutralized and their DNA content determined using the PicoGreen assay 
(Invitrogen) [75]. DNA measures were translated to cell number using a conversion 
factor of 6.6 pg DNA per cell. Calf thymus DNA (Sigma) served as a standard.  
 
Sulfated GAG analysis. sGAG production was measured using a modification of 
the Blyscan assay (Biocolor). In brief, 80 lL of each sample digest (n = 3–6 per 
formulation) was neutralized, mixed with 120 μL Blyscan dye reagent, and the 
absorbance at 525 nm immediately measured relative to chondroitin sulfate B (Sigma). 
 
Collagen analysis. Levels of hydroxyproline were quantified as an indirect 
measure of total collagen. In brief, supernatants (n = 5–6 per formulation) collected for 
collagen quantitation were hydrolyzed for 18 h at 110°C in 6M HCl. Hydrolyzed 
samples were then dried (Centrivap, Labconco) followed by resuspension in dIH2O and 
reaction with chloramine T and p-dimethylbenzaldehyde reagents [136]. Sample 
absorbance was read at 550 nm relative to that of L-4-hydroxyproline (Sigma) [136]. 
Total collagen content was estimated from measured grams of hydroxyproline by 
dividing by 0.13. 
 
Elastin analysis Elastin levels were determined according to the procedure 
detailed in Long and Tranquillo [137]. Briefly, material pelleted following 100 ºC NaOH 
exposure was further digested in 6M HCl at 110°C for 18 h. Samples (n = 3–8 per 
formulation) were then dried (Centrivap, Labconco). The resulting free amino acids were 
boiled in the presence of ninhydrin reagent (Sigma), cooled, and their absorbance read at 
570 nm [75]. Hydrolyzed α-elastin (MP Biochemicals) was used as the standard. The 
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ninhydrin-based elastin readings were verified for a subset of samples (n = 1–6 per 
formulation) using direct ELISA according to the following protocol. Undigested 
samples were hydrolyzed with 0.1M NaOH for 24 h at 37°C, neutralized, and further 
digested with 0.25M oxalic acid at 100 °C overnight. Oxalic acid was then removed and 
exchanged for PBS using Microcon YM-3 centrifugal filters (Millipore). One hundred 
microliters of the resulting samples were applied to a high binding EIA 96 well plate 
(Nunc) for 3 h at room temperature. Adsorbed elastin fragments were detected by 
applying elastin antibody (clone BA-4, Santa Cruz Biotechnology [SCBT]) followed by 
donkey anti-mouse HRP secondary antibody (SCBT) and 2,20-azino-bis(3-
ethylbenzthiazoline-6-sulphonic acid) (Sigma). Absorbance was read at 410 nm, with 
bovine aortic elastin (Sigma) serving as a standard. 
For the DNA, sGAG, hydroxyproline, and direct ELISA assays, the standards 
used were subjected to the same association with PEG-DA, hydrolysis, and processing 
conditions as the samples. Resulting collagen, elastin, and sGAG levels were normalized 
to cell number. 
 
Histological analyses. Samples harvested for histological analyses were fixed in 
10% formalin for 30 min, embedded in Tissue-Tek freezing media, and frozen at -80°C. 
Sections of 35 μm were cut using a cryomicrotome. All immunostaining steps took place 
at room temperature unless otherwise noted.  
 
Active RhoA analysis. Active RhoA was detected by a double-staining approach 
based on the method of Ren et al. [138]. The first immunostaining detected GTP-bound 
(active) RhoA/B/C, and the second staining detected RhoA (both active and inactive). 
Overlap between these two stains indicated the presence of active RhoA. In brief, 
rehydrated sections were treated with cytoskeletal buffer (10 mM HEPES, pH 6.8, 100 
mM NaCl, 3 mM MgCl2, 300 mM sucrose, 0.5% triton X-100) for 30 min. GST tagged 
rhotekin-RBD (Cytoskeleton, Inc.) was applied at 10 μg/mL for 1 h at 4°C in 50 mM 
Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1% NP-40, 1 mM DTT and 5% 
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glycerol. The sections were then blocked for 10 min with Terminator (Biocare Medical), 
after which primary antibody for GST (GST-2, Schistosoma japonicum specific, Sigma) 
diluted in HBS was applied for 2 h. Bound primary antibody was detected by application 
of donkey anti-mouse AP secondary antibody (Jackson Immunoresearch) followed by 
chromogen Ferangi Blue (Biocare Medical). The sections were then blocked with 
peroxidase (Biocare Medical) for 10 min followed by Terminator block for 10 min. 
Primary antibody for RhoA (C-15, SCBT) diluted in HBS was applied for 2 h. Bound 
primary antibody was detected by application of bovine antigoat HRP secondary 
antibody (Jackson Immunoresearch) followed by chromogen DAB (SCBT). 
Cell counting was employed to semi-quantitatively evaluate the staining results. 
For each cell, i, in a given section, the intensity of blue stain (GTP-bound RhoA/B/C), 
denoted bli, was recorded on a scale of 0–3, 0 = ‗‗no staining‘‘ and 3 = ‗‗highest 
intensity among all treatment groups for the GST antibody.‘‘ For this same cell, the 
presence of brown stain (RhoA), denoted Pi, was also recorded, 0 = ‗‗absent‘‘ and 1 = 
‗‗present.‘‘ The cumulative staining intensity for GTP-bound RhoA, Ractive, in each 
section was then calculated according to the following equation: Ractive = (Ʃbli* Pi)/(total 
cell number). 
To compare the levels of active RhoA to total RhoA, intensity assessments for 
RhoA staining were separately conducted on the same sections. For each cell, i, in a 
given section, the intensity of brown stain (RhoA), denoted bri, was recorded on a scale 
of 0–3, as above. The cumulative staining intensity for RhoA, Rtotal, in a given section 
was then calculated according to the following equation: Rtotal = (Ʃ bri)/(total cell 
number). Four sections (1000–2000 cells) per formulation were stained and counted. 
 
ECM and cell phenotype analyses. ECM deposition was analyzed in duplicate 
sections for each formulation using standard immunohistochemical technique. 
Rehydrated sections were blocked with peroxidase for 10 min followed by 10 min 
exposure to Terminator. Primary antibodies for elastin (BA-4, SCBT), collagen type I 
(Rockland Immunochemicals), or chondroitin sulfate proteoglycan (cs-56, SCBT) 
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diluted in HBS was then applied for 1 h. Bound primary antibody were detected by using 
AP-conjugated secondary antibody followed by application of the chromogen Ferangi 
Blue or by using HRP-conjugated secondary antibody followed by application of the 
chromogen AEC (Labvision). 
Immunohistochemical stainings for calponin h1 (CALP, SCBT) and two 
regulators of calponin h1 expression, SRF (G-20, SCBT) and myocardin (H-300, 
SCBT), were similarly conducted to examine SMC phenotype. Prior to Terminator 
application, SRF and myocardin sections were exposed to cytoskeletal buffer for 10 min. 
To identify cells undergoing proliferation, separate sections were stained with 
proliferating cell nuclear antigen (PCNA; PC10, Invitrogen). 
For intracellular markers of cell phenotype (SRF, myocardin, calponin h1, and 
PCNA), cell counts were conducted to semi-quantitatively evaluate immunostaining 
results. In addition, since deposited ECM remained localized around the parent cells in 
each hydrogel formulation, the relative ECM production among hydrogel formulations 
could also be evaluated by cell counts. For each cell, i, a staining intensity, di, was 
recorded on a scale of 0–3, 0 = ‗‗no staining‘‘ and 3 = ‗‗highest intensity among all 
treatment groups for that antibody.‘‘ The cumulative staining intensity, d, for a given 
antibody in a particular section was calculated using the following equation: d = (Ʃ 
di)/(total cell number). A total of 500–1000 cells were counted per formulation per 
antibody, and immunostained sections were imaged using an Axiovert 200 microscope 
(Zeiss). 
 
Cell metabolic state. To evaluate the metabolic state of encapsulated cells, 
sections were stained for glucose 6-phosphate dehydrogenase (G6PD, Abcam) or for 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH, SCBT). Both G6PD and GAPDH 
are key enzymes in cell metabolism, with GAPDH being associated with a catabolic 
pathway and G6PD being associated with a primarily anabolic pathway essential in the 
regulation of oxidative stress [139, 140]. Relative G6PD and GAPDH levels among 
formulations were probed using same intensity- based counting system used to evaluate 
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collagen type I immunostaining. As cell growth and viability are compromised by 
oxygen deprivation (hypoxia), immunostaining for hypoxia inducible factor-1α (HIF-1α; 
C-19, SCBT) was conducted. This staining was performed to ensure that observed 
differences in G6PD or GAPDH were not due to hypoxia, which could result from the 
smaller mesh sizes of the 30% 20 kDa and 20% 10 kDa formulations. 
 
5.3.4 Comparative analyses 
To gain insight into the potential dependence of ECM production (collagen and 
elastin), cell phenotype (SRF and myocardin), and cell signaling (G6PD and RhoA) on 
scaf-fold modulus and mesh size, surface plots were generated using Graphis software 
(Graphis). In these plots, the measured values for a given ECM component or 
phenotypic marker were plotted versus initial compressive modulus and mesh size. 
 
5.3.5 Statistical analyses 
Data are reported as mean ± standard error of the mean. Comparison of sample 
means was performed by ANOVA and Tukey‘s post hoc test (SPSS software), p < 0.05. 
 
5.4 Results 
The aim of this study was to validate a systematic approach for analyzing, in an 
uncoupled manner, the effects of initial scaffold mesh size and modulus on cell ECM 
production and phenotype. 
 
5.4.1 Hydrogel material properties 
To identify a set of PEG-DA hydrogels that would permit uncoupled examination 
of mesh size and modulus, six hydrogel formulations were screened. Hydrogel resistance 
to the diffusion of dextrans of various Mws was used as a quantitative indicator of 
scaffold mesh size. The resulting mesh sizes relative to that of the 10% 10 kDa gels are 
given in Table 5.1. As expected, initial mesh size increased as PEG-DA concentration 
decreased or as Mw increased [68, 130].  
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Furthermore, because cells exert significant contractile forces on their 
surrounding microenvironment during matrix remodeling, the initial compressive 
modulus of each hydrogel was characterized to assess the initial mechanical environment 
experienced by encapsulated SMC. The compressive modulus of each hydrogel ranged 
from ~30–300 kPa (Table 5.1). In agreement with previous studies, hydrogel 
compressive modulus decreased as PEG-DA Mw increased or as concentration decreased 
[75]. To directly compare the mechanical properties of the selected hydrogel 
formulations to literature values for native arteries, hydrogel incremental tensile modulus 
was also evaluated. For each gel formulation, the measured incremental tensile modulus 
matched the corresponding compressive modulus within a multiplicative factor of 1–1.2 
(data not shown), as has been observed by other investigators for PEG-DA gels [55]. 
Four of the six hydrogel compositions, namely the 10% 10 kDa, 20% 10 kDa, 30% 10 
kDa, and 30% 20 kDa gels, were within the incremental modulus range of interest 
(~100–300 kPa, see compressive modulus values in Table 5.1). Of these four 
formulations, three (10% 10 kDa, 20% 10 kDa, 30% 20 kDa) permitted uncoupled 
investigation of the impact of modulus and mesh size. Specifically, the 20% 10 kDa and 
the 30% 20 kDa hydrogels had similar initial mesh sizes but initial compressive moduli 
which differed by a factor of ~2. Conversely, the 10% 10 kDa and the 30% 20 kDa 
hydrogels had similar moduli but mesh sizes that differed by a factor of ~1.5. Thus, 
although the mesh size of a hydrogel prepared from PEG-DA of a single Mw cannot be 
tailored independently of its compressive modulus, the effects of mesh size and modulus 
can be explored in an uncoupled manner by appropriately varying both PEG-DA 
concentration and Mw. 
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Table 5.1. Modulus and relative mesh size data for six PEG-DA formulations. 
 
Formulation 
Compressive 
Modulus (kPa) 
Relative Mesh 
Size (µ)** 
10% 10kDa 110.9 ± 8.4 1.00 ± 0.04 
20% 10kDa 221.8 ± 11.0 0.65 ± 0.10 
30% 10kDa 311.1 ± 26.6 0.50 ± 0.10 
10% 20kDa 29.0 ± 7.5 1.73 ± 0.26 
20% 20kDa 54.6 ± 7.7 1.06 ± 0.08 
30% 20kDa 109 ± 10.8 0.73 ± 0.04 
Highlighted formulations indicated compositions selected for cell studies. 
aTo translate these relative mesh sizes to approximate absolute values, the mesh size of the 30% 10 kDa 
gel can be estimated as ~ 9 nm, as described in Materials and Methods. 
 
5.4.2 Cell encapsulation studies 
SMCs were encapsulated within 10% 10 kDa, 30% 20 kDa, and 20% 10 kDa 
hydrogels so as to yield a postswelling cell concentration of ~0.5 x 106 cells/g. 
Following equilibrium swelling of the cell-laden gels, samples were collected to 
characterize the initial (day 3) mechanical properties and mesh size of each formulation. 
Results are displayed in Figure 5.1. As shown by comparison of Figure 5.1 with Table 
5.1, the encapsulated cells had limited impact on hydrogel properties at the selected 
seeding density. Furthermore, SMCs were intentionally encapsulated at relatively low 
densities so that the evolution of the modulus of each hydrogel could be assumed to be 
dominated by scaffold degradation kinetics rather than by cell ECM deposition. Based 
on the modulus data at day 3 versus day 21, the mean degradation half-life of all 
hydrogel formulations was ~126 ± 4 days, assuming first-order degradation kinetics per 
Anseth et al. [73]. Thus, as each hydrogel formulation displayed a similar degradation 
rate, the rate of change in hydrogel modulus (and, hence, the rate of change in hydrogel 
mesh size) could be treated as a design ‗‗constant.‘‘ This allowed variations in SMC 
phenotype and ECM deposition with scaffold formulation to be evaluated relative to 
initial scaffold material properties without loss of information. SMC phenotype and 
ECM production will therefore be discussed referencing initial hydrogel mesh size and 
compressive modulus. 
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Cell density, proliferation, and metabolic state. PEG-DA constructs were 
harvested at day 21 for biochemical and histological analyses. No significant differences 
in net cell proliferation and loss were observed among hydrogel formulations based on 
DNA assessments (Figure 5.2(A)). Furthermore, each hydrogel composition showed a 
similar fraction of cells in a proliferative state (Figure 5.2(B)). In contrast, semi-
quantitative analysis of the expression of GAPDH, an enzyme that catalyzes the sixth 
step of glycolysis, indicated that cell metabolic activity was higher in the 10% 10 kDa 
hydrogels than in the 20% 10 kDa and 30% 20 kDa gels (p < 0.001). Examination of 
G6PD, a key enzyme in the primarily anabolic pentose phosphate pathway, supported a 
decrease in average cell metabolic activity from the 10% 10 kDa to the 30% 20 kDa gels 
(p = 0.012). A combined decrease in mesh size and increase in modulus (10% 10 kDa vs. 
20% 10 kDa gels) was associated with decreased levels of hypoxia indicator, HIF-1α (p 
= 0.017). 
 
 
Figure 5.2 Cell density, proliferation, and metabolic activity. (A) SMC density (n = 3–6 per formulation), 
(B) fraction of cells expressing proliferation marker PCNA, and (C) relative levels of GAPDH, G6PD, and 
HIF-1α among hydrogel formulations. *, significantly different from 10% 10 kDa hydrogels, p < 0.05. 
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ECM deposition. Measured collagen, sGAG, and elastin levels for each hydrogel 
formulation are given on a per cell basis in Figure 5.3. Collagen deposition was ~4- and 
~2.5-fold higher, respectively, in the 10% 10 kDa and 20% 10 kDa hydrogels than in 
30% 20 kDa gels (p < 0.001). Total sGAG content was statistically indistinguishable 
among formulations. Similarly, elastin production in the 10% 10 kDa and the 30% 20 
kDa hydrogels did not differ significantly. However, elastin levels were lower in the 
20% 10 kDa hydrogels relative to the 10% 10 kDa (p = 0.004) and the 30% 20 kDa (p = 
0.038) gels.  
 
 
Figure 5.3. SMC ECM deposition. (A) Collagen production (n = 5–6 per formulation), (B) sGAG content 
(n = 3–6 per formulation), and (C) elastin levels (n 5 4–11 per formulation). Representative images for 
elastin immunostaining are shown directly below (C), scale bar 5 40 lm. *, significantly different from 
10% 10 kDa hydrogels, p < 0.05. ζ, significantly different from 30% 20 kDa hydrogels, p < 0.05. 
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Semi-quantitative analysis of collagen type I immunostaining supported the total 
collagen biochemical assessments (Figure 5.4(A)). Although the chondroitin sulfate 
proteoglycan (CSPG) content of the 10% 10 kDa and 20% 10 kDa gels could not be 
statistically distinguished, CSPG synthesis was significantly higher in the 10% 10 kDa 
gels than in the 30% 20 kDa hydrogels (p = 0.039, Figure 5.4(A)). As expected for PEG-
DA gels, [62] collagen type I, elastin (Figure 5.3(C)), and CSPG staining was confined 
to the immediate pericellular space in each formulation, although CSPG staining in the 
10% 10 kDa gels appeared to be more diffusely present than in the remaining hydrogels.  
 
 
 
Figure 5.4 Relative intensity of collagen type I and chondroitin sulfate proteoglycan (CSPG) 
immunostaining (A). Representative images for collagen type I and CSPG immunostaining are shown in 
(B). Scale bars 5 40 μm.*, significantly different from 10% 10 kDa hydrogels, p <0.05. ζ, significantly 
different from 30% 20 kDa hydrogels, p < 0.05.  
 
SMC phenotype. Figure 5.5 illustrates results from cell counting of sections 
immunostained for SRF, myocardin, and calponin h1 toward assessment of SMC 
phenotype. Expres- sion of transcription factor SRF was significantly higher in the 10% 
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10 kDa and 20% 10 kDa hydrogels than in 30% 20 kDa hydrogels (p < 0.001 and p = 
0.002, respectively). Calponin h1 levels among formulations could not be statistically 
distinguished. Myocardin expression, however, was significantly higher in the 10% 10 
kDa hydrogels than in the 20% 10 kDa and the 30% 20 kDa gels (p < 0.001). Although 
total RhoA levels were not statistically different among formulations (data not shown), 
comparison among gels indicated a significant decrease in the fraction of active RhoA 
(Ractive/Rtotal) from the 10% 10 kDa to the 30% 20 kDa gels (p = 0.031, Figure 
5.5(D)). 
 
 
 
Figure 5.5. Relative expression of (A) SRF, (B) myocardin, and (C) calponin h1. (D) Fraction of active 
RhoA (Ractive/Rtotal) by formulation. Representative images for each immunostaining are shown under 
the respective bar graphs, scale bars = 40 μm. For the active RhoA images, blue stain indicates rhotekin 
binding (active RhoA/B/C) and brown stain indicates RhoA. Cells staining for both RhoA and rhotekin 
indicate the presence of active RhoA. *, significantly different from 10% 10 kDa hydrogels, p < 0.05, f 
significantly different from 30% 20 kDa hydrogels, p < 0.05.  
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Comparative analyses. The above observations regarding the modulation of 
ECM deposition and SMC phenotype with gel formulation are further underscored in 
Figure 5.6, which displays surface plots of total collagen and elastin (Figures 5.6(A,B), 
respectively) as well as SRF and myocar-din (Figures 5.6(C,D), respectively] versus 
modulus and mesh size. To accurately evaluate the potential impact of mesh size relative 
to that of modulus, the ECM and cell marker data were plotted such that the modulus 
and mesh size axes each spanned the same data range, that is, the high and low modulus 
plotted differed by a factor of 2, and the high and low mesh size plotted also differed by 
a factor of 2. For each graph, the maximum value of the ECM component or cell marker 
is shown in red and the minimum in blue.  
From these graphs, it is apparent that myocardin expression displayed a strong 
correlation with mesh size but only a weak correlation with modulus. This can be seen 
from the fact that the color gradient of the myocardin surface plot is at an ~75° angle to 
the mesh size axis, that is, at a given mesh size there is minimal change in myocardin 
levels (color) with a change in modulus. SRF and collagen content increased 
significantly with an increase in modulus, but increased more markedly with an increase 
in mesh size. Their greater correlation with mesh size than with modulus is reflected in 
the ~60° angle of the SRF color gradient and the ~65° angle of the collagen color 
gradient relative to their respective mesh size axes. Following a similar logic, the angle 
of the elastin color gradient lines relative to the mesh size axis (~40°) suggests that 
elastin has a similar degree of correlation with modulus and mesh size. The surface plots 
for G6PD and active RhoA were similar to that of collagen (data not shown). 
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Figure 5.6 Surface plots of (A) collagen, (B) elastin, (C) SRF, and (D) myocardin versus mesh size and 
modulus. For each graph, the maximum value of the ECM component or cell marker is shown in red and 
the minimum in blue. The axis labeled X represents modulus, whereas the axis labeled Y represents 
relative mesh size.  
 
5.5 Discussion 
Interrogation of the impact of isolated scaffold material properties on cell 
response has proven problematic due, in part, to the complexity and/or interdependence 
of scaffold variables. This situation has limited our ability to correlate specific cell 
responses to particular scaffold properties, hampering the rational selection of scaffold 
material properties so as to elicit desired cell responses. The aim of this study was to 
validate an approach for systematically evaluating the dependence of cell phenotype and 
ECM production on isolated scaffold material properties, with a focus on mesh size and 
modulus. 
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For the subset of PEG-DA hydrogels investigated herein, both SMC phenotype 
and ECM deposition exhibited marked correlations with initial hydrogel mesh size and 
modulus. For instance, CSPG production increased with increasing scaffold mesh size 
(30% 20 kDa vs. 10% 10 kDa hydrogels). Previous studies have suggested a dependence 
of sGAG levels and distribution on scaffold mesh size [62, 117]. However, these works 
noted a decrease in sGAG content with increasing mesh size, which was attributed to 
increased diffusional loss of small- to moderately-sized proteoglycans as mesh sizes 
exceeded ~9 nm.6,8 Although diffusional loss likely modulated CSPG presence to some 
extent in this work, as suggested by the increased spread of CSPG staining in the 10% 10 
kDa hydrogels relative to the lower mesh size formulations, the overall trend in CSPG 
content (increasing with increasing mesh size) is contrary to that expected if diffusion 
were the primary regulator of CSPG levels. The discrepancy between the present results 
and those of Bryant and Anseth [62, 117] may arise from differences in cell type and/or 
from the fact that hydrogel modulus and mesh size were not uncoupled variables in the 
latter works (i.e., formulations with lower mesh sizes also had higher moduli). 
Although collagen deposition was correlated with modulus (30% 20 kDa vs. 20% 
10 kDa), results suggest that mesh size may have a greater absolute impact on SMC 
collagen production than modulus, at least over the material property range probed 
(Figure 5.6). Similarly, expression of GAPDH and G6PD displayed a greater correlation 
with scaffold mesh size than with scaffold modulus. As with collagen and CSPG 
production, the mechanisms underlying the observed modulation of cell metabolic 
activity with scaffold formulation are unclear. Specifically, limitations in glucose 
transport through the hydrogel networks should not be an issue, because glucose, with a 
hydrodynamic radius ~0.4 nm, should pass rapidly and freely through the PEG-DA gels 
used herein. In addition, the decrease in G6PD and GAPDH levels with decreasing mesh 
size is unlikely to be due to hypoxia induced by decreased mesh size. Under hypoxic 
conditions, HIF-1α expression is increased so as to restore oxygen homeostasis [141]. 
However, HIF-1α levels decreased, rather than increased, with decreasing mesh size. 
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As with cell metabolic activity, RhoA activity was highly correlated with 
hydrogel mesh size, although the mechanisms by which RhoA activity depends on 
scaffold mesh size remain to be elucidated. Figure 5.5(D) also suggests that RhoA 
activity may be increased with increasing modulus at constant mesh size (30% 20 kDa 
vs. 20% 10 kDa), although this link with modulus was not statistically significant. The 
separate impact of scaffold modulus on RhoA activity therefore requires further 
confirmation. However, an increase in RhoA activity with increasing PEG-DA hydrogel 
modulus would be consistent with a number of previous 2D studies [126, 127]. 
Combined, the current data indicate that the effects of scaffold properties on RhoA 
activity in 3D may be distinct from those in 2D and underscore the need for controlled 
and uncoupled examination of the influence of scaffold properties on cell behavior in 
3D. Furthermore, these data suggest that RhoA signaling and cell metabolic regulation 
may be closely linked. This would be consistent with the known influence of RhoA 
signaling on cell metabolism, in particular on glucose transport and insulin sensitivity 
[142]. In addition, GAPDH has recently been implicated in several nonmetabolic 
processes, including transcription activation [143] and initiation of apoptosis [144]. 
The present results also suggest a correlation between RhoA and cell metabolic 
activity and the expression of transcription factor SRF, often referred to as the master 
regulator of SMC phenotype. A link between RhoA activity and SRF would be in 
agreement with previous studies indicating that RhoA influences SRF through its 
interactions with SMADs [145-148]. A link between SRF and cell metabolism would 
also be consistent with the literature. Specifically, a decrease in G6PD levels in rat glial 
cells has been associated with inhibition of the expression of inducible nitric oxide 
synthase, [149] an enzyme associated with maintenance of a mature vascular SMC 
phenotype [150]. 
Based on the present results, the 10% 10 kDa hydrogels would be the most 
beneficial of the formulations examined for the fabrication of TEVGs, in which both 
high rates of ECM production and a mature SMC phenotype are desirable. Data also 
suggest that at least short-term induction of increased RhoA activity may be desirable in 
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TEVG development. A limitation of this study is the relatively restricted initial scaffold 
mesh size/modulus range interrogated. Future experiments will explore a broader range 
of initial scaffold moduli and mesh sizes as well as probe the impact of degradation rate 
and bioactivity. An additional limitation of this approach can be seen in examining 
Figures 5.3, 5.4, and 5.5. Despite the presence of adhesion peptide RGDS, encapsulated 
SMC took on rounded or stellate morphologies when encapsulated in PEG-DA 
hydrogels. This particular characteristic of PEG-DA hydrogels, which results from their 
dense crosslinking and relatively slow degradation rates, [55, 57, 75, 117] is not optimal 
for cells such as SMC, which natively take on spindleshaped morphologies. However, 
because of several of their unique properties, PEG-DA hydrogels have been employed as 
a model scaffold by a number of researchers focusing on smooth muscle- or fibroblast- 
like cells, in spite of this limitation [75, 113, 151, 152]. In this study, the encapsulated 
cells showed the ability to display SMC marker, calponin h1, and thus the ability to 
attain certain key aspects of a native SMC phenotype, lending validity to this model 
system. 
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CHAPTER VI 
INORGANIC–ORGANIC HYBRID SCAFFOLDS FOR OSTEOCHONDRAL 
REGENERATION* 
 
 
6.1 Overview 
Ligament graft failure frequently results from poor integration of the replacement 
tissue with associated bone. Thus, the ability to regenerate the bone-ligament 
osteochondral interface would be advantageous in ligament reconstruction. At the 
osteochondral interface, the tissue transitions from a bone-like matrix to fibrocartilage. 
Therefore, a scaffold which promotes a spatially regulated transition in cell behavior 
from osteoblast-like to chondrocyte-like would be desirable. Previous research indicates 
that addition of inorganic components to organic scaffolds can enhance the deposition of 
bone-like matrix by associated osteoblasts. We therefore reasoned that a gradient in the 
inorganic content of a hybrid inorganic–organic scaffold may induce an osteochondral-
like transition in cell phenotype and matrix production. To test this hypothesis, 
hydrogels were prepared from poly(ethylene glycol) (PEG) and star 
poly(dimethylsiloxane) (PDMSstar). As anticipated, both the matrix deposition and 
phenotype of encapsulated osteoblasts varied with scaffold inorganic content, although 
the directionality of this modulation was contrary to expectation. Specifically, 
osteoblasts appeared to transdifferentiate into chondrocyte-like cells with increasing 
scaffold inorganic content, as indicated by increased chondroitin sulfate and collagen 
type II production and by upregulation of sox9, a transcription factor associated with 
chondrocytic differentiation. Furthermore, the deposition of bone-like matrix (collagen 
type I, calcium phosphate, and osteocalcin) decreased with increasing PDMSstar content. 
____________ 
*Reprinted with permission from ―Inorganic-organic hybrid scaffolds for osteochondral regeneration‖ by 
Dany J. Munoz-Pinto, Rebecca E. McMahon, Melissa A. Kanzelberer, Andrea C. Jimenez-Vergara, 
Melissa A. Grunlan and Mariah S. Hahn 2009, Journal of Biomedical Materials Research: Part A, 
Copyright 2009, Wiley Periodicals, Inc. 
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The resistance of the PDMSstar-PEG scaffolds to protein adsorption and/or the changes in 
gel modulus/mesh structure accompanying PDMSstar incorporation may underlie the 
unexpected increase in chondrocytic phenotype with increasing inorganic content. 
Combined, the present results indicate that PDMSstar-PEG hybrid gels may prove 
promising for osteochondral regeneration. 
 
6.2 Introduction 
The cruciate ligaments of the human knee withstand a variety of tensile and 
torsional forces during the course of normal daily routine and athletic activity. Damage 
can result in pain, joint instability and dysfunction, and eventual degenerative joint 
disease[153]. As such, ~150,000 surgical procedures are performed to treat injured 
anterior cruciate ligaments (ACLs) each year in the United States alone [154]. Currently, 
autologous tissue is the preferred graft material for ACL reconstruction [155]. However, 
the limited supply of autologous tissue suitable for grafting and the risk of donor site 
morbidity complicate the use of autologous grafts [156]. Tissue engineering is an 
alternative approach for ligament repair that may avoid many of limitations associated 
with autografts. 
Although rapid progress has been achieved in ligament tissue engineering over 
the past decade, engineered ligaments have, thus far, generally failed to achieve 
mechanical properties sufficiently similar to their native counterparts to serve as viable 
grafts [157]. In addition, these engineered tissues usually lack the osteochondral 
interface critical to the appropriate transfer of load between ligament and bone [157]. As 
graft failure frequently results from poor integration of the replacement tissue with 
associated bone [158], the ability to regenerate the bone-ligament osteochondral 
interface would be advantageous in ligament reconstruction. 
At the osteochondral interface, the tissue transitions from a bone-like matrix to 
fibrocartilage-like matrix [159]. Thus, a scaffold which promotes a spatially regulated 
transition in cell behavior from osteoblastlike to chondrocyte-like would be desirable for 
osteochondral regeneration [160]. For instance, a recent osteochondral tissue engineering 
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study employed a scaffold containing a spatial gradient in levels of a retrovirus encoding 
for Runx2, an osteogenic transcription factor [161]. This design induced a 
spatiallygraded transdifferentiation of associated dermal fibroblasts into osteoblast-like 
cells. Similarly, an extensive body of literature indicates that appropriately tailoring 
scaffold inorganic composition (hydroxyapatite and bioactive glass) can enhance its 
osteoconductivity [162-165]. Recently, silica-calcium phosphate (CaP) composite 
scaffolds were shown to induce increasing osteoblast alkaline phosphatase activity [166] 
and osteocalcin expression [167] with increasing silica (decreasing CaP) content. 
Another work demonstrated elevated alkaline phosphatase activity in osteoblasts 
cultured on gelatin scaffolds of increasing siloxane content [168].We therefore reasoned 
that a gradient in the siloxane content of a hybrid inorganic–organic scaffold may induce 
an osteochondral-like transition in cell phenotype. 
To test this hypothesis, we employed hydrogels composed of varying ratios of 
poly(ethylene glycol) (PEG) to star poly(dimethylsiloxane) (PDMSstar). PEG was 
selected for the organic component since spatial gradients can readily be fabricated in 
hydrogels prepared from diacrylate-derivatized PEG due to its photoactivity. For 
instance, PEG hydrogels with a continuous linear material property gradient can be 
generated by simple adaptation of the equipment normally used to make gradient 
polyacrylamide gels for electrophoresis [169] More complex spatial gradients or patterns 
can be fabricated using photolithographic techniques [61, 63, 94]. PDMS was chosen 
over other polysiloxanes due to its known biocompatibility and its widespread use in 
biomedical applications [170]. In addition, a star conformation of PDMS was selected 
over a linear form in order to reduce potential phase separation between the hydrophobic 
PDMS and hydrophilic PEG prior to hydrogel polymerization [171]. 
In this study, rat calvarial osteoblasts were encapsulated in PEG gels of varying 
PDMSstar content, and the resulting modulation of cell behavior was examined. In 
assessing cell response, biochemical and histological analyses were conducted for 
extracellular matrix (ECM) components associated with mature bone (collagen type I, 
osteocalcin, and CaP) and fibrocartilage [collagen types I and II as well as chondroitin 
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sulfate proteoglycan (CSPG)] [159]. To gain insight into the signaling underlying 
observed cell responses, immunostaining for the chondrogenic transcription factor sox9 
[172] was also performed. 
 
6.3 Materials and methods 
6.3.1 Polymer synthesis  
Synthesis of methacrylate-derivatized PDMSstar (PDMSstar-MA. Methacrylate-
derivatized star PDMS (PDMSstar-MA) was prepared via a two step synthetic strategy 
per a modification of the methodology validated in Grunlan et al. [173]. First, silane 
terminated PDMSstar (PDMSstar-SiH) was prepared by the acid-catalyzed equilibration 
of octamethylcyclotetrasiloxane with tetrakis(dimethylsiloxane)silane. The desired 
PDMSstar Mw of ~14 kDa was achieved by appropriately setting the ratio of these two 
components[173]. Briefly, octamethylcyclotetrasiloxane (30 g, 0.10 mol) and 
tetrakis(dimethylsiloxane) silane (0.5 g, 1.5 mmol) were combined in a 100 mL round 
bottom flask and purged with N2. Triflic acid (15 μL) was then added and the reaction 
was allowed to stir for 1 h at 90°C. After cooling, the pH was neutralized by combining 
with MgCO3 (0.5 g) and dichloromethane (DCM, 20 mL) and stirring for 2 h. After 
filtration through a pad of Celite, the volatiles were removed under reduced pressure. In 
this way, PDMSstar-SiH was obtained (26.3 g, 86% yield) as a colorless liquid and 
subsequently characterized by 1H NMR, 13C NMR, IR, and gel permeation 
chromatography (GPC). The silane terminal groups of PDMSstar-SiH were then 
converted into photosensitive moieties by the hydrosilylation reaction of PDMSstar-SiH 
and allyl methacrylate [174]. Briefly, PDMSstar-SiH (6 g, 0.72 mmol) was combined 
with 10 mL of dry toluene in a 100 mL round bottom flask and purged with N2. After 
Karstedt‘s catalyst (Pt-divinyltetramethyldisiloxane complex in xylene, 2% Pt; 15 μL) 
was added, the reaction was heated under constant stirring to 45 °C. Allyl methacrylate 
(0.39 mL, 2.9 mmol) was added to this solution via an addition funnel over 15 min, after 
which the reaction was heated to 90°C and stirred overnight. Completion of the reaction 
was confirmed by the disappearance of the Si—H (~2100 cm-1) absorbance in the IR 
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spectrum. The reaction mixture was decolorized by refluxing with activated carbon for 
12 h. After filtration, the volatile side products were removed under reduced pressure. In 
this way, methacrylate-derivatized PDMSstar (PDMSstar-MA) was obtained (5.23 g, 82% 
yield) and subsequently characterized by 1H NMR. 
 
Preparation of diacrylate-terminated PEG. Photosensitive acrylate groups were 
introduced to the terminal ends of linear PEG (Mw ~3.4 kDa, Sigma) per established 
protocols [94]. Briefly, PEG (10 g, 3.3 mmol) and dry DCM (50 mL) were combined in 
a 100 mL round bottom flask and purged with N2. Triethylamine (0.96 mL, 6.6 mmol) 
was added slowly to the solution followed by the dropwise addition of acryloyl chloride 
(1.08 mL, 13.2 mmol). The reaction mixture was allowed to stir at room temperature 
overnight. Removal of HCl was accomplished by washing the mixture with 2M K2CO3 
and separating into aqueous and organic phases. The organic (DCM) phase was then 
dried with anhydrous MgSO4, and diacrylate- derivatized PEG (PEG-DA) was 
precipitated in diethyl ether and dried under vacuum. In this way, PEG-DA was obtained 
and subsequently characterized by 1H NMR. 
 
Synthesis of acrylate-derivatized cell adhesion ligand. Cell adhesion peptide 
RGDS (American Peptide) was reacted with acryloyl-PEG-N-hydroxysuccinimide 
(ACRLPEG-NHS, Mw ~3.4 kDa, Nektar) at a 1:1 molar ratio for 2 h in 50 mM sodium 
bicarbonate buffer, pH 8.5 [63, 94, 167]. The product (ACRL-PEG-RGDS) was purified 
by dialysis, lyophilized, and stored at -20°C until use. 
 
6.3.2 Hydrogel fabrication 
Three distinct hydrogel precursor solutions were prepared by dissolving desired 
levels of PDMSstar-MA and PEG-DA in HEPES buffered saline (HBS; 10 mM HEPES, 
150 mM NaCl, pH 7.4). Each solution contained 10 weight percent (wt %) total polymer 
comprised of one of the following three wt ratios of PDMSstar-MA to PEG-DA: 0:100, 
1:99, and 5:95. Ten microliters of photoinitiator consisting of a 30 wt % solution of 2,2-
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dimethyl-2-phenyl-acetophenone in N-vinylpyrrolidone was added per milliliter of 
precursor solution. The resulting solutions were mixed by vortex and then filtered (0.22 
μm PES membrane, Millipore) immediately prior to being pipetted into 0.5-mmthick 
transparent rectangular molds. In addition to performing a sterilization function, the 
filtration process served to create a fine and stable dispersion of hydrophobic PDMSstar-
MA within the aqueous PEG-DA solution. The precursor solutions were polymerized by 
2 min exposure to longwave UV light (Spectroline, ~6 mW/cm2, 365 nm). 
 
6.3.3 Hydrogel characterization 
The elemental composition, surface hydrophilicity, modulus, mesh size, and 
equilibrium swelling of prepared hydrogels were characterized using established 
methods. The hydrogel samples were immersed in media or HBS for at least 24 h before 
all characterization steps, aside from bulk swelling assessments. 
 
Hydrogel composition. To verify the incorporation of varying levels of PDMSstar 
into the fabricated hydrogels, compositional analysis was performed using a Kratos Axis 
Ultra X-ray photoelectron spectrometer (XPS) with a monochromatized Mg Kα source. 
Swollen hydrogels were transferred to dIH2O for 24 h and then dried under vacuum. The 
dried gel discs were then placed onto steel gravity mounts and loaded into the XPS. 
Elemental atomic percent compositions were obtained from survey spectra, which were 
performed from 0 to 1100 eV. High-resolution analyses with pass energies of 40 eV 
were performed at a take-off angle of 90°. The binding energies were referenced to C1s 
peak at 285.0 eV. The raw data was quantified and analyzed using XPS Peak Processing 
software [175]. 
 
Contact angle and protein adsorption. The dependence of gel surface 
hydrophilicity and protein adsorption on increased PDMSstar content was evaluated. 
Static contact angle measurements were performed on swollen PDMSstar-PEG hydrogels 
using a CAM-200 (KSV Instruments) contact angle measurement system equipped with 
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an autodispenser, video camera, and dropshape analysis software. Briefly, 5 μL of dIH2O 
was dispensed onto each hydrogel surface, and the angle of the water droplet relative to 
the surface was monitored for a period of 2 min. Five separate measurements were 
performed for each hydrogel formulation.  
For protein adsorption analyses, four 6-mm diameter samples were harvested 
from swollen hydrogels of each formulation. These samples were exposed to a 50 μg/mL 
solution of AlexaFluor 488-labeled fibronectin in PBS. Fibronectin adsorption was 
selected for characterization based on previous bone tissue engineering studies [162, 
176]. Following 1 h at room temperature, the protein solutions were removed and 
exchanged with PBS. One hour and12 h after removal of the protein solution, the 
fluorescence of the hydrogel surfaces was monitored using a Zeiss Axiovert 200 
microscope and separately using a microplate reader at ex/em 488/532. Prior to each 
time point measurement, the PBS was removed and exchanged with fresh PBS. A 
fibronectin standard curve was used to convert each fluorescence signal to a protein 
concentration. 
 
Hydrogel swelling. To characterize equilibrium swelling, 8-mm diameter 
samples were cored from each PEG-DA hydrogel immediately following polymerization 
and weighed. The samples were then transferred to HBS supplemented with 0.05 wt% 
sodium azide (HBS-azide). After 24 h, samples were blotted and weighed. The swollen 
gels were then dried in vacuo and their dry weight recorded. As PEG-DA hydrogels are 
primarily water, the increase in weight with swelling can be directly related to the 
increase in gel volume (V) with swelling, i.e., 
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values were found to be 1.10 ± 0.01, 1.07 ± 0.01, and 1.11 ± 0.01 for the 0:100, 1:99, 
and 5:95 gels, respectively. These ratios were used to calculate the amount of cells and 
ACRL-PEG-RGDS to be added to each hydrogel precursor solution so as to ensure the 
desired postswelling cell density and RGDS concentration. The dry weight measures 
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were used to calculate the swelling ratio for each formulation: R = (swollen weight/dry 
weight). This ratio served as an indicator of gel crosslink density. 
 
Hydrogel mesh size. PEG-DA hydrogel mesh structure cannot be visualized 
using techniques such as conventional scanning electron microscopy (SEM) [131]. Thus, 
a variety of methods to estimate PEG-DA hydrogel mesh size have been developed, 
including correlations linking measurable quantities, such as equilibrium hydrogel 
swelling and PEG-DA Mn, to mesh size [68, 130]. Although these correlations yield 
reasonable mesh size estimates for homopolymer hydrogels, [68, 130] these correlations 
cannot readily be applied to PDMSstar-PEG hybrid hydrogels. Thus, in this study, 
hydrogel mesh size was characterized via dextran diffusion based on an adaptation of the 
methodology of Watkins et al. [69]. 
A series of PDMSstar-PEG hydrogels were prepared, each containing 1 mM 
ACRL-PEG-RGDS postswelling. These gels were allowed to swell overnight at 37°C in 
HBS-azide, after which 8 mm discs were cored from each sample. FITC-labeled dextran 
(70 kDa, Sigma) was dissolved at 0.05 mg/mL in HBS-azide and added at 1 mL per 
hydrogel disc. Dextran was then allowed to diffuse into the hydrogels for 24 h at 37°C. 
Each gel disc was gently blotted and transferred to 1 mL fresh HBS-azide. 
Dextran that had penetrated into the hydrogels was then permitted to diffuse out into the 
surrounding solution at 37°C. After 24 h, the fluorescence of the HBS-azide solution 
surrounding each disc was measured at ex/em 488/532. Dextran standard curves were 
used to convert each fluorescence signal to microgram dextran. For each gel sample, 
these dextran readings were divided by gel weight to yield a quantitative indicator of 
hydrogel permissivity (C). These permissivity measures were used to estimate the 
relative mesh size (ξ) of each hydrogel (x) as follows: 

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Hydrogel mechanical properties. PDMSstar-PEG hydrogels were prepared 
containing 1 mM ACRL-PEG-RGDS postswelling. Three 8-mm discs were cored from 
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each swollen gel and mechanically tested under unconstrained compression at room 
temperature using an Instron 3342. Following application of a 0.01 N preload, each 
hydrogel was subjected to 10 µm cyclic compression (~1% cyclic strain) at 1 Hz. The 
compressive modulus of each hydrogel was extracted from the resulting stress-strain 
data. 
 
6.3.4 Cell encapsulation studies 
Cell expansion. Cryopreserved rat calvarial osteoblasts (Dominion Pharmakine) 
were thawed and expanded at 37 ºC/5% CO2 in Dulbecco‘s Modified Eagles‘ Media 
(DMEM, Hyclone) supplemented with 10% fetal bovine serum (FBS), and 100 U/mL 
penicillin and 100 mg/L streptomycin (Hyclone). 
 
Cell encapsulation. Osteoblasts at passage 6 were harvested and combined. 
Precursor solutions containing 10 wt % total polymer were prepared by dissolving 
PDMSstar-MA and PEG-DA at ratios of 0:100, 1:99, and 5:95 in HBS followed by 
photoinitiator. These wt ratios will be used to refer to the various hydrogel formulations 
throughout the remainder of the text. ACRL-PEG-RGDS was added to each precursor 
solution to achieve 1 mM RGDS post-swelling. Each precursor solution was sterile-
filtered, immediately after which osteoblasts were added at a postswelling density of 
~3x106cells/mL. The hydrogel slabs were transferred to Omnitrays (Nunc) fitted with 
four sterile polycarbonate bars to simultaneously prevent gel flotation and prevent gel 
contact with the tray bottom. Gels were maintained at 37 °C/ 5% CO2 in DMEM 
supplemented with 10% FBS and 100 U/mL penicillin and 100 mg/L streptomycin. 
Media was changed every 2 days. 
 
Day 3 construct analyses. Following 3 days of culture to allow for complete 
hydrogel equilibration, 8-mm diameter samples were collected to characterize the initial 
mechanical properties of the cell-laden gels. These measures were conducted as 
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described earlier to assess the impact of cells on initial bulk-average hydrogel material 
properties (since hydrogel modulus, mesh size, and swelling are interdependent) [73]. 
 
Day 28 construct biochemical analyses. After 28 days total culture time, a series 
of 8-mm samples were collected from each hydrogel formulation for biochemical and 
histological analyses. Samples harvested for biochemical analyses were weighed, flash-
frozen in liquid nitrogen, and stored at -80°C. 
 
DNA and total collagen biochemical analyses. Hydrogel samples were digested 
for 72 h at 37°C in 1 mL of 0.12M NaOH per 0.2 g hydrogel wet weight. Aliquots of the 
NaOH hydrolyzed samples (n = 5 3–6 per formulation) were neutralized and their DNA 
content determined using the PicoGreen assay (Invitrogen) [75]. DNA measures were 
translated to cell number using a conversion factor of 6.6 pg DNA per cell. Calf thymus 
DNA (Sigma) served as a standard. Levels of hydroxyproline were quantified as an 
indirect measure of total collagen. NaOH digested hydrogels (n = 5 3–5 per formulation) 
were further hydrolyzed for 18 h at 110°C in 6M HCl. The samples were then dried 
(Centrivap, Labconco) followed by resuspension in dIH2O and reaction with chloramine 
T and p-dimethylbenzaldehyde reagents [101]. Sample absorbance was read at 550 nm 
relative to that of l-4-hydroxyproline (Sigma). Total collagen content was estimated 
from measured hydroxyproline  using the collagen type I conversion factor of 0.13 
grams hydroxyproline per gram collagen [77]. For each assay, the standards used were 
subjected to the same association with PEG-DA and PDMSstar-MA and the same 
digestion conditions as the samples. 
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Figure 6.1 Relative expression of (A) total collagen, (B) collagen type II, (C) collagen type I, and (D) 
chondroitin sulfate across hydrogel formulations. *, significantly different from 0:100 gels; ζ, significantly 
different from 1:99 gels. Representative images of staining for collagen type I and chondroitin sulfate are 
shown below the respective graphs. Scale bars apply to each image in the series and equal 50 μm.  
 
Calcium and alkaline phosphatase analyses. Hydrogels (n 5 2 per formulation) 
were transferred to 2 mL screw-cap microfuge tubes containing 1 mL of lysis buffer 
from the EnzoLyte FDP Alkaline Phosphatase assay kit and 1 mL of 3.2 mm stainless 
steel beads. Each sample was homogenized at 4800 rpm in a Bead-Beater homogenizer 
(Biospec) in 10 s cycles with 1 min intermediate cooling on ice. Two hundred microliter 
aliquots of each sample homogenate were analyzed for alkaline phosphatase activity 
 97 
using EnzoLyte kit reagents. Total calcium was assessed from 5 μL aliquots of each 
sample homogenate using the Calcium CPC liquid color kit (Stanbio). 
 
Day 28 histological analyses. To gain further understanding of the effects of 
hydrogel composition on the behavior of encapsulated cells, staining was conducted for 
ECM components associated with mature bone (collagen type I, osteocalcin, and CaP). 
Similarly, immunostaining for fibrocartilage-associated ECM components (collagen type 
I, collagen type II, and CSPG) and for chondrogenic transcription factor sox9 was 
carried out. Samples harvested for histological analyses were fixed with 10% formalin 
for 30 min, embeddedin freezing media (Tissue-Tek), and cut into 35 μm sections. 
 
Immunostaining. Immunostaining was conducted according to standard 
protocols. In brief, sections were blocked with peroxidase (Biocare Medical) for 30 min 
followed by Terminator (Bio-care Medical) for 10  min. Primary antibody for 
osteocalcin [FL-95, Santa Crux Biotechnology (SCBT)], collagen type I (Rockland 
Immunochemicals), collagen type II (Rockland), CSPG (cs-56, SCBT), or sox9 (H-90, 
SCBT) was then applied for 1 h following dilution in HBS. For the sox9 antibody, 
sections were permeabilized before antibody application with PBS containing 0.05% 
Triton-100X. For each antibody and hydrogel sample, 2–3 sections were stained. Bound 
primary antibody was detected by using AP-/HRP-conjugated secondary antibodies 
(Jackson Immunochemicals) followed by application of chromogen (LabVision). 
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Figure 6.2 Relative expression of (A) sox9, (B) alkaline phosphatase, (C) calcium, and (D) osteocalcin 
levels across hydrogel formulations. *, significantly different from 0:100 gels; ζ, significantly different 
from 1:99 gels. Representative images of staining for collagen type I and chondroitin sulfate are shown 
below the respective graphs. Scale bars apply to each image in the series and equal 50 μm.  
 
Van Kossa staining. To detect calcium deposits, sections were stained using a 
standard van Kossa staining kit (American MasterTech Scientific). In brief, rehydrated 
sections were rinsed with dIH2O, after which a 5% silver nitrate solution was applied. 
Sections were then exposed to full spectrum light in a humidified chamber for 45 min. 
After rinsing with dIH2O, sections were exposed to a 5% sodium thiosulfate for 2.5 min, 
briefly rinsed, and mounted. 
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Semiquantitative histological assessments. For intracellular transcription factor 
sox9, cell counts were conducted to semiquantitatively evaluate immunostaining results. 
In addition, as deposited ECM remained localized around the parent cells in each 
hydrogel formulation (Figures 6.1 and 6.2), the relative ECM protein production among 
hydrogel formulations could also be evaluated bycell counts. For each stained section 
(containing 250 cells), these semiquantitative analyses were conducted perestablished 
protocol [83, 95, 103, 104]. In brief, staining intensity, di, was recorded for each cell, i, 
on a scale of  0–3, with 0 = ‗‗no staining‘‘ and 3 = ‗‗highest staining intensity among all 
sections for that antibody‘‘. The cumulative staining intensity, d, for a given antibody in 
a particular section was calculated as: d = (Ʃdi)/(total cell number). The d values for all 
sections of a given hydrogel formulation were averaged to yield an overall sample 
average for each antibody. Immunostained samples were imaged using an Axiovert 200 
microscope (Zeiss). 
 
Table 6.1 Initial material properties of PDMSstar-PEG Hybrid Hydrogels. 
PDMSstar to PEG 
Weight Ratio 
Relative Mesh 
Size (ξ) a,b 
Modulus 
(kPa) b 
Mass Percent Si 
c
 
measured predicted 
0:100 1.0 ± 0.1    167 ± 8 0.0 0.0 
1:99 1.1 ± 0.1   142 ± 4d 0.6 0.4 
5:95 1.3 ± 0.1d 142 ± 11d 2.3 2.0 
aTo give insight into the absolute mesh sizes represented by these relative mesh size values, the mesh size 
of the 0:100 PDMSstar-PEG hydrogel was determined to be ~14 nm per Canal and Peppas [170]. 
bHydrogels contained 1 mM ACRL-PEG-RGDS postswelling. 
cThe mass percent of Si is given relative to the total mass of Si, C, and O. 
dSignificantly different from 0:100 gels, P < 0.05. 
 
6.3.5 Statistical analyses 
Data are reported as mean ± standard deviation. Comparison of sample means 
was performed by ANOVA and Tukey‘s post hoc test (SPSS software), p < 0.05. 
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6.4 Results 
In the present work, rat calvarial osteoblasts were encapsulated in a series of 
hybrid hydrogels of increasing inorganic PDMSstar content. Cell ECM production and 
phenotype were evaluated in all formulations after 28 days of culture. 
 
6.4.1 Hydrogel material properties  
Hydrogels with a 0:100, 1:99, or 5:95 wt ratio of PDMSstar to PEG were prepared 
and their initial composition, mesh size, and mechanical properties characterized. 
Results from these characterization studies are summarized in Table 6.1. For each gel 
formulation, the mass percent of Si determined by XPS was consistent with the value 
predicted from the known Mw of both polymers and the wt ratio of PDMSstar-to-PEG in 
the precursor solution. These data support the successful incorporation of PDMSstar into 
the hydrogel networks. 
The equilibrium diffusion of dextran was used to evaluate the mesh size of the 
1:99 and 5:95 gels relative to the 0:100 gels (i.e., relative to pure PEG hydrogels). Gel 
mesh size increased directionally with increasing PDMSstar content (Table 6.1). In 
contrast the compressive moduli of the 1:99 (p = 0.018) and 5:95 (p = 0.015) hydrogels 
were significantly lower than that of the 0:100 gel (Table 6.1). Cell presence did not 
significantly impact observed initial bulk modulus assessments (data not shown), as 
expected given the relatively low initial cell density employed (~3 x106 cells/mL) [36]. 
Furthermore, the swelling ratios, R, for the 0:100, 1:99, and 5:95 gels were 8.75 ± 0.03, 
8.93 ± 0.06, and 9.73 ± 0.06, respectively. Each of these material property trends was 
consistent with a reduced hydrogel crosslink density with increasing PDMSstar content 
[32]. 
As scaffold hydrophilicity [41] and protein adsorption [10, 27] have been 
demonstrated to significantly impact osteoblast behavior, the surface hydrophilicity of 
and fibronectin adsorption on each hydrogel was investigated. In agreement with the 
literature, [26, 42] contact angle measures indicated that PDMSstar-PEG hybrid scaffolds 
maintained the hydrophilic character of pure PEG gels (Table 6.2). Similarly, the 
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equilibrium (12 h) levels of fibronectin adsorption on the PDMSstar-containing gels 
were statistically indistinguishable from those on pure, ‗‗non-biofouling‘‘ PEG 
hydrogels (i.e., the 0:100PDMSstar-PEG gels, Table 6.2) [43].  Furthermore, the swelling 
ratios, R, for the 0:100, 1:99, and 5:95 gels were 8.75 ± 0.03, 8.93 ± 0.06, and 9.73 ± 
0.06, respectively. Each of these material property trends was consistent with a reduced 
hydrogel crosslink density with increasing PDMSstar content [32]. 
 
6.4.2 Cell ECM production and phenotype 
Net cell density and ECM synthesis were evaluated in each hydrogel formulation 
to probe the influence of PDMSstar levels on osteoblast behavior. Based on DNA 
measures, the cell densities in the 0:100, 1:99, and 5:95 hydrogels at day 28 were 1.93 ± 
0.11, 1.93 ± 0.25, and 2.15 ± 0.19 million cells per gram, respectively. These data 
indicate that the net cell proliferation and loss over the time course of the study was 
similar across hydrogels and consistent with previous tissue engineering studies using 
‗‗nondegradable‘‘ PEG-DA gels [44]. In contrast, osteoblast total collagen production 
showed marked variations with hydrogel composition. Specifically, the total collagen 
levels in the 0:100 (p = 0.049) and 5:95 (p = 0.006) gels were ~2 times greater than in 
the 1:99 hydrogels (Figure 6.1(A)). 
 
Table 6.2 PDMSstar-PEG hydrogel surface hydrophilicity and protein adsorption. 
PDMSstar to PEG 
Weight Ratio 
Contact Angle (°) 
Fibronectin Adsorption 
(ng/cm
2
) 
1 min 2 min 1 h 12 h 
0:100 38.8 ± 3.9 35.3 ± 4.9 48.9 ± 1.1 13.3 ± 2.3 
1:99 34.2 ± 3.4 32.0 ± 2.9 36.6 ± 3.0 14.5 ± 3.1 
5:95 37.0 ± 9.1 34.6 ± 8.5 33.0 ± 14.7 14.5 ± 3.1 
 
To gain further insight into the observed total collagen results, immunostaining 
was conducted for collagen type I (associated with mature bone and, to a lesser extent, 
with fibrocartilage) and for collagen type II (associated with fibrocartilage) [7]. These 
histological analyses revealed a modulation of collagen types I and II with gel 
formulation. Collagen type II production was significantly higher in the 5:95 hydrogels 
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relative to the 0:100 (p = 0.032) and 1:99 (p = 0.019) gels (Figure 6.1(B)). In contrast, 
collagen type I expression appeared to decrease directionally with increasing hydrogel 
inorganic content, although this trend was not statistically significant (Figure 6.1(C)). 
CSPG and sox9 (associated with fibrocartilage) as well as alkaline phosphatase, 
calcium deposits, and osteocalcin (mid-to-late term markers of bone tissue formation) 
were also assessed. CSPG levels were significantly higher in the 5:95 gels relative to the 
0:100 hydrogels (p=0.037, Figure 6.1(D)). In addition, sox9 expression increased with 
an increase in hydrogel inorganic content from 0:100 to 5:95 (p = 0.011, Figure 6.2(A)). 
Although no significant differences in alkaline phosphatase expression were noted 
among formulations (Figure 6.2(B)), van Kossa staining results revealed the levels of 
deposited calcium to be markedly higher in the 0:100 PDMSstar-PEG gels than in the 
1:99 (p < 0.001) and 5:95 (p < 0.001) gels (Figure 6.2(C)). This decrease in calcium 
deposition with increasing hydrogel inorganic content was further reflected in the results 
from the CPC assay, which yielded 0.54 ± 0.13, 0.20 ± 0.14, and 0.18 ± 0.05 ng calcium 
per cell for the 0:100, 1:99, and 5:95 gels, respectively. Similarly, osteocalcin levels 
were reduced in the 5:95 gels relative to both the 0:100 (p = 0.008) and 1:99 (p = 0.027) 
hydrogels (Figure 6.2(D)). 
 
6.5 Discussion 
This study was designed to test the hypothesis that a gradient in the siloxane 
content of a hybrid inorganic–organic scaffold would induce a transition in cell behavior 
from osteoblast-like to chondrocytelike. Both the matrix deposition and phenotype of 
encapsulated osteoblasts were indeed modulated by varying scaffold inorganic content. 
In terms of cell ECM production, increasing hydrogel PDMSstar content was associated 
with increased production of collagen type II and CSPG. This increase in the synthesis 
of fibrocartilage-like ECM components was accompanied by a decrease in cell 
production of bone-like ECM. Specifically, both osteocalcin and calcium deposition 
decreased with increasing inorganic content. To further evaluate the modulation of cell 
phenotype with scaffold composition, the relative expression of sox9, a transcription 
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factor associated with chondrocytic differentiation, was examined. Consistent with the 
trends in fibrocartilage-like matrix production, sox9 levels increased with increasing 
PDMSstar levels. Combined, the present results suggest that encapsulated osteoblasts 
were transdifferentiating into chondrocyte-like cells in the higher inorganic content 
hydrogels. 
These trends in osteoblast response are contrary to those expected based on the 
literature, which collectively supports the idea of heightened osteoinductivity with 
increasing scaffold silica/siloxane content [14, 15, 45, 46]. It is possible that the 
observed discrepancies with previous literature arise from the absence of calcium or 
phosphate in the initial PDMSstar-PEG hydrogels. For instance, Song et al. [16] observed 
a significant increase in the alkaline phosphatase levels produced by MC3T3-E1 cells 
cultured on gelatin-siloxane scaffolds relative to pure gelatin controls only when the 
gelatin-siloxane hybrids were prepared in the presence of CaCl2. However, Ning et al. 
[14] observed increased osteoblast alkaline phosphatase activity with an increase in the 
silica levels of silica-CaP composite scaffolds despite an associated decrease in scaffold 
CaP content. Similarly, the highest silica (lowest CaP) content scaffold examined by 
Gupta et al. [15] stimulated greater cell collagen type I and osteocalcin expression than 
hydroxyapatite (Ca10(PO4)6(OH)2). Thus, the impact of the absence of CaP in the initial 
PDMSstar-PEG gels is unclear. 
Another potential source of the observed discrepancies between the current 
results and previous literature is differences in the levels, identities, and orientations of 
scaffold absorbed proteins. It is now well established that cell responses to a particular 
scaffold depend not only on the initial scaffold composition but also on the scaffold 
pretreatment, hydrophilicity, and resultant protein adsorption [10, 12, 41, 47]. Both the 
contact angle and fibronectin adsorption profiles for the PDMSstar-PEG scaffolds suggest 
that these hybrid scaffolds maintain the ‗‗biological blank slate‘‘ character of pure PEG 
gels, in agreement with the literature [26, 42, 43]. The term ‗‗biological blank slate‘‘ 
refers that the fact that the adsorption of cell adhesive proteins on pure PEG gels is 
sufficiently low that cells cannot significantly attach and spread onto these hydrogels 
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without the specific addition of cell adhesion ligands [43]. This is in contrast to most 
silica-containing scaffolds, pure PDMS substrates, and native polymer scaffolds (e.g., 
gelatin) which generally adsorb significant levels bioactive proteins from serum [12, 42, 
48]. Thus, although the adhesion ligand RGDS was incorporated into the present 
PDMSstar-PEG formulations, the adsorption of serum proteins conducive to bone 
formation was likely limited. 
A limitation of this study is that the observed modulation of osteoblast responses 
cannot be defini-tively attributed to the inorganic composition of the scaffolds alone. 
Specifically, alterations in the inorganic content of the PDMSstar-PEG gels resulted in 
concomitant alterations in scaffold modulus and mesh size, both of which can influence 
cell behavior [34, 36, 49]. Indeed, just as calcium deposition is negatively correlated 
with gel PDMSstar levels, it is also negatively correlated with mesh size and positively 
correlated with modulus. Similarly, collagen type II and CSPG are positively correlated 
with hydrogel PDMSstar content and scaffold mesh size, and negatively correlated with 
modulus. Thus, it is possible that scaffold modulus and/or mesh size could be the 
primary compositional variables underlying observed cell behaviors. This limitation 
results from the Mw of the PDMSstar (~14 kDa) employed in this study relative to that of 
PEG (~3.4 kDa). That being said, the present results indicate that gradient PDMSstar-
PEG hydrogels may be promising for osteochondral tissue engineering. Future studies 
will probe the impact of a broader range of siloxane levels on osteoblast responses while 
employing a PDMSstar Mw that minimally alters base hydrogel mesh size and modulus. 
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CHAPTER VII 
INFLUENCE OF INORGANIC-ORGANIC HYBRID HYDROGELS ON 
MULTIPOTENT STEM CELL DIFFERENTIATION 
 
 
7.1 Overview 
The cellular microenvironment appears to modulate stem cell lineage 
specification. In particular, matrix stiffness and the identity and concentration of 
biochemical stimuli have been demonstrated to influence stem cell differentiation. The 
aim of the present study was to evaluate the influence of two additional matrix 
parameters, hydrophobicity and inorganic content, on the lineage progression and 
extracellular matrix (ECM) production of 10T½ mouse mesenchymal stem cells. To 
execute these studies, novel hybrid hydrogels formed from the photocure of hydrophilic 
poly(ethyleneglycol) diacrylate (PEG-DA) and methacrylated star polydimethylsiloxane 
(PDMSstar-MA) were developed so as to extend the material property range attainable by 
single component PEG hydrogels. Naive 10T½ cells were shown to commit to 
phenotypes with fine sensitivity to tissue-level hydrophobicity. Increasing scaffold 
hydrophobicity was associated with an increased percent of osteoblast-like cells. In 
contrast, levels of adipocyte-like myocoyte-like and chondrocyte-like seem to be 
unaffected across the selected formulations. This modulation of cell lineage specification 
toward osteoblast differentiation was reflected on the observed ECM deposition of 
collagen type I as well as the differentiation marker osteocalcin. 
 
7.2 Introduction 
Mesenchymal stem cells (MSCs) are naturally found in tissue and are considered 
to play an important role in cell renewal and tissue regeneration. MSCs are multipotent 
cells, capable of differentiating into different cell types including adipocytes, 
chondrocytes, myocytes and osteoblasts. Even though the plasticity potential of MSCs 
has motivated its study for tissue engineering applications, the achievement of the 
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optimal control and guidance of this exceptional ability constitutes a major challenge. 
Several works in this research area have provided insight about the effect of soluble 
factors in cell fate; however, the influence of scaffold biochemical stimuli on MSC 
differentiation still remains unclear, which in turn brings about the necessity to enhance 
the understanding of the chemical functionality of the material scaffold and its impact on 
stem cell behavior, initial protein adsorption and ultimately, cell differentiation.  
For example, some studies have already started elucidating the influence of the 
chemical character of tethered functional groups. For instance, 2D studies have revealed 
that the introduction of hydrophobic groups guides adipogenic differentiation, and that 
inorganic content through silicon or phosphate groups promotes stem cell differentiation 
into osteoblast-like cells [103, 177]. 
The main goal of this manuscript is to explore the effects of inorganic content of 
3D environments on stem cell response. In order to achieve this, we have chosen to use a 
novel organic-inorganic hydrogel system, which was previously described by Hou et al. 
[178]. This hydrogel scaffold is based on the crosslink between hydrophilic 
poly(ethylene glycol) diacrylated (PEG-DA) and hydrophobic inorganic star 
poly(dimethyl siloxane) metacrylated (PDMSstarMA). 
PEG-DA was selected because of its photoactivity, low cytotoxicity, high 
controllability and wide conjugation potential to several substrates through vinyl bone 
conjugation. On the other hand, PDMS was chosen given the fact that it is highly 
biocompatible and widely used in biomedical applications. 
The aims of the present study were: (1) to characterize the material properties of 
a set of PDMSstar-PEG hydrogel formulations which allow the study of the effect of 
inorganic content on cell behavior as well as the modulation of the 
hydrophilicity/hydrophobicity interactions, and (2) to examine the impact of these 
material property variations on the lineage specification of 10T½ mouse mesenchymal 
stem cells. 10T½ cells have been demonstrated to differentiate into a variety of cell 
types, including myocytes, smooth muscle cells (SMC), adipocytes, osteoblasts and 
chondrocytes. In analyzing 10T½ cell lineage commitment, immunostaining for various 
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mid-to-late term differentiation markers was conducted. Specifically, smooth muscle 
alpha actin (SM22α), adipocyte fatty acid binding protein (A-FABP), collagen type II, 
and osteocalcin were examined as indicators of 10T½ progression down SMC, 
adipocyte, chondrocyte, or osteoblast lineages, respectively. 
 
7.3 Material and methods 
7.3.1 Preparation of diacrylate-terminated PEG (PEG-DA)  
 Photo-sensitive acrylate groups were introduced to the terminal ends of linear 
PEG in accordance to known methods [75]. Briefly, in a 250 mL round bottom (rb) flask 
equipped with a Teflon-covered stir bar, PEG (Sigma Mn = 3.4 kDa) was dissolved in 
dry DCM (20 mL/mmol PEG) and purged with Ar. Triethylamine (Sigma, 2:1 molar 
ratio) was added slowly to the solution, followed by the dropwise addition of acryloyl 
chloride (Sigma, 4:1 molar ratio) via a syringe. The reaction mixture was allowed to stir 
at room temperature (RT) overnight. Removal of HCl was accomplished by washing the 
mixture 2X with 2M K2CO3 and separating into aqueous and organic phases. The 
organic (DCM) phase was then dried with anhydrous MgSO4 and the volatiles removed 
under reduced pressure. The resulting crude oil was precipitated in diethyl ether in an ice 
bath, filtered and dried under vacuum at RT overnight. Extent of acrylation was 
confirmed by 1H NMR. 
 
7.3.2 Synthesis of methacrylate-terminated PDMSstar (PDMSstar-MA) 
 PDMSstar-MA (Mn = 2 kDa) was prepared via a two-step synthetic strategy per a 
modification of the methodology validated in Grunlan et al. [173].  In brief, silane (SiH)-
terminated star PDMS (PDMSstar-SiH) was prepared by the acid-catalyzed equilibration 
of D4 (octamethylcyclotetrasiloxane) with tetrakis(dimethylsiloxane)silane (tetra-SiH) 
[173]. Briefly, D4 and tetra-SiH were combined in a 100 mL rb flask equipped with a 
Teflon-covered stir bar under N2 at a 4:1 molar ratio, with the ratio of D4 and tetra-SiH 
selected to yield a product of the desired Mn.. Triflic acid (0.060 L/mmol D4) was then 
added and the reaction was allowed to stir for 1 h at 90 ºC. After cooling, the mixture 
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was neutralized by combining with MgCO3 and DCM (0.020 mL/mmol D4) and stirring 
for 2 h. After filtration through a pad of Celite, the volatiles were removed under 
reduced pressure. The chemical structure and Mn of the resulting colorless product 
(PDMSstar-SiH) were confirmed by 1H NMR, 13C NMR, IR, and gel permeation 
chromatography (GPC). 
 The SiH terminal groups of the PDMSstar-SiH were converted into photo-
sensitive methacrylate moieties by the subsequent hydrosilylation reaction with allyl 
methacrylate [174]. Briefly, PDMSstar-SiH was dissolved in dry toluene using a 100 mL 
rb flask equipped with a Teflon-covered stir bar and purged with N2. Karstedt‘s catalyst 
(Pt-divinyltetramethyldisiloxane complex in xylene, 2% Pt) was added at 33 L/mmol, 
and the reaction mixture was heated to 45 ºC. Allyl methacrylate was then added via an 
addition funnel over 15 min in a 4:1 molar ratio, after which the reaction was heated to 
90 ºC and stirred overnight. Completion of the reaction was confirmed by the 
disappearance of the Si-H (~2100 cm-1) absorbance in the IR spectrum. The reaction 
mixture was decolorized by refluxing with activated carbon for 12 h. After filtration, the 
volatiles were removed under reduced pressure. The resulting product (PDMSstar-MA) 
was confirmed by 1H-NMR. 
 
7.3.3 Synthesis of acrylate-derivatized cell adhesion ligand 
Cell adhesion peptide RGDS (American Peptide) was reacted with acryloyl-
PEG-N-hydroxysuccinimide (ACRL-PEG-NHS, 3.4 kDa, Nektar) at a 1:1 molar ratio 
for 2 h in 50 mM sodium bicarbonate buffer, pH 8.5 [63, 94]. The product (ACRL-PEG-
RGDS) was purified by dialysis, lyophilized, and stored at -20 ºC until use. 
 
7.3.4 Cell culture 
Cyropreserved 10T½ mouse mesenchymal stem cells (ATCC) were thawed and 
expanded in monolayer culture. Prior to encapsulation, cells were maintained at 37 ºC 
5% CO2 in Dulbecco`s Modified Eagle‘s Media (DMEM, Hyclone) supplemented with 
10% heat-inactivated fetal bovine serum (FBS, Hyclone). 
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7.3.5 Hydrogel preparation 
PEG-PDMSstar hydrogels were prepared by the photopolymerization of aqueous 
mixtures of PEG-DA and PDMSstar-MA. A series of precursor solutions were prepared, 
each with 10 weight % (wt%) total polymer but with varying weight ratios of PEG-DA 
to PDMSstar-MA. Three weight ratios were investigated: 100:0, 95:5, and 80:20. ACRL-
PEG-RGDS was added to each solution so as to yield 1 mM RGDS in the swollen gels. 
Photoinitiator consisting of a 30 wt% solution of 2,2-dimethyl-2-phenyl-acetophenone in 
N-vinylpyrrolidone was added at 10 µL/mL of precursor solution. The resulting mixtures 
were passed through 0.22 μm PET filters, which served both to sterilize the solutions as 
well as to create a fine dispersion of hydrophobic PDMS in the aqueous PEG solutions. 
Thee dispersions, although used immediately in the present studies, were stable 
(displayed no visible phase separation) for at least several hours. The filtered precursor 
solutions were vortexed, immediately poured into 0.75 mm thick transparent rectangular 
molds, and polymerized by 6 min exposure to longwave UV light (Spectroline, ~6 
mW/cm2, 365 nm). The time between vortexing and the onset of polymerization was 
held constant at ~ 1 min to ensure consistency in sample preparation.  
 
7.3.6 Initial construct evaluation  
Hydrogel mechanical properties. Following 24 h immersion in PBS, four 8-mm 
discs were cored from each hydrogel formulation for mechanical tested under 
unconstrained compression at RT using an Instron 3342. Following application of a 0.05 
N preload, each hydrogel was subjected to 10 µm cyclic compression (~1% cyclic strain) 
at 1 Hz. The compressive modulus of each hydrogel was extracted from the resulting 
stress-strain data over a 10-20% strain range. 
 
Hydrogel mesh size.  PEG-based hydrogel mesh structure cannot be readily 
visualized using techniques such as conventional scanning electronmicroscopy (SEM). 
Thus, a variety of methods to estimate PEG-DA hydrogel mesh size have been 
developed, including correlations linking measurable quantities, such as equilibrium 
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hydrogel swelling and PEG-DA Mn, to mesh size [66, 68]. Although these correlations 
yield reasonable average mesh size estimates for homopolymer hydrogels, [66, 68] they 
cannot readily be applied to PEG-PDMSstar hybrid hydrogels. Thus, in this study, 
average hydrogel mesh size was characterized via dextran diffusion based on an 
adaptation of the methodology of Watkins et al. [69]. Briefly, four 8 mm discs were 
cored from each hydrogel formulation following 24 h swelling and immersed in 0.5 mL 
HBS-azide (HEPES-buffered saline plus 0.05 wt% azide) containing 50 µg/mL FITC-
labeled dextran (10 kDa, Sigma). Dextran was then allowed to diffuse into the hydrogels 
for 24 h at 37 ºC, after which each disc was gently blotted and transferred to 0.5 mL 
fresh HBS-azide. After 24 h at 37 ºC, the fluorescence of the HBS-azide solution 
surrounding each disc was measured at ex/em 488/532. Each fluorescence measure was 
converted to micrograms dextran using dextran standard curves and then divided by gel 
weight to yield a quantitative indicator of hydrogel permissivity (C). These permissivity 
measures were used to estimate the mesh size (ξ) of each hydrogel (x) relative to pure 
PEG-DA (A-control) as follows: 

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Serum protein adsorption. Following 24 h of swelling, twelve 21 mm discs were 
harvested from hydrogels of each formulation to evaluate the dependence of hydrogel 
serum protein adsorption on increasing PDMSstar content. Each disc samples was 
exposed to 10% FBS in PBS for 24 h at 37 °C. Non-adsorbed proteins were then 
removed by immersing he specimens in dIH2O at 37 °C for 60 min, with dIH2O changes 
every 20 min. Adsorbed proteins were then stripped from the hydrogels by progressive 
extraction with 10%, 30%, 50%, and 70% aqueous isopropanol solutions (I10, I30, I50, 
I70) at 37 °C. For each hydrogel sample, the resulting isopropanol fractions were 
combined, evaporated under vacuum, and resuspended in 500 μL of PBS. The total 
amount of protein in each fraction was quantified using the CBQCA total protein 
quantitation kit (Invitrogen).  For the purpose of comparison, the resulting protein 
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measures for each hydrogel compositiom were normalized to that of the 100:0 PEG-
PDMSstar formulation. 
 
Relative bulk hydrophilicity/hydrophobicity. Contact angle measurements are 
widely used to analyze differences in the hydrophilic/hydrophobic character of material 
surfaces. However, this method is limited to assessment of surface interactions, and 
associated results cannot generally be readily extended to bulk behavior. An alternative 
method that can be used to assess differences in the bulk hydrophilicity/hydrophobicity 
of PEG-PDMSstar hydrogels involves the comparison of hydrogel swelling in solvents of 
varying polarity. Specifically, solvents of higher polarity interact preferentially with 
hydrophilic domains of the bulk material while solvents of lower polarity show more 
affinity for hydrophobic segments of the material. Thus, differences in the relative 
uptake of solvents of distinct polarities by a given hydrogel formulation can serve as an 
indicator of its bulk hydrophilicity/hydrophobicity.  
 The bulk hydrophilicity of each PEG-PDMSstar hydrogel formulation was 
therefore evaluated by conducting swelling assays using two solvents with different 
polarity indices (P): deionized water (dIH2O; P =12.1) and 70% isopropanol in dIH2O 
(I70; P = 10.0) [179].  In brief, four discs from each hydrogel formulation were 
submerged in dIH2O or I70 for 24 h at RT, after which the swollen weight (Ws) of each 
disc was recorded.  The samples were then dried under vacuum for 48 h and their 
corresponding dry weights (Wd) measured. The equilibrium mass swelling ratio (q) of 
each formulation in each solvent (x) was calculated as 





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d
s
x
W
W
q . The relative bulk 
hydrophilicity of each hydrogel formulation was estimated as follows:
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7.3.7 Fabrication and culture of cell-laden constructs 
Mixtures containing 10 wt% total polymer at PEG-DA:PDMSstar-MA ratios of 
100:0, 95:5, and 80:20 were prepared in HBS. Following addition of ACRL-PEG-RGDS 
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(to yield a bulk RGDS concentration of 1 mM in each swollen hydrogel) and 
photoinitiator, the mixtures were sterilized by filtration. 10T½ cells were harvested and 
resuspended in each precursor solution such that the post-swelling cell density would be 
~3x106 cells/g. The resulting suspensions were polymerized into hydrogel networks by 6 
min exposure to longwave UV light (~6 mW/cm2), a process which has been 
demonstrated to be cytocompatible in a number of tissue engineering studies [62, 64, 
65]. Gels were immersed in DMEM supplemented with 10% heat-inactivated FBS, 100 
U/mL penicillin and 100 mg/L streptomycin and maintained at 37 ºC and 5% CO2. 
Media was changed every two days. 
 
7.3.8 Endpoint construct analyses 
After 21 days of culture, a series of samples were collected from each hydrogel 
formulation for biochemical and histological analyses. 
 
Biochemical analyses. Proteins were extracted from samples harvested for 
biochemical analyses either via homogenization in Trizol followed by protein isolation 
as detailed in Bulick et al.[180]  or by base hydrolysis per Liao et al. [101] Isolated 
sample proteins were analyzed as detailed below.  
 
Competitive ELISA for differentiation markers. Sample proteins isolated by 
homogenization were evaluated via competitive ELISA using antibodies for various 
mid-to-late term markers of osteogenesis (osteocalcin), chondrogenesis (collagen II), 
smooth muscle progression (SM22α), and adipogenesis (A-FABP) as well as 
housekeeping protein GAPDH. In brief, primary antibodies and their corresponding 
peptide antigens were purchased from Santa Cruz Biotechnology (SCBT). High binding 
EIA 96 well plates (Costar) were coated overnight at 4 °C with 2 ng per well of peptide 
for A-FABP (FABP4, C-15), SM22α (Transgelin, P-15), osteocalcin (M-15), or collagen 
II (Col2A1, N-19) and 1 ng per well of peptide for GAPDH (V-18). The coated wells 
were then blocked with bovine serum albumin (BSA). Peptide standards and aliquots of 
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isolated sample proteins were diluted in PBS containing 3% BSA and 0.05% Tween 20 
and incubated with primary antibody for 1 h at RT prior to transfer to the coated wells. 
Well plates were then incubated for 1 h at RT with continuous gentle mixing. For both 
samples and standards, primary antibody which had bound to the coated well surface 
was detected using an appropriate HRP-conjugated secondary antibody (Jackson 
ImmunoResearch Laboratories, JIRL), followed by application of 2,2'-azino-bis(3-
ethylbenzthiazoline-6-sulphonic acid) (ABTS, Sigma) and monitoring of absorbance at 
410 nm. Each target protein was as analyzed in duplicate/triplicate for each sample (n = 
3 – 4 per hydrogel formulation) and normalized to GAPDH. For the purposes of 
comparison, the resulting protein concentrations for each formulation were further 
normalized to the 100:0 PDMSstar-PEG hydrogels.  
 
Indirect ELISA analyses.  Proteins isolated by hydrolysis were also used for 
elastin and collagen III quantification (n = 3 per formulation per assay). collagen III 
samples and standards were applied to a high binding 96 well EIA plate for 3 h at RT, 
after which the plate was blocked with 3 wt% BSA. Following application of primary 
antibody for collagen III (Calbiochem, San Diego, CA) donkey anti-rabbit HRP 
secondary antibody (JIRL) and ABTS were applied. Absorbance was read at 410 nm, 
with human collagen III (Sigma) serving as a standard. To quantify elastin, the above 
produced was followed except that isolated sample proteins were first exposed to 0.25 M 
oxalic acid at 100 ºC overnight to convert elastin to -elastin. Oxalic acid was then 
removed and exchanged for PBS using Microcon YM-3 centrifugal filters (Millipore). 
Resulting samples were then applied to a high binding EIA 96 well plate (Nunc) for 3 h 
at RT.  Adsorbed elastin fragments were detected by applying elastin antibody (BA-4, 
SCBT), with bovine aortic elastin (Sigma) serving as a standard.  Measured elasitn and 
collagen III levels were normalized to cell number as assessed by the PicoGreen assay 
(Invitrogen). For the purposes of comparison, the resulting protein concentrations for 
each formulation were further normalized to the 100:0 PDMSstar-PEG hydrogels. 
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Hydroxyproline and Blyscan assays. Sample proteins isolated by hydrolysis were 
evaluated using standard assays for sulfated glycosaminoglycans (sGAG) and total 
collagen. sGAG production was measured using a modification of the Blyscan assay 
(Biocolor). In brief, 40 μL of sample protein (n = 4 per formulation) was neutralized, 
mixed with 60 μL Blyscan dye reagent, and the absorbance at 525 nm immediately 
measured relative to chondroitin sulfate B (Sigma). Similarly, levels of hydroxyproline 
were quantified as an indirect measure of total collagen. Sample proteins (n = 4 per 
formulation) were first further hydrolyzed for 18 h at 110 ºC in 6 M HCl. The samples 
were then dried under vacuum followed by resuspension in dIH2O and reaction with 
chloramine T and p-dimethylbenzaldehyde reagents [31]. Sample absorbance was read at 
550 nm relative to that of L-4-hydroxyproline (Sigma). Total collagen content was 
estimated from measured grams of hydroxyproline by dividing by 0.13. For both the 
total collagen and sGAG assays, standards used were subjected to the same association 
with PEG-DA and PDMSstar-MA and the same digestion conditions as the samples. 
Measured total collagen and sGAG levels were normalized to cell number as assessed by 
the PicoGreen assay (Invitrogen). For the purposes of comparison, the resulting protein 
concentrations for each formulation were further normalized to the 100:0 PDMSstar-PEG 
hydrogels. 
Histological analyses. Samples harvested for histological analyses were fixed 
with 10% formalin for 30 min, embedded in Tissue-Tek media, and cut into 35 μm 
sections. To gain insight into cell differentiation, immunohistochemical staining was 
conducted using the same A-FABP, SM22α, osteocalcin, and collagen II primary 
antibodies used for competitive ELISA analyses. After 10 min treatment with peroxidase 
(Biocare Medical), sections for were blocked with Terminator (Biocare Medical) for 30 
min followed by exposure for 1 h to primary antibody diluted in HBS. Bound primary 
antibody (SCBT) was detected by using either AP- or HRP-conjugated secondary 
antibodies (JIRL) followed by application of an appropriate chromogen 
(LabVision).Immunostained sections were imaged under brightfield using an Axiovert 
microscope (Zeiss). 
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7.3.9 Statistical analyses 
All data are reported as mean ± standard error of the mean. Comparison of 
sample means was performed by ANOVA and Tukey`s post-hoc test (SPSS software), p 
< 0.05. 
 
7.4 Results 
In the present work, mouse 10T½ cells were encapsulated in a series of PEG-
PDMSstar hydrogels. Cell phenotype was assessed in all formulations after 21 days of 
culture, a time point selected based on previous studies examining stem cell lineage 
progression in 3D materials [181]. 
 
7.4.1 Hydrogel material properties 
In order to assess the initial microenvironment experienced by encapsulated cells, 
we characterized modulus, mesh size, hydrophilicity/hydrophobicity interactions as well 
as the protein adsorption profile of each selected hydrogel formulation. Analysis of 
mechanical properties and mesh size reveals that while the modulus of the 80:20 
hydrogels was significantly lower than the 95:5 formulation (p < 0.001), its mesh size 
increased around 37%.  In addition, there were no statistic differences between the 
moduli and mesh size of the 100:0 and 95:5 formulations (Figures 7.1A and 7.1B).  
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Figure 7.1 Elastic modulus and relative mesh size. (A) Modulus. (B) Relative mesh size. 
* Significantly different from 0:100 gels, P < 0.001. 
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Increasing levels of PDMSstar-MA induced significant alterations in 
hydrophilic/hydrophobic interactions (Table 7.1), with a monotonic decrease from 100:0 
to 80:20 hydrogels (100:0 vs 95:5, p = 0.017; 100:0 vs 80:20, p = 0.001; 95:5 vs 80:20, p 
= 0.022).  Changes in PDMSstarMA levels seem to primarily control changes in 
hydrophilicity/hydrophobicity interactions as well as the enhancement of the protein 
retention profiles when compared to similar formulations in the absence of PDMSstarMA. 
Furthermore, 5% PDMSstarMA content showed a 2 fold increase while the 20% 
PDMSstarMA formulation revealed an average 5 fold increase in the total retained protein 
relative to pure PEG-DA. Hydrogels lacking PDMSstarMA content but with similar 
levels of PEG-DA showed an unchanged profile in hydrophilicity/hydrophobicity 
interactions. PDMSstarMA content appears to modulate protein adsorption through 
changes in the hydrophilicity/hydrophobicity interaction by enhancing protein retention, 
while PEG-DA content primarily modulates modulus (Table 7.1); mesh size was 
impacted by both the reduction of PEG-DA content and the increase in PDMSstarMA 
levels.  
 
Table 7.1 Hydrophilicity/Hydrophobicity interaction and protein retention. 
 
 
 
 
 
 
7.4.2 Cell differentiation 
Biochemical analysis of mid-to-late term cell differentiation into smooth muscle 
cells (SMC) (SM22α), osteoblasts (osteocalcin), adipocytes (A-FABP), and 
chondrocytes (collagen type II) indicated that encapsulated cells phenotype appeared to 
be modulated by hydrogel formulation.  ELISA analysis exposed a modulation of 
osteocalcin production with PDMSstar-MA levels. Specifically, osteocalcin expression 
Formulation 
Water 
uptake 
I70 
uptake 
H 
qwater/qI70 
Relative adsorbed 
protein 
100:0 8.0 ± 0.0 8.3 ± 0.1 0.96 ± 0.01 1.00 ± 0.18 
95:5 7.6 ± 0.0 8.4 ± 0.1 0.91 ± 0.01a 1.97 ± 0.17 
80:20 8.8 ± 0.1 10.2 ± 0.2 0.85 ± 0.02a,b 5.06 ± 0.27 
95:0 8.4 ± 0.1 8.7 ± 0.1 0.96 ± 0.01 1.12 ± 0.25 
80:0 10.0 ± 0.1 10.2 ± 0.1 0.97 ± 0.01 2.76 ± 0.68 
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seemed to increase from the 100:0 to the 80:20 hydrogels (p =0.013 and p = 0.02, 
respectively, Figure 7.2). On the other hand, increasing PDMSstar-MA levels across 
formulations did not appear to have an effect on collagen type II, AFABP and SM22α 
production. 
 
 
Figure 7.2 Relative expression of osteocalcin, AFABP, Collagen II and SM22alpha. 
 
Additional biochemical analysis (Figure 7.3) by hydroxyproline analysis, 
collagen III ELISA, GAG quantitation and elastin levels, showed significant expression 
of total collagen production. Since collagen type II and III were maintained consistent 
across formulations, the increase in total collagen production can be attributed to an 
increase in collagen type I production (another osteoblast marker) given the fact that 
collagen production is mostly composed of collagen type I, II and III in connective 
tissues.  
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Figure 7.3 Total collagen, collagen III, GAG and elastin relative production. 
 
In addition to the ELISA analysis, qualitative assessments by immunostaining 
were conducted for the selected differentiation markers. The results obtained supported 
the substantial differences in cell lineage progression with gel formulation. Specifically, 
osteocalcin levels were highest in the 80:20 hydrogels compared to the other 
formulations. In addition, collagen II and SM22α expression tended to be relatively 
consistent across formulations (Figure7.4). 
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Figure 7.4 Representative inmunostaining for osteocalcin and SM22alpha. 
 
7.5 Discussion 
We have developed a novel hydrogel system formed by the photocrosslinking of 
hydrophilic PEG-DA and hydrophobic PDMSstar-MA in order to enable the study of the 
impact of scaffold inorganic content and hydrophilicity/hydrophobicity interactions on 
cell lineage progression. In the present study, hydrogel composition was formulated such 
that the levels of ACRL-PEG-RGDS in each formulation were 1 mM after full swelling 
was achieved. Thus, in examining the modulation of cell response by PEG-PDMSstar 
hydrogel systems, we were able to consider bulk concentration and identify the 
biochemical stimulus initially presented to the cells as a design constant. Aqueous 
precursor solutions containing PDMSstar-MA were stable but slightly cloudy (hazy) 
compared to aqueous solutions containing pure PEG-DA, which indicated phase 
separation. Therefore, it is likely that PEG-PDMSstar bead-like ―islands‖ of less than 0.22 
μm size (two order of magnitude of encapsulated cells) after filtration were formed. 
Previous studies reported by Hou, Y., et al. [178] revealed that unfiltered PEG-PDMSstar 
hydrogels showed regions of crosslinked PDMSstar-MA surrounded by crosslinked PEG-
DA resulting from the phase separation of hydrophilic PEG-DA and hydrophobic 
PDMSstar-MA prior to gelation. Since the incorporated cell adhesion ligand RGDS was 
conjugated to PEG (ACRL-PEG-RGDS), the phase separation between PEG-DA and 
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PDMSstar-MA implies that the RGDS was localized primarily in the PEG regions 
surrounding the PEG-PDMSstar bead-like particles.  
In contrast, increasing incorporation of PDMSstar-MA into PEG-DA based 
hydrogels induced significant variations in scaffold hydrophilic/hydrophobic interactions 
and total protein retention. Increased hydrophobicity levels were observed with 
increased PDMSstar-MA content by comparison of the swelling behavior of the 
hydrogels in the two different solvent systems. The ratio between the more polar (water) 
to the less polar (I70) solvent was decreased by the increase in PDMSstar-MA content, 
while this ratio in gels with same levels of PEG-DA but in the absence of PDMSstar-MA 
appeared to remain constant. The observed increase in hydrophobicity with increasing 
levels of PDMSstar-MA seemed to modulate protein retention.  
It has been shown that adsorption of protein as well as protein configuration is 
affected by the hydrophilic/hydrophobic interactions of material scaffolds [182] having 
direct impact on cell behavior. Studies in 2D have demonstrated that high cell 
attachment and cell spreading are observed at intermedia levels of hydrophobicity due 
the appropriated amount of adsorbed protein as well as their configuration.  
The modulation of scaffold hydrophilicity/hydrophobicity interaction and protein 
retention appeared to contribute significantly to the lineage progression of 10T½ 
progenitor cells. In hydrogels of relatively high hydrophobicity (80-20 gels), cells 
displayed a significant preference for an osteocyte phenotype relative to the remaining 
formulations. Cells expressing higher levels of osteocalcin in 80-20 formulations were 
exposed to higher level of siloxane levels, increase in hydrophobicity as well as high 
protein retention profile. Although modulus and mesh size also may be impacting cell 
fate, the decrease in modulus should be resulting in a decrease in osteoblast cell 
phenotype, since stiffer materials are considered more appropriate for osteogenic 
scaffold [92]. Therefore, we hypothesized that a synergy effect between increase and 
mesh size, siloxane content, modulation of hydrophobicity and retention protein from 
serum, overcome the effect in reduction in modulus. Furthermore, inorganic content 
(phosphate or silane) has been reported to contribute to osteogenesis of human 
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mesenchymal stem cells (hMSC). Particularly, in 2D studies by Curran at al [177], silane 
content was reported to promote and maintain osteogenesis in the presence or absence of 
biological stimuli. Interestedly, osteoblast differentiation also seems to show high 
dependence on the initial cell state; when mature rat osteoblast were cultured in a similar 
system, Munoz-Pinto et al. [183] reported that decreasing levels in siloxane content 
promoted a more osteoblast-like cell phenotype. In addition, Liao et al. [184] show in 2D 
systems that increased hydrophilicity on flat surface as well as patterned surfaces 
promoted and maintained osteoblast phenotype of rat calvarian osteoblasts.  
On the other hand, adipogenic, chondrogenic and myogenic differentiation seem 
to be unaffected by changes in material properties at least in the range explored. 
Unexpectedly, the increasing levels of hydrophobicity of the scaffold did not lead 
adipogenic differentiation as it has been suggested by Benoit at al. [103]. This could be 
explained by the fact that increased levels of hydrophobicity were achieved by the 
increase in levels of inorganic siloxane content. 
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CHAPTER VIII 
CONCLUSIONS  
 
8.1 Summary 
The accomplished work has shown that scaffold properties impact mature cell 
phenotype. Specifically, the results indicated that VFFs were induced into an undesirable 
myofibroblast-like phenotype. Increasing levels of SM-α-actin collagen production were 
coupled with decreasing initial mesh size/increasing initial modulus. Similarly, slight 
alterations in the biochemical stimuli presented to VFF cells (HAIMW versus HAHMW) 
impacted VFF behavior, which suggests that, among the examined formulations, the 
HAHMW gels would be the most suitable system for VF regeneration. Particularly, the 
elastin and collagen composition of the HAHMW gel most closely resembled normal 
superficial LP, which contains ~40% collagen type III  and a relatively low elastin to 
collagen ratio. Furthermore, for prolonged culture times, the lower induction of a 
myofibroblastic phenotype observed in the HAHMW gels relative to the HAIMW gels is 
desirable for the inhibition of LP scar formation. 
In addition, this work has validated a systematic approach for uncoupled 
evaluation of the impact of initial scaffold modulus and mesh size on SMC responses 
toward rational TEVG scaffold design. Collagen deposition and SMC phenotype were 
strongly correlated with initial hydrogel mesh size. Modulation of RhoA and metabolic 
activity may underlie these observed correlations, although further studies are required 
to establish causation. Even though the current study has focused on the influence of 
initial scaffold modulus and mesh size on SMC behavior, the described approach can be 
expanded to include the systematic interrogation of cell responses to scaffold 
degradation rate and bioactivity and can be employed in a variety of tissue engineering 
contexts. 
Moreover, the effect of inorganic siloxane content was examined for bone and 
osteochondral tissue engineering applications. Rat calvarial osteoblasts were 
encapsulated in a series of organic PEG hydrogels of increasing inorganic PDMSstar 
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content. Osteoblasts appeared to transdifferentiate into chondrocyte-like cells with 
increasing scaffold inorganic content, as indicated by the increased chondroitin sulfate 
and collagen type II production and the upregulation of sox9. Furthermore, the 
deposition of bone-like matrix (collagen type I, calcium phosphate, and osteocalcin) 
decreased with increasing PDMSstar content. In contrast, increasing levels of inorganic 
content seemed to have a different effect on undifferentiated cells, driving mesenchymal 
stem cells toward bone-like cells. Relative production of osteocalcin and total collagen 
in 10T ½ cells seemed to be upregulated by the increase in siloxane content while levels 
of collagen type II, AFABP, SM22α specific markers for chondrocytes, adipocyte and 
myocytes respectably appears be unperturbed across selected formulations. 
 
8.2 Recommendations 
 PEG-DA hydrogels have been shown to be a useful tool in the study of the 
impact of scaffold properties on cell behavior. The explored range of mesh size and 
modulus of PEG-DA hydrogels could be expanded by the introduction of non-linear 
PEG conformations. Specifically, four-arm PEG tetraacrylated (PEG-TA) may be able to 
retain the biochemical inert character of liner PEG while offering a higher degree of 
control over mechanical properties and mesh structure. The present study also tested the 
relevance of two different HA Mw on VFF ECM production and cell phenotype. It has 
also shown the effect of inorganic content on rat osteoblast and mouse mesenchymal 
stem cell behavior.  
These results evidenced the potential of PEG-DA hydrogels as platforms for the 
study of physical and biochemical stimuli on cell behavior, which opens the window for 
more comprehensive studies that could include the incorporation of human 
mesenchymal stem cells (hMSC), given their high potential for regenerative medicine. 
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